0001213900-21-059367.txt : 20211115 0001213900-21-059367.hdr.sgml : 20211115 20211115161255 ACCESSION NUMBER: 0001213900-21-059367 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 58 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUNHYDROGEN, INC. CENTRAL INDEX KEY: 0001481028 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54437 FILM NUMBER: 211410698 BUSINESS ADDRESS: STREET 1: 10 E. YANONALI, SUITE 36 CITY: SANTA BARBARA STATE: CA ZIP: 93101 BUSINESS PHONE: 805-966-6566 MAIL ADDRESS: STREET 1: 10 E. YANONALI, SUITE 36 CITY: SANTA BARBARA STATE: CA ZIP: 93101 FORMER COMPANY: FORMER CONFORMED NAME: Hypersolar, Inc. DATE OF NAME CHANGE: 20100114 10-Q 1 f10q0921_sunhydrogeninc.htm QUARTERLY REPORT
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2021

 

or

 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM __________ TO __________

 

COMMISSION FILE NUMBER: 000-54437

 

SUNHYDROGEN, INC.

(Name of registrant in its charter)

 

Nevada   26-4298300

(State or other jurisdiction of

incorporation or organization)

   (I.R.S. Employer
Identification No.)

 

10 E. Yanonali, Suite 36, Santa Barbara, CA 93101

(Address of principal executive offices) (Zip Code)

 

Issuer’s telephone Number: (805) 966-6566

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Ticker symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer ☒ Smaller reporting company ☒
      Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No ☒

 

The number of shares of registrant’s common stock outstanding, as of November 12, 2021 was 4,029,789,187.

 

 

 

 

 

 

SUNHYDROGEN, INC.

 

INDEX

 

    Page
PART I: FINANCIAL INFORMATION    
ITEM 1:   FINANCIAL STATEMENTS   1
    Condensed Balance Sheets   1
    Condensed Statements of Operations   2
    Condensed Statements of Shareholders’ Deficit   3
    Condensed Statements of Cash Flows   4
    Notes to the Condensed Financial Statements   5
ITEM 2:   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS   15
ITEM 3:   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK   18
ITEM 4:   CONTROLS AND PROCEDURES   18
         
PART II: OTHER INFORMATION    
ITEM 1   LEGAL PROCEEDINGS   19
ITEM 1A:   RISK FACTORS   19
ITEM 2:   UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS   19
ITEM 3:   DEFAULTS UPON SENIOR SECURITIES   19
ITEM 4:   MINE SAFETY DISCLOSURES   19
ITEM 5:   OTHER INFORMATION   19
ITEM 6:   EXHIBITS   20
         
SIGNATURES   21

 

i

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

SUNHYDROGEN, INC.
CONDENSED BALANCE SHEETS

  

   September 30,
2021		   June 30,
2021		 
ASSETS        
CURRENT ASSETS        
Cash and cash equivalent  $45,493,787   $56,006,555 
Marketable securities   2,580,795    
-
 
Prepaid expenses   9,047    
-
 
TOTAL CURRENT ASSETS   48,083,629    56,006,555 
           
LONG TERM INVESTMENTS          
Marketable securities   5,812,647    
-
 
           
PROPERTY & EQUIPMENT          
Computers and peripherals   11,529    11,529 
Vehicle   155,000    155,000 
    166,529    166,529 
Less: accumulated depreciation   (21,356)   (11,072)
NET PROPERTY AND EQUIPMENT   145,173    155,457 
           
OTHER ASSETS          
Domain, net of amortization of $4,665 and $4,223, respectively   650    738 
Trademark, net of amortization of $514 and $371, respectively   628    657 
Patents, net of amortization of $24,856 and $16,250, respectively   76,287    77,928 
TOTAL OTHER ASSETS   77,565    79,323 
           
TOTAL ASSETS  $54,119,014   $56,241,335 
           
LIABILITIES AND SHAREHOLDERS’ DEFICIT          
CURRENT LIABILITIES          
Accounts payable  $127,034   $223,520 
Accrued expenses   12,056    11,912 
Accrued expenses, related party   221,583    214,820 
Accrued interest on convertible notes   262,563    282,505 
Derivative liability   85,895,178    135,247,303 
Convertible promissory notes, net of debt discount of $329,178 and $409,074, respectively   123,540    125,598 
TOTAL CURRENT LIABILITIES   86,641,954    136,105,658 
           
LONG TERM LIABILITIES          
Convertible promissory notes, net of debt discount of $0 and $0, respectively   698,082    703,000 
TOTAL LONG TERM LIABILITIES   698,082    703,000 
           
TOTAL LIABILITIES   87,340,036    136,808,658 
           
COMMIMENTS AND CONTINGENCIES (SEE NOTE 9)   
-
    
-
 
           
SHAREHOLDERS’ DEFICIT          
Preferred Stock, $0.001 par value; 5,000,000 authorized preferred shares, no shares issued or outstanding   
-
    
-
 
Common Stock, $0.001 par value; 5,000,000,000 authorized common shares 4,029,789,187 and 3,849,308,495 shares issued and outstanding, respectively   4,029,789    3,849,308 
Additional Paid in Capital   87,101,297    88,560,321 
Accumulated deficit   (124,352,108)   (172,976,952)
TOTAL SHAREHOLDERS’ DEFICIT   (33,221,022)   (80,567,323)
           
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT  $54,119,014   $56,241,335 

  

The accompanying notes are an integral part of these condensed unaudited financial statements

 

1

 

 

SUNHYDROGEN, INC.
CONDENSED STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020

 

   Three Months Ended 
   September 30,
2021		   September 30,
2020		 
REVENUE  $
-
   $
-
 
           
OPERATING EXPENSES          
Selling and Marketing   109,776    
-
 
General and administrative expenses   326,585    438,190 
Research and development cost   151,362    138,260 
Depreciation and amortization   12,043    2,036 
TOTAL OPERATING EXPENSES   599,766    578,486 
           
LOSS FROM OPERATIONS BEFORE OTHER INCOME (EXPENSES)   (599,766)   (578,486)
           
OTHER INCOME/(EXPENSES)          
Other income   17,023    
-
 
Gain (Loss) on change in derivative liability   49,352,125    (1,380,085)
Interest expense   (144,538)   (247,689)
TOTAL OTHER INCOME (EXPENSES)   49,224,610    (1,627,774)
           
NET INCOME (LOSS)  $48,624,844   $(2,206,260)
           
BASIC EARNINGS (LOSS) PER SHARE  $0.01   $(0.00)
           
DILUTED EARNINGS (LOSS) PER SHARE  $0.01   $(0.00)
           
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING          
BASIC   4,000,362,987    2,139,179,833 
DILUTED   5,523,313,069    2,139,179,833 

   

The accompanying notes are an integral part of these condensed unaudited financial statements

 

2

 

 

SUNHYDROGEN, INC.
CONDENSED STATEMENTS OF SHAREHOLDERS’ DEFICIT
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020

 

   THREE MONTHS ENDED SEPTEMBER 30, 2020 
                   Additional         
   Preferred stock   Common stock   Paid-in   Accumulated     
   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
Balance at June 30, 2020   
-
   $
-
    2,053,410,161   $2,053,410   $11,664,657   $(75,550,515)  $(61,832,448)
                                    
Issuance of common stock for conversion of debt and accrued interest   
-
    
-
    35,573,090    35,573    764,427    
-
    800,000 
                                    
Issuance of common stock for services   
-
    
-
    79,908,088    79,908    177,327    
-
    257,235 
                                    
Issuance of common stock for services   
-
    
-
    2,813,903    2,814    85,487    
-
    88,301 
                                    
Stock based compensation expense   -    
-
    -    
-
    112,035    
-
    112,035 
                                    
Net Loss   -    
-
    -    
-
    
-
    (2,206,260)   (2,206,260)
                                    
Balance at September 30, 2020 (unaudited)   
-
   $
-
    2,171,705,242   $2,171,705   $12,803,933   $(77,756,775)  $(62,781,137)

  

    THREE MONTH ENDED SEPTEMBER 30, 2021  
                            Additional              
    Preferred stock     Common stock     Paid-in     Accumulated        
    Shares     Amount     Shares     Amount     Capital     Deficit     Total  
Balance at June 30, 2021    
-
     $
-
       3,849,308,495     $ 3,849,308     $ 88,560,321     $ (172,976,952 )   $ (80,567,323 )
                                                         
Issuance of common stock for conversion of debt and accrued interest    
-
      
-
       180,480,692       180,481       (9,024 )    
-
       171,457  
                                                         
Stock options redeemed by Company     -      
-
       -      
-
       (1,450,000 )    
-
       (1,450,000 )
                                                         
Net Income     -      
-
       -      
-
      
-
       48,624,844       48,624,844  
                                                         
Balance at September 30, 2021 (unaudited)    
-
     $
-
       4,029,789,187     $ 4,029,789     $ 87,101,297     $ (124,352,108 )   $ (33,221,022 )

 

 

The accompanying notes are an integral part of these condensed unaudited financial statements

 

3

 

 

SUNHYDROGEN, INC.
CONDENSED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020

  

   Three Months Ended 
   September 30,
2021		   September 30,
2020		 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net Income (loss)  $48,624,844   $(2,206,260)
Adjustment to reconcile net income (loss) to net cash (used in) provided by operating activities          
Depreciation & amortization expense   12,043    2,036 
Stock based compensation expense   
-
    112,035 
Stock issued for services   
-
    88,301 
Net (Gain) Loss on change in derivative liability   (49,352,125)   1,380,085 
Amortization of debt discount recorded as interest expense   113,425    199,024 
Change in assets and liabilities :          
Prepaid expense   (9,047)   (3,167)
Accounts payable   (96,486)   (76,515)
Accrued expenses   6,907    11,861 
Accrued interest on convertible notes   31,114    48,234 
NET CASH USED IN OPERATING ACTIVITIES   (669,326)   (444,366)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchase of marketable securities   (8,393,442)   
-
 
Purchase of property and equipment   
-
    (50,000)
NET CASH USED IN INVESTING ACTIVITIES:   (8,393,442)   (50,000)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Redemption of related parties stock options   (1,450,000)   
-
 
Net proceeds from common stock purchase agreements   
-
    800,000 
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES   (1,450,000)   800,000 
           
NET INCREASE (DECREASE) IN CASH   (10,512,768)   305,634 
CASH, BEGINNING OF PERIOD   56,006,555    195,010 
CASH, END OF PERIOD  $45,493,787   $500,644 
           
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION          
Interest paid  $
-
   $2,249 
Taxes paid  $
-
   $
-
 
           
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS          
Fair value of common stock upon conversion of convertible notes, and accrued interest  $171,457   $257,235 

 

The accompanying notes are an integral part of these condensed unaudited financial statements

 

4

 

 

SUNHYDROGEN, INC.

CONDENSED NOTES TO FINANCIAL STATEMENTS – UNAUDITED

SEPTEMBER 30, 2021 AND 2020

 

1.Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ended June 30, 2022. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended June 30, 2021.

 

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies of SunHydrogen, Inc. is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

 

Cash and Cash Equivalent

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

 

Investments

 

The Company considers corporate bonds (“bonds”) as investments due to their ratings. The bonds are rated based on their default probability, health of the corporation’s debt structure, as well as the overall health of the economy. The bonds fall into the category as investments if they have a rating of AAA and BBB.

 

The bonds have varied due dates and were classified as current and noncurrent, based on to their maturity dates. The bonds are generally valued using quoted prices and are classified in Level 2 of the fair value hierarchy as prices are not always from active markets. We consider our investments held to maturity and we believe there are no other than temporary declines in fair value. Our investments are recorded at historical cost.

 

Use of Estimates

 

In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Binomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates.

 

Property and Equipment

 

Property and equipment are stated at cost and are depreciated using straight line over its estimated useful lives.

 

Computers and peripheral equipment   5 Years 
Vehicle   5 Years 

 

The Company recognized depreciation expense of $10,284 and $278 for the three months ended September 30, 2021 and 2020, respectively. 

 

5

 

 

SUNHYDROGEN, INC.

CONDENSED NOTES TO FINANCIAL STATEMENTS – UNAUDITED

SEPTEMBER 30, 2021 AND 2020

 

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Intangible Assets

 

The Company has patent applications to protect the inventions and processes behind its proprietary solar-to-hydrogen based technology. Intangible assets that have finite useful lives continue to be amortized over their useful lives.

 

The Company recognized amortization expense of $1,758 and $1,758 for the three months ended September 30, 2021 and 2020, respectively. 

 

Net Earnings (Loss) per Share Calculations

 

Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5). 

 

September 30, 2021 

 

For the three months ended September 30, 2021, the Company calculated the dilutive impact of the outstanding stock options of 157,965,711, common stock purchase warrants of 94,895,239, and the convertible debt of $1,150,800, which is convertible into shares of common stock. The stock options were not included, because their impact was antidilutive.

 

September 30, 2020

 

For the three months ended September 30, 2020, the Company calculated the dilutive impact of the outstanding stock options of 186,000,000, and the convertible debt of $1,797,000, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. 

 

Equity Incentive Plan and Stock Options

 

Equity Incentive Plan

 

On December 17, 2018, the Board of Directors approved and adopted the 2019 Equity Incentive Plan (“the Plan”), with 300,000,000 shares reserved for issuance pursuant to the Plan. The purpose of the Plan is to promote the success of the Corporation and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. The awards are performance-based compensation that are granted under the Plan as incentive stock options (ISO) or nonqualified stock options. The per share exercise price for each option shall not be less than 100% of the fair market value of a share of common stock on the date of grant of the option. The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing cost. The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date. The options are exercisable into common stock.

 

As of September 30, 2021, there were 157,965,711 stock options issued, and a reserve of 142,034,289.

 

6

 

 

SUNHYDROGEN, INC.

CONDENSED NOTES TO FINANCIAL STATEMENTS – UNAUDITED

SEPTEMBER 30, 2021 AND 2020

 

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Stock Based Compensation

 

The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date.

 

Warrant Accounting 

 

The Company accounts for the warrants to purchase shares of common stock using the estimated fair value on the date of issuance as calculated using the Black-Scholes valuation model.

 

Fair Value of Financial Instruments

 

Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized on the balance sheet, where it is practicable to estimate that value. As of September 30, 2021, the amounts reported for cash, accrued interest and other expenses, notes payables, convertible notes, and derivative liability approximate the fair value because of their short maturities.

 

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

 

●Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets.

 

●Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active.

 

●Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows on September 30, 2021 (See Note 6):

 

   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                    
Corporate bonds  $8,393,442   $
-
   $8,393,442   $
-
 
Liabilities:                    
Derivative liability measured at fair value  $85,895,178   $
-
   $
-
   $85,895,178 

 

7

 

 

SUNHYDROGEN, INC.

CONDENSED NOTES TO FINANCIAL STATEMENTS – UNAUDITED

SEPTEMBER 30, 2021 AND 2020

 

2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Fair Value of Financial Instruments (Continued)

 

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:

 

Balance as of June 30, 2021   135,247,303 
Gain on change in derivative liability   (49,352,125)
Balance as of September 30, 2021  $85,895,178 

 

Research and Development

 

Research and development costs are expensed as incurred. Total research and development costs were $151,362 and $138,260 for the three months ended September 30, 2021 and 2020, respectively.

 

Accounting for Derivatives

 

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates.

 

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 

Recently Issued Accounting Pronouncements

 

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements as of September 30, 2021.

 

3.CAPITAL STOCK

 

Three months ended September 30, 2021

 

During the three months ended September 30, 2021, the Company issued 180,480,692 shares of common stock upon conversion of convertible notes in the amount of $120,400 of principal, plus accrued interest of $51,057 based upon a conversion price of $0.00095 per share. The notes were converted per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded.

 

Three months ended September 30, 2020

 

During the three months ended September 30, 2020, the Company issued 35,573,090 shares of common stock for cash for aggregate gross proceeds of $800,000.

 

During the three months ended September 30, 2020, the Company issued 79,908,088 shares of common stock upon conversion of convertible notes in the amount of $233,000 in principal, plus accrued interest of $23,335 and other fees of $900 based upon conversion prices ranging from $0.00095 - $0.017995 per share. All note conversions were performed per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded.

 

During the three months ended September 30, 2020, the Company issued 2,813,903 shares of common stock for services rendered at fair value prices of $0.028 - $0.035 per share in the aggregate amount of $88,301.

 

8

 

 

SUNHYDROGEN, INC.

CONDENSED NOTES TO FINANCIAL STATEMENTS – UNAUDITED

SEPTEMBER 30, 2021 AND 2020

 

4.OPTIONS AND WARRANTS

 

As of September 30, 2020, 10,000,000 non-qualified common stock options were outstanding. Each option expires on the date specified in the option agreement, which date is not later than the fifth (5th) anniversary from the grant date of the options. Of the 10,000,000 non-qualified common stock options, one-third vest immediately, and one-third vest the second and third year, such that, the options are fully vested with a maturity date of October 2, 2022 and are exercisable at an exercise price of $0.01 per share.

 

On January 23, 2019, the Company issued 170,000,000 stock options. One-third of the options vested immediately, and the remainder vest 1/24 per month over the first twenty-four months following the option grant. The options expire 10 years from the initial grant date. The options fully vest by January 23, 2022

 

On January 31, 2019, the Company issued 6,000,000 stock options, of which two-third (2/3) vest immediately, and the remaining amount shall vest one-twelfth (1/12) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on January 31, 2020.

 

On July 22, 2019, the Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on July 22, 2020.

 

A summary of the Company’s stock option activity and related information follows:

 

   9/30/21   9/30/2020 
       Weighted       Weighted 
   Number   average   Number   average 
   Of   exercise   of   exercise 
   Options   price   Options   price 
Outstanding, beginning of period   182,853,174   $0.01    196,250,000   $0.01 
Granted   
-
   $0.01    
-
   $
-
 
Exercised   
-
    
-
    
-
    
-
 

Buyback of options

   (24,887,463)  $0.0099    (250,000)   0.01 
Outstanding, end of period   157,965,711   $0.0089    196,000,000   $0.01 
Exercisable at the end of period   157,965,711   $0.0089    174,332,250   $0.01 

 

During the three months ended September 30, 2021, the Company bought back a total of 24,887,463 of the Company’s stock options for a total of $1,450,000. The options were bought back for the market price at the date of the buy back less the exercise price of the grant similar to a cashless feature. All options that were bought back were fully vested and previously expensed accordingly.

 

The weighted average remaining contractual life of options outstanding as of September 30, 2021 and 2020 was as follows: 

 

9/30/2021   9/30/2020 
Exercise
Price		   Stock Options
Outstanding		   Stock Options
Exercisable		   Weighted Average Remaining
Contractual Life
(years)		   Exercise
Price		   Stock Options
Outstanding		   Stock Options
Exercisable		   Weighted Average Remaining
Contractual Life
(years)		 
$0.0100    3,071,212    3,071,212    1.01   $0.0100    10,000,000    10,000,000    2.01 
$0.0097    6,000,000    6,000,000    4.34    0.0097    6,000,000    6,000,000    5.32 
$0.0099    138,894,499    138,894,499    4.32   $0.0099    170,000,000    157,110,167    5.34 
$0.0060    10,000,000    10,000,000    4.81   $0.0060    10,000,000    7,222,083    5.81 
      157,965,711    157,965,711              196,250,000    180,332,250      

 

The stock-based compensation expense recognized in the statement of operations during the three months ended September 30, 2021 and 2020, related to the granting of these options was $0 and $112,035, respectively.

 

9

 

 

SUNHYDROGEN, INC.

CONDENSED NOTES TO FINANCIAL STATEMENTS – UNAUDITED

SEPTEMBER 30, 2021 AND 2020

 

4.OPTIONS AND WARRANTS (Continued)

 

WARRANTS

 

As of September 30, 2021, the Company had an aggregate of 94,895,239 common stock purchase warrants outstanding, with exercise prices ranging from $0.0938 - $0.13125 per share. The warrants were estimated at fair value on the date of issuance as calculated using the Black-Scholes valuation model. The warrants can be exercised over a three (3) year period.

 

A summary of the Company’s warrant activity and related information follows for the three months ended September 30, 2021. 

 

   9/30/21 
       Weighted 
   Number   average 
   of   exercise 
   Warrants   price 
Outstanding, beginning of period   94,895,239   $0.11 
Granted   
-
    
-
 
Exercised   
-
    
-
 
Forfeited/Expired   
-
    
-
 
Outstanding, end of period   94,895,239   $0.11 
Exercisable at the end of period   94,895,239   $0.11 

 

 

9/30/2021   Weighted
Average
Remaining		 
Exercise
Price		   Warrants
Outstanding		   Warrants
Exercisable		   Contractual
Life (years)		 
$0.0938    16,800,000    16,800,000   1.67 - 2.25 
$0.13125    6,666,667    6,666,667   4.41 
$0.12    71,428,572    71,428,572   4.42 
      94,895,239    94,895,239     

 

At September 30, 2021, the aggregate intrinsic value of the warrants outstanding was $0.

 

5.CONVERTIBLE PROMISSORY NOTES

 

As of September 30, 2021, the outstanding convertible promissory notes net of debt discount are summarized as follows:

 

Convertible Promissory Notes, net of debt discount  $821,622 
Less current portion   123,540 
Total long-term liabilities  $698,082 

 

Maturities of long-term debt for the next four years are as follows:

 

Period Ended September  Amount 
2022  $152,800 
2023   888,000 
2024   100,000 
2025   10,000 
   $1,150,800 

 

10

 

 

SUNHYDROGEN, INC.

CONDENSED NOTES TO FINANCIAL STATEMENTS – UNAUDITED

SEPTEMBER 30, 2021 AND 2020

 

5.CONVERTIBLE PROMISSORY NOTES (Continued)

 

At September 30, 2021, the $1,150,800 in convertible promissory notes had a remaining debt discount of $329,178, leaving a net balance of $821,622.

 

The Company issued a 10% convertible promissory note on February 3, 2017 (the “Feb 2017 Note”) in the aggregate principal amount of up to $500,000. The Company received tranches for an aggregate principal total of $500,000. The Feb 2017 Note had a maturity date of February 3, 2018, the investor extended the Feb 2017 Note for an additional sixty (60) months from the effective date of the note, which matures on February 3, 2022. The Feb 2017 Note is convertible into shares of common stock of the Company at a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Feb 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. During the period ended on September 30, 2021, the Company issued 180,480,692 shares of common stock upon conversion of principal in the amount of $120,400, plus accrued interest of $51,057. The balance of the Feb 2017 Note as of September 30, 2021 was $187,800.

 

The Company issued a 10% convertible promissory note on November 9, 2017 (the “Nov 2017 Note”) in the aggregate principal amount of up to $500,000. The Company received tranches for an aggregate principal total of $500,000. The Nov 2017 Note had a maturity date of November 9, 2018, with an automatic extension of sixty (60) months from the effective date of the note. The Nov 2017 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Nov 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The balance of the Nov 2017 Note as of September 30, 2021 was $313,000.

 

The Company issued a 10% convertible promissory note on June 27, 2018 (the “Jun 2018 Note”) in the aggregate principal amount of up to $500,000. The Company received tranches for an aggregate principal total of $500,000. The Jun 2018 Note matured on June 27, 2019, which was automatically extended for sixty (60) months from the effective date of the note. The Jun 2018 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Jun 2018 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $103,342 during the three months ended September 30, 2021. The balance of the Jun 2018 Note as of September 30, 2021 was $500,000.

 

11

 

 

SUNHYDROGEN, INC.

CONDENSED NOTES TO FINANCIAL STATEMENTS – UNAUDITED

SEPTEMBER 30, 2021 AND 2020

 

5.CONVERTIBLE PROMISSORY NOTES (Continued)

 

The Company issued a 10% convertible promissory note on August 10, 2018 (the “Aug 2018 Note”) in the aggregate principal amount of up to $100,000. The Aug 2018 Note had a maturity date of August 10, 2019, with an extension of sixty (60) months from the date of the note. The Aug 2018 Note matures on August 10, 2023. The Aug 2018 Note may be converted into shares of the Company’s common stock at a conversion price of the lesser of a) $0.005 per share or b) sixty-one (61%) percent of the lowest trading price per common stock recorded on any trade day after the effective date. The conversion feature of the Aug 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The balance of the Aug 2018 Note as of September 30, 2021 was $100,000.

 

On April 15, 2020, the Company issued a convertible promissory note (the “Apr 2020 Note”) to an investor in the aggregate principal amount of $50,000. The Company received tranches for an aggregate principal total of $50,000. The Apr 2020 Note matures twelve (12) months from the effective dates of each respective tranche, such that the Apr 2020 Note matures on April 15, 2021, with an automatic extension of sixty (60) months from the effective date of each tranche. The Apr Note is convertible into shares of common stock of the Company at a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price of the common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of four (4) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Apr 2020 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the fourth business day (inclusive of the day of the conversion) until the shares are delivered. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Apr 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $10,083 during the three months ended September 30, 2021. The balance of the Apr 2020 Note as of September 30, 2021 was $50,000.

 

All note conversions were performed per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded.

 

6.DERIVATIVE LIABILITIES

 

ASC Topic 815 provides guidance applicable to convertible debt issued by the Company in instances where the number into which the debt can be converted is not fixed. For example, when a convertible debt converts at a discount to market based on the stock price on the date of conversion, ASC Topic 815 requires that the embedded conversion option of the convertible debt be bifurcated from the host contract and recorded at their fair value. In accounting for derivatives under accounting standards, the Company recorded a liability representing the estimated present value of the conversion feature considering the historic volatility of the Company’s stock, and a discount representing the imputed interest associated with the embedded derivative. The discount is amortized over the life of the convertible debt, and the derivative liability is adjusted periodically according to stock price fluctuations.

 

The convertible notes (the “Notes”) issued do not have fixed settlement provisions because their conversion prices are not fixed. The conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.

 

During the three months ended September 30, 2021, the Company recorded a net gain in change in derivative of $49,352,125 in the statement of operations due to the change in fair value of the remaining notes, for the three months ended September 30, 2021.

 

At September 30, 2021, the fair value of the derivative liability was $85,895,178.

 

12

 

 

SUNHYDROGEN, INC.

CONDENSED NOTES TO FINANCIAL STATEMENTS – UNAUDITED

SEPTEMBER 30, 2021 AND 2020

 

6.DERIVATIVE LIABILITIES (Continued)

 

For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Binomial lattice formula. The significant assumptions used in the Binomial lattice formula of the derivatives are as follows:

 

Risk free interest rate  0.09% - 0.35% 
Stock volatility factor  153.0% - 243.0% 
Weighted average expected option life  3 months - 5 year 
Expected dividend yield  None 

 

7.MARKETABLE SECURITIES

 

During the period ended September 30, 2021, the Company invested in corporate bonds, which have been recognized in the financial statements at historical cost.

 

The Company considers corporate bonds (“bonds”) as investments due to their ratings. The bonds are rated based on their default probability, health of the corporation’s debt structure, as well as the overall health of the economy. The bonds fall into the category as investments if they have a rating between AAA and BBB.

 

As of September 30, 2021, the components of the Company’s cash and short and long-term investments are summarized as follows:

 

Cash    
Cash and cash equivalents  $45,493,787 
      
Short term investments:     
Bonds (held-to-maturity)   2,580,795 
      
Long term investments:     
Bonds (held-to-maturity)   5,812,647 
Total cash and short and long-term investments  $53,887,229 

 

The Company has invested in bonds maturing from April 1, 2022 through August 16, 2023 that are held to maturity. The current trading prices or fair market value of the bonds vary, and we believe any decline in fair value is temporary. All bonds are current and not in default.

 

The following table summarizes the amortized cost of the held-to-maturity bonds at September 30, 2021, aggregated by credit quality indicator.

 

Credit Quality Indicators for the Corporate Bonds    
AA/A  $2,629,275 
BBB  $5,764,167 
Total  $8,393,442 

 

The amortized cost of our corporate bonds and the related gross unrealized gains and losses, were as follows at September 30, 2021:

 

            Gross Unrealized     
    Level   Cost   Gains   Losses   Fair Value 
Bonds    2    8,393,442    
-
    (77,735)  $8,315,707 

 

During the period ended September 30, 2021, the Company recognized interest income of $11,625 in the financial statements.

 

13

 

 

SUNHYDROGEN, INC.

CONDENSED NOTES TO FINANCIAL STATEMENTS – UNAUDITED

SEPTEMBER 30, 2021 AND 2020

 

8.COMMITMENTS AND CONTINGENCIES

 

On September 15, 2020, the Company entered into a marketing agreement. The fees are to be paid in cash and registered unrestricted stock. As of September 30, 2021, the Company has paid a $34,250 deposit, with the balance of the payments and the stock issuances due upon completion of a deliverable.

 

Effective September 1, 2021, the Company entered into a new research agreement with the University of Iowa. As consideration under the research agreement, the University of Iowa will receive a maximum of $350,000 from the Company. The contract period is from September 1, 2021 through August 31, 2022. The research agreement may be terminated by either party upon sixty (60) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. This agreement was signed by the Company on September 13, 2021. As of September 30, 2021, the Company has accrued the amount due of $29,167.

 

Effective October 1, 2021, the Company entered into a research agreement with the University of Michigan. As consideration under the research agreement, the University of Michigan will receive a maximum of $296,448, from the Company. The research agreement may be terminated by either party upon ninety (90) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. This agreement was signed by the Company on September 23, 2021.

 

In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position or results of operation.

 

9.RELATED PARTY

 

As of June 30, 2021, the Company reported an accrual associated with the CEO’s prior years’ salary in the amount of $211,750, plus current accrual of $9,833 for a total of $221,583, which is recorded in accrued expenses, related party. The Company began accruing the salary in 2011 and used the funds for operating expenses. The CEO will be paid during the fiscal year.

 

During the three months ended September 30, 2021, the Company redeemed 24,887,463 of the Company’s stock options to related parties for a total of $1,450,000.

 

10.SUBSEQUENT EVENTS

 

Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855, and there are no events to report.

 

14

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Cautionary Statement Regarding Forward-Looking Statements

 

The information in this report may contain forward-looking statements. These forward-looking statements involve risks and uncertainties, including statements regarding our capital needs, business strategy and expectations. Any statements that are not of historical fact may be deemed to be forward-looking statements. These forward-looking statements involve substantial risks and uncertainties. In some cases you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” or “continue”, the negative of the terms or other comparable terminology. Actual events or results may differ materially from the anticipated results or other expectations expressed in the forward-looking statements. In evaluating these statements, you should consider various factors, including the risks included from time to time in our reports filed with the Securities and Exchange Commission, or the SEC. These factors may cause our actual results to differ materially from any forward-looking statements. We disclaim any obligation to publicly update these statements, or disclose any difference between actual results and those reflected in these statements, except as may be required under applicable law.

 

Unless the context otherwise requires, references in this Form 10-Q to “we,” “us,” “our,” or the “Company” refer to SunHydrogen, Inc.

 

Overview

 

At SunHydrogen, our goal is to replace fossil fuels with clean, renewable hydrogen.

 

Hydrogen is the most abundant chemical element in the universe. When hydrogen fuel is used to power transportation and industry, the only byproduct left behind is pure water, unlike hydrocarbon fuels such as oil, coal and natural gas that release carbon dioxide and other contaminants into the atmosphere when used. However, naturally occurring elemental hydrogen is rare – so rare, in fact, that today over 95% of hydrogen still comes from methane, a fossil fuel (Source: Forbes, Estimating the Carbon Footprint of Hydrogen Production). This hydrogen is procured through steam methane reforming (SMR), a capital-intensive process that emits carbon dioxide and other harmful pollutants.

 

We believe the SunHydrogen solution potentially offers an efficient and cost-effective way to produce truly green hydrogen using sunlight and any source of water. Our core technology is a self-contained, nanoparticle-based hydrogen generator that mimics photosynthesis to split water molecules, resulting in hydrogen. By optimizing the science of water electrolysis at the nano-level, we believe we have developed a low-cost method to potentially produce environmentally friendly renewable hydrogen.

 

We believe renewable hydrogen is the fuel of the future, and we believe our technology potentially offers solutions to the challenges that the hydrogen future presents, including cost of production and transportation.

 

Because our process only requires sunlight and water, our technology can be installed near the point of hydrogen use. This eliminates the need for pipelines and trucks that result in high carbon emissions and high capital investment. With a target cost of $2.50/kg., we aspire for our technology to be cost-competitive with brown hydrogen and below the cost of clean hydrogen competitors. We believe our solution has the potential to clear a path for green hydrogen to compete with natural gas hydrogen and gain mass market acceptance as a true replacement for fossil fuels.

 

Our technology is primarily developed at the University of Iowa, through a sponsored research agreement. A longtime development partner to SunHydrogen, The University of Iowa research team has worked over the past several years to both lead and optimize the scale-up of our nanoparticle technology.

 

In 2021, we made strides toward the commercialization of our nanoparticle technology and entered agreements with two new technology development partners; InRedox in Longmont, Colorado and SCHMID Group in Freudenstadt, Germany.

 

Under our agreement with InRedox, they support the design and production of essential materials for our nanoparticle technology.

 

Concurrently, SCHMID has worked to develop the process and equipment to manufacture and scale up our nanoparticle technology.

 

15

 

 

We will continue working diligently with our existing technology partners to drive our technology to commercialization while we simultaneously prepare for mass production and seek out potential manufacturing partners for production facility, equipment design and engineering.

 

Critical Accounting Policies

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to impairment of property, plant and equipment, intangible assets, deferred tax assets and fair value computation using the Binomial valuation option pricing model. We base our estimates on historical experience and on various other assumptions, such as the trading value of our common stock and estimated future undiscounted cash flows, that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above-described items, are reasonable.

 

Use of Estimates

 

In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Binomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates.

 

Fair Value of Financial Instruments

 

Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2021, the amounts reported for cash, accrued interest and other expenses, notes payables, and derivative liability approximate the fair value because of their short maturities.

 

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

 

Recently Issued Accounting Pronouncements

 

Management reviewed currently issued pronouncements during the three months ended September 30, 2021, and does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements. Pronouncements are disclosed in notes to the financial statements.

 

Results of Operations for the Three Months Ended September 30, 2021 compared to Three Months Ended September 30, 2020.

 

Operating Expenses

 

Operating expenses for the three months ended September 30, 2021 were $599,766 compared to $578,486 for the prior period ended September 30, 2020. The net increase of $21,278 in operating expenses consisted primarily due an increase in office salary of $108,333, an increase in research and development of $13,102, and a decrease in stock compensation of $112,035, with an offset by $11,878 in other expenses. 

 

16

 

 

Other Income/(Expenses)

 

Other income and (expenses) for the three months ended September 30, 2021 were $49,224,609 compared to $(1,627,774) for the prior period ended September 30, 2020. The increase in other income of $50,852,383 was the result of the non-cash loss in net change in derivative of $50,732,210, a decrease in interest expense of $103,151, which includes the net change in amortization of debt discount of $85,599, with an increase in other income of $17,022.

 

Net Income/(Loss)

 

For the three months ended September 30, 2021, our net income was $48,624,844, as compared to a net loss of $(2,206,260) for the prior period ended September 30, 2020. The majority of the increase in net income of $50,831,104, was related primarily to the increase in net change of derivative instruments estimated each period. These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price, volatility, variable conversion prices based on market prices defined in the respective agreements and probabilities of certain outcomes based on managements’ estimates. These inputs are subject to significant changes from period to period, therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material. The Company has not generated any revenues. 

 

Liquidity and Capital Resources

 

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures. 

 

As of September 30, 2021, we had a working capital deficit of $38,558,325, compared to a working capital deficit of $80,099,103 as of June 30, 2021. This decrease in working capital deficit of $41,540,778 was primarily due to an increase in gain on change in derivative liability.

 

Cash used in operating activities was $(669,326) for the three months ended September 30, 2021 compared to $(444,366) for the prior period ended September 30, 2020. The increase in cash used in operating activities was due to an increase in office salaries, and a decrease in accounts payable. The Company has had no revenues.

 

Cash used in investing activities during the three months ended September 30, 2021 and 2020 was $(8,393,442) and $(50,000), respectively. The increase in investing activities was due to the purchase of marketable securities.

 

Cash used in financing activities was $(1,450,000) for the three months ended September 30, 2021 compared to $800,000 provided by the prior period ended September 30, 2020. The increase in cash used in financing activities was a result of the redemption of stock options. Our ability to continue as a going concern is dependent upon raising capital through financing transactions and future revenue.

 

We have historically obtained funding from investors, through private placements and registered offerings of equity and debt securities. Management believes that the Company will be able to continue to raise funds through the sale of its securities to its existing shareholders and prospective new investors which will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the Company to continue to develop its core business. There can be no assurance that we will be able to continue raising the required capital for our operations on terms and conditions that are acceptable to us, or at all. If we are unable to obtain sufficient funds, we may be forced to curtail and/or cease our operation.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues or expenses, result of operations, liquidity or capital expenditures.

 

17

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act). Based upon this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is: (i) recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, and (ii) accumulated and communicated to our management, including our chief executive officer and chief financial officer, or person performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control Over Financial Reporting

 

There was no change to our internal control over financial reporting that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

18

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

We are not currently a party to, nor is any of our property currently the subject of, any material legal proceeding.

 

Item 1A. Risk Factors.

 

There are no material changes from the risk factors previously disclosed in our annual report on Form 10-K filed with the SEC on October 8, 2021.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

During the three months ended September 30, 2021, the Company issued 180,480,692 shares of common stock upon conversion of principal in the amount of $120,400, plus accrued interest of $51,067.

 

In connection with the foregoing, the Company relied upon an exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, for transactions not involving a public offering.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

19

 

 

Item 6. Exhibits.

 

Exhibit No.   Description
31.1*   Certification by Chief Executive Officer and Acting Chief Financial Officer pursuant to Sarbanes-Oxley Section 302*
32.1**   Certification by Chief Executive Officer and Acting Chief Financial Officer pursuant to 18 U.S.C. Section 1350**
101*   Inline XBRL Document Set for the consolidated financial statements and accompanying notes in Part I, Item 1, of this Quarterly Report on Form 10-Q.
104*   Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.

 

 

* Filed herewith
** Furnished herewith

 

20

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

November 15, 2021 SUNHYDROGEN, INC.
     
  By: /s/ Timothy Young
   

Timothy Young

Chief Executive Officer and
Acting Chief Financial Officer

(Principal Executive Officer,
Principal Financial Officer and
Principal Accounting Officer)

 

21

false --06-30 Q1 0001481028 0.0009 0001481028 2021-07-01 2021-09-30 0001481028 2021-11-12 0001481028 2021-09-30 0001481028 2021-06-30 0001481028 2020-07-01 2020-09-30 0001481028 us-gaap:PreferredStockMember 2020-06-30 0001481028 us-gaap:CommonStockMember 2020-06-30 0001481028 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001481028 us-gaap:RetainedEarningsMember 2020-06-30 0001481028 2020-06-30 0001481028 us-gaap:PreferredStockMember 2020-07-01 2020-09-30 0001481028 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001481028 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001481028 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001481028 us-gaap:PreferredStockMember 2020-09-30 0001481028 us-gaap:CommonStockMember 2020-09-30 0001481028 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001481028 us-gaap:RetainedEarningsMember 2020-09-30 0001481028 2020-09-30 0001481028 us-gaap:PreferredStockMember 2021-06-30 0001481028 us-gaap:CommonStockMember 2021-06-30 0001481028 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001481028 us-gaap:RetainedEarningsMember 2021-06-30 0001481028 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001481028 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001481028 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001481028 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001481028 us-gaap:PreferredStockMember 2021-09-30 0001481028 us-gaap:CommonStockMember 2021-09-30 0001481028 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001481028 us-gaap:RetainedEarningsMember 2021-09-30 0001481028 hysr:EquityIncentiveMember 2018-12-01 2018-12-17 0001481028 2018-12-01 2018-12-17 0001481028 hysr:ComputersAndPeripheralEquipmentMember 2021-07-01 2021-09-30 0001481028 hysr:VehicleMember 2021-07-01 2021-09-30 0001481028 us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001481028 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001481028 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001481028 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001481028 us-gaap:FairValueInputsLevel3Member 2021-06-30 0001481028 us-gaap:FairValueInputsLevel3Member 2021-07-01 2021-09-30 0001481028 us-gaap:FairValueInputsLevel3Member 2021-09-30 0001481028 srt:MinimumMember us-gaap:CommonStockMember 2020-09-30 0001481028 srt:MaximumMember us-gaap:CommonStockMember 2020-09-30 0001481028 srt:MaximumMember 2020-09-30 0001481028 srt:MaximumMember 2020-07-01 2020-09-30 0001481028 hysr:StockOptionPlanMember 2020-09-02 2020-09-30 0001481028 hysr:StockOptionPlanMember 2019-01-01 2019-01-23 0001481028 2019-01-01 2019-01-31 0001481028 2019-07-01 2019-07-22 0001481028 us-gaap:WarrantMember 2021-07-01 2021-09-30 0001481028 srt:MinimumMember us-gaap:WarrantMember 2021-09-30 0001481028 srt:MaximumMember us-gaap:WarrantMember 2021-09-30 0001481028 hysr:RangeOneMember 2021-09-30 0001481028 hysr:RangeOneMember 2021-07-01 2021-09-30 0001481028 hysr:RangeOneMember 2020-09-30 0001481028 hysr:RangeOneMember 2020-07-01 2020-09-30 0001481028 hysr:RangeTwoMember 2021-09-30 0001481028 hysr:RangeTwoMember 2021-07-01 2021-09-30 0001481028 hysr:RangeTwoMember 2020-09-30 0001481028 hysr:RangeTwoMember 2020-07-01 2020-09-30 0001481028 hysr:RangeThreeMember 2021-09-30 0001481028 hysr:RangeThreeMember 2021-07-01 2021-09-30 0001481028 hysr:RangeThreeMember 2020-09-30 0001481028 hysr:RangeThreeMember 2020-07-01 2020-09-30 0001481028 hysr:RangeFourMember 2021-09-30 0001481028 hysr:RangeFourMember 2021-07-01 2021-09-30 0001481028 hysr:RangeFourMember 2020-09-30 0001481028 hysr:RangeFourMember 2020-07-01 2020-09-30 0001481028 us-gaap:WarrantMember 2021-06-30 0001481028 us-gaap:WarrantMember 2021-09-30 0001481028 hysr:ExercisePriceOneMember us-gaap:WarrantMember 2021-09-30 0001481028 srt:MinimumMember hysr:ExercisePriceOneMember us-gaap:WarrantMember 2021-07-01 2021-09-30 0001481028 srt:MaximumMember hysr:ExercisePriceOneMember us-gaap:WarrantMember 2021-07-01 2021-09-30 0001481028 hysr:ExercisePriceTwoMember us-gaap:WarrantMember 2021-09-30 0001481028 hysr:ExercisePriceTwoMember us-gaap:WarrantMember 2021-07-01 2021-09-30 0001481028 hysr:ExercisePriceThreeMember us-gaap:WarrantMember 2021-09-30 0001481028 hysr:ExercisePriceThreeMember us-gaap:WarrantMember 2021-07-01 2021-09-30 0001481028 hysr:ConvertiblePromissoryNotesTenMember 2021-09-30 0001481028 hysr:ConvertiblePromissoryNotesTenMember 2021-07-01 2021-09-30 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:Feb2017NoteMember 2017-02-03 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:ConvertiblePromissoryNotesFourMember 2017-02-01 2017-02-03 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:Feb2017NoteMember 2017-02-01 2017-02-03 0001481028 us-gaap:CommonStockMember 2021-09-30 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:Feb2017NoteMember 2021-09-30 0001481028 2017-11-01 2017-11-09 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:ConvertiblePromissoryNotesSixMember 2017-11-09 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember 2017-11-09 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:ConvertiblePromissoryNotesSixMember 2021-09-30 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:Jun2018NoteMember 2018-06-27 0001481028 2018-06-27 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:Jun2018NoteMember 2018-06-01 2018-06-27 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:ConvertiblePromissoryJuneOneNotesMember 2021-09-30 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryNotesNineMember 2018-08-10 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryNotesNineMember 2018-08-01 2018-08-10 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:April2020NoteMember 2018-08-01 2018-08-10 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryMarchOneNotesMember 2021-09-30 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryFebNotesMember 2020-04-15 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryMarchNotesMember 2020-04-15 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:April2020NoteMember 2020-04-15 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryAprilOneNotesMember 2020-04-15 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryAprilOneNotesMember 2021-09-30 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryAprilOneNotesMember 2021-07-01 2021-09-30 0001481028 2021-12-30 0001481028 srt:MinimumMember 2007-04-01 2008-03-31 0001481028 srt:MaximumMember 2007-04-01 2008-03-31 0001481028 2007-04-01 2008-03-31 0001481028 hysr:CorporateBondsOneMember 2021-09-30 0001481028 hysr:CorporateBondsTwoMember 2021-09-30 0001481028 us-gaap:FairValueInputsLevel2Member us-gaap:BondsMember 2021-07-01 2021-09-30 0001481028 2021-08-25 2021-09-01 0001481028 2021-09-25 2021-10-01 0001481028 2021-06-02 2021-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
EX-31.1 2 f10q0921ex31-1_sunhydrogen.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION

PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

 

I, Timothy Young, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of SunHydrogen, Inc. for the fiscal quarter ended September 30, 2021;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d – 15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 15, 2021

 

/s/ Timothy Young  
Timothy Young  

Chief Executive Officer & Acting Chief Financial Officer

  
(Principal Executive and Financial Officer)  
 EX-32.1 3 f10q0921ex32-1_sunhydrogen.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 USC, SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of SunHydrogen, Inc. (the “Company”) on Form 10-Q for the fiscal quarter ended September 30, 2021 as filed with the Securities and Exchange Commission the date hereof (the “Report”), I, Timothy Young, Chief Executive Officer & Acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 15, 2021 /s/ Timothy Young
  Timothy Young
  Chief Executive Officer & Acting Chief Financial Officer
  (Principal Executive and Financial Officer)
 EX-101.SCH 4 hysr-20210930.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Statements of Operations link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Statements of Shareholders’ Deficit link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Capital Stock link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Options and Warrants link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Convertible Promissory Notes link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Derivative Liabilities link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Marketable Securities link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Related Party link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Options and Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Convertible Promissory Notes (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Derivative Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Marketable Securities (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful lives link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of measurement of assets and liabilities at fair value on recurring basis link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the derivative liability link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Capital Stock (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Options and Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Options and Warrants (Details) - Schedule of the company's stock option activity and related information link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Options and Warrants (Details) - Schedule of company's warrant activity and related information link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Convertible Promissory Notes (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Convertible Promissory Notes (Details) - Schedule of convertible promissory notes link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Convertible Promissory Notes (Details) - Schedule of maturities of long-term debt link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Derivative Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Derivative Liabilities (Details) - Schedule of fair market value of the derivative liability link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Marketable Securities (Details) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Marketable Securities (Details) - Schedule of cash and short and long-term investments link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Marketable Securities (Details) - Schedule of amortized cost of the held-to-maturity bonds link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Marketable Securities (Details) - Schedule of gross unrealized gains and losses link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Related Party (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 5 hysr-20210930_cal.xml XBRL CALCULATION FILE EX-101.DEF 6 hysr-20210930_def.xml XBRL DEFINITION FILE EX-101.LAB 7 hysr-20210930_lab.xml XBRL LABEL FILE EX-101.PRE 8 hysr-20210930_pre.xml XBRL PRESENTATION FILE XML 9 f10q0921_sunhydrogeninc_htm.xml IDEA: XBRL DOCUMENT 0001481028 2021-07-01 2021-09-30 0001481028 2021-11-12 0001481028 2021-09-30 0001481028 2021-06-30 0001481028 2020-07-01 2020-09-30 0001481028 us-gaap:PreferredStockMember 2020-06-30 0001481028 us-gaap:CommonStockMember 2020-06-30 0001481028 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001481028 us-gaap:RetainedEarningsMember 2020-06-30 0001481028 2020-06-30 0001481028 us-gaap:PreferredStockMember 2020-07-01 2020-09-30 0001481028 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001481028 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001481028 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001481028 us-gaap:PreferredStockMember 2020-09-30 0001481028 us-gaap:CommonStockMember 2020-09-30 0001481028 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001481028 us-gaap:RetainedEarningsMember 2020-09-30 0001481028 2020-09-30 0001481028 us-gaap:PreferredStockMember 2021-06-30 0001481028 us-gaap:CommonStockMember 2021-06-30 0001481028 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001481028 us-gaap:RetainedEarningsMember 2021-06-30 0001481028 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001481028 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001481028 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001481028 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001481028 us-gaap:PreferredStockMember 2021-09-30 0001481028 us-gaap:CommonStockMember 2021-09-30 0001481028 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001481028 us-gaap:RetainedEarningsMember 2021-09-30 0001481028 hysr:EquityIncentiveMember 2018-12-01 2018-12-17 0001481028 2018-12-01 2018-12-17 0001481028 hysr:ComputersAndPeripheralEquipmentMember 2021-07-01 2021-09-30 0001481028 hysr:VehicleMember 2021-07-01 2021-09-30 0001481028 us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001481028 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001481028 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001481028 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001481028 us-gaap:FairValueInputsLevel3Member 2021-06-30 0001481028 us-gaap:FairValueInputsLevel3Member 2021-07-01 2021-09-30 0001481028 us-gaap:FairValueInputsLevel3Member 2021-09-30 0001481028 srt:MinimumMember us-gaap:CommonStockMember 2020-09-30 0001481028 srt:MaximumMember us-gaap:CommonStockMember 2020-09-30 0001481028 srt:MaximumMember 2020-09-30 0001481028 srt:MaximumMember 2020-07-01 2020-09-30 0001481028 hysr:StockOptionPlanMember 2020-09-02 2020-09-30 0001481028 hysr:StockOptionPlanMember 2019-01-01 2019-01-23 0001481028 2019-01-01 2019-01-31 0001481028 2019-07-01 2019-07-22 0001481028 us-gaap:WarrantMember 2021-07-01 2021-09-30 0001481028 srt:MinimumMember us-gaap:WarrantMember 2021-09-30 0001481028 srt:MaximumMember us-gaap:WarrantMember 2021-09-30 0001481028 hysr:RangeOneMember 2021-09-30 0001481028 hysr:RangeOneMember 2021-07-01 2021-09-30 0001481028 hysr:RangeOneMember 2020-09-30 0001481028 hysr:RangeOneMember 2020-07-01 2020-09-30 0001481028 hysr:RangeTwoMember 2021-09-30 0001481028 hysr:RangeTwoMember 2021-07-01 2021-09-30 0001481028 hysr:RangeTwoMember 2020-09-30 0001481028 hysr:RangeTwoMember 2020-07-01 2020-09-30 0001481028 hysr:RangeThreeMember 2021-09-30 0001481028 hysr:RangeThreeMember 2021-07-01 2021-09-30 0001481028 hysr:RangeThreeMember 2020-09-30 0001481028 hysr:RangeThreeMember 2020-07-01 2020-09-30 0001481028 hysr:RangeFourMember 2021-09-30 0001481028 hysr:RangeFourMember 2021-07-01 2021-09-30 0001481028 hysr:RangeFourMember 2020-09-30 0001481028 hysr:RangeFourMember 2020-07-01 2020-09-30 0001481028 us-gaap:WarrantMember 2021-06-30 0001481028 us-gaap:WarrantMember 2021-09-30 0001481028 hysr:ExercisePriceOneMember us-gaap:WarrantMember 2021-09-30 0001481028 srt:MinimumMember hysr:ExercisePriceOneMember us-gaap:WarrantMember 2021-07-01 2021-09-30 0001481028 srt:MaximumMember hysr:ExercisePriceOneMember us-gaap:WarrantMember 2021-07-01 2021-09-30 0001481028 hysr:ExercisePriceTwoMember us-gaap:WarrantMember 2021-09-30 0001481028 hysr:ExercisePriceTwoMember us-gaap:WarrantMember 2021-07-01 2021-09-30 0001481028 hysr:ExercisePriceThreeMember us-gaap:WarrantMember 2021-09-30 0001481028 hysr:ExercisePriceThreeMember us-gaap:WarrantMember 2021-07-01 2021-09-30 0001481028 hysr:ConvertiblePromissoryNotesTenMember 2021-09-30 0001481028 hysr:ConvertiblePromissoryNotesTenMember 2021-07-01 2021-09-30 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:Feb2017NoteMember 2017-02-03 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:ConvertiblePromissoryNotesFourMember 2017-02-01 2017-02-03 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:Feb2017NoteMember 2017-02-01 2017-02-03 0001481028 us-gaap:CommonStockMember 2021-09-30 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:Feb2017NoteMember 2021-09-30 0001481028 2017-11-01 2017-11-09 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:ConvertiblePromissoryNotesSixMember 2017-11-09 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember 2017-11-09 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:ConvertiblePromissoryNotesSixMember 2021-09-30 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:Jun2018NoteMember 2018-06-27 0001481028 2018-06-27 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:Jun2018NoteMember 2018-06-01 2018-06-27 0001481028 hysr:ConvertiblePromissoryNotesTenPercentMember hysr:ConvertiblePromissoryJuneOneNotesMember 2021-09-30 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryNotesNineMember 2018-08-10 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryNotesNineMember 2018-08-01 2018-08-10 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:April2020NoteMember 2018-08-01 2018-08-10 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryMarchOneNotesMember 2021-09-30 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryFebNotesMember 2020-04-15 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryMarchNotesMember 2020-04-15 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:April2020NoteMember 2020-04-15 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryAprilOneNotesMember 2020-04-15 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryAprilOneNotesMember 2021-09-30 0001481028 hysr:UnsecuredConvertibleNotesTenPercentMember hysr:ConvertiblePromissoryAprilOneNotesMember 2021-07-01 2021-09-30 0001481028 2021-12-30 0001481028 srt:MinimumMember 2007-04-01 2008-03-31 0001481028 srt:MaximumMember 2007-04-01 2008-03-31 0001481028 2007-04-01 2008-03-31 0001481028 hysr:CorporateBondsOneMember 2021-09-30 0001481028 hysr:CorporateBondsTwoMember 2021-09-30 0001481028 us-gaap:FairValueInputsLevel2Member us-gaap:BondsMember 2021-07-01 2021-09-30 0001481028 2021-08-25 2021-09-01 0001481028 2021-09-25 2021-10-01 0001481028 2021-06-02 2021-06-30 shares iso4217:USD iso4217:USD shares pure 10-Q true 2021-09-30 2021 false 000-54437 SUNHYDROGEN, INC. NV 26-4298300 10 E. Yanonali Suite 36 Santa Barbara CA 93101 (805) 966-6566 Yes Yes Non-accelerated Filer true false false 4029789187 45493787 56006555 2580795 9047 48083629 56006555 5812647 11529 11529 155000 155000 166529 166529 -21356 -11072 145173 155457 4665 4223 650 738 514 371 628 657 24856 16250 76287 77928 77565 79323 54119014 56241335 127034 223520 12056 11912 221583 214820 262563 282505 85895178 135247303 329178 409074 123540 125598 86641954 136105658 0 0 698082 703000 698082 703000 87340036 136808658 0.001 0.001 5000000 5000000 0.001 0.001 5000000000 5000000000 4029789187 4029789187 3849308495 3849308495 4029789 3849308 87101297 88560321 -124352108 -172976952 -33221022 -80567323 54119014 56241335 109776 326585 438190 151362 138260 12043 2036 599766 578486 -599766 -578486 17023 49352125 -1380085 144538 247689 49224610 -1627774 48624844 -2206260 0.01 0 0.01 0 4000362987 2139179833 5523313069 2139179833 2053410161 2053410 11664657 -75550515 -61832448 35573090 35573 764427 800000 79908088 79908 177327 257235 2813903 2814 85487 88301 112035 112035 -2206260 -2206260 2171705242 2171705 12803933 -77756775 -62781137 3849308495 3849308 88560321 -172976952 -80567323 180480692 180481 -9024 171457 -1450000 -1450000 48624844 48624844 4029789187 4029789 87101297 -124352108 -33221022 -48624844 2206260 12043 2036 112035 88301 49352125 -1380085 113425 199024 9047 3167 -96486 -76515 6907 11861 31114 48234 -669326 -444366 8393442 50000 -8393442 -50000 1450000 800000 -1450000 800000 -10512768 305634 56006555 195010 45493787 500644 2249 171457 257235 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Basis of Presentation</span></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ended June 30, 2022. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended June 30, 2021.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This summary of significant accounting policies of SunHydrogen, Inc. is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Cash and Cash Equivalent </span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="text-decoration:underline">Investments</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">The Company considers corporate bonds (“bonds”) as investments due to their ratings. The bonds are rated based on their default probability, health of the corporation’s debt structure, as well as the overall health of the economy. The bonds fall into the category as investments if they have a rating of AAA and BBB.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The bonds have varied due dates and were classified as current and noncurrent, based on to their maturity dates. The bonds are generally valued using quoted prices and are classified in Level 2 of the fair value hierarchy as prices are not always from active markets. We consider our investments held to maturity and we believe there are no other than temporary declines in fair value. Our investments are recorded at historical cost.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Use of Estimates</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Binomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Property and Equipment</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost and are depreciated using straight line over its estimated useful lives.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 82%; text-align: left">Computers and peripheral equipment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 Years</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 Years</span></td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognized depreciation expense of $10,284 and $278 for the three months ended September 30, 2021 and 2020, respectively. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Intangible Assets</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has patent applications to protect the inventions and processes behind its proprietary solar-to-hydrogen based technology. Intangible assets that have finite useful lives continue to be amortized over their useful lives.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognized amortization expense of $1,758 and $1,758 for the three months ended September 30, 2021 and 2020, respectively. </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Net Earnings (Loss) per Share Calculations</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5). </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">September 30, 2021</span> </b></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">For the three months ended September 30, 2021, the Company calculated the dilutive impact of the outstanding stock options of 157,965,711, common stock purchase warrants of 94,895,239, and the convertible debt of $1,150,800, which is convertible into shares of common stock. The stock options were not included, because their impact was antidilutive. </p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">September 30, 2020</span></b></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended September 30, 2020, the Company calculated the dilutive impact of the outstanding stock options of 186,000,000, and the convertible debt of $1,797,000, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Equity Incentive Plan and Stock Options</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Equity Incentive Plan</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On December 17, 2018, the Board of Directors approved and adopted the 2019 Equity Incentive Plan (“the Plan”), with 300,000,000 shares reserved for issuance pursuant to the Plan. The purpose of the Plan is to promote the success of the Corporation and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. The awards are performance-based compensation that are granted under the Plan as incentive stock options (ISO) or nonqualified stock options. The per share exercise price for each option shall not be less than 100% of the fair market value of a share of common stock on the date of grant of the option. The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing cost. The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date. The options are exercisable into common stock.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2021, there were 157,965,711 stock options issued, and a reserve of 142,034,289.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Stock Based Compensation</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Warrant Accounting</span> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the warrants to purchase shares of common stock using the estimated fair value on the date of issuance as calculated using the Black-Scholes valuation model.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Fair Value of Financial Instruments</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized on the balance sheet, where it is practicable to estimate that value. As of September 30, 2021, the amounts reported for cash, accrued interest and other expenses, notes payables, convertible notes, and derivative liability approximate the fair value because of their short maturities.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows on September 30, 2021 (See Note 6):</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; vertical-align: top; padding-left: 0.25in; width: 52%; text-align: left; padding-bottom: 1.5pt">Corporate bonds</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">8,393,442</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">8,393,442</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; vertical-align: top; padding-left: 0.25in; text-align: left; padding-bottom: 4pt">Derivative liability measured at fair value</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85,895,178</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85,895,178</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Balance as of June 30, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">135,247,303</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Gain on change in derivative liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(49,352,125</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Balance as of September 30, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85,895,178</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> </p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Research and Development </span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development costs are expensed as incurred. Total research and development costs were $151,362 and $138,260 for the three months ended September 30, 2021 and 2020, respectively.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Accounting for Derivatives </span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Recently Issued Accounting Pronouncements</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements as of September 30, 2021.</span></p> <p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Cash and Cash Equivalent </span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="text-decoration:underline">Investments</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">The Company considers corporate bonds (“bonds”) as investments due to their ratings. The bonds are rated based on their default probability, health of the corporation’s debt structure, as well as the overall health of the economy. The bonds fall into the category as investments if they have a rating of AAA and BBB.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The bonds have varied due dates and were classified as current and noncurrent, based on to their maturity dates. The bonds are generally valued using quoted prices and are classified in Level 2 of the fair value hierarchy as prices are not always from active markets. We consider our investments held to maturity and we believe there are no other than temporary declines in fair value. Our investments are recorded at historical cost.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Use of Estimates</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Binomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Property and Equipment</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost and are depreciated using straight line over its estimated useful lives.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 82%; text-align: left">Computers and peripheral equipment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 Years</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 Years</span></td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognized depreciation expense of $10,284 and $278 for the three months ended September 30, 2021 and 2020, respectively. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 82%; text-align: left">Computers and peripheral equipment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 Years</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 Years</span></td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> P5Y P5Y 10284 278 <p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Intangible Assets</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has patent applications to protect the inventions and processes behind its proprietary solar-to-hydrogen based technology. Intangible assets that have finite useful lives continue to be amortized over their useful lives.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognized amortization expense of $1,758 and $1,758 for the three months ended September 30, 2021 and 2020, respectively. </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1758 1758 <p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Net Earnings (Loss) per Share Calculations</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5). </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">September 30, 2021</span> </b></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">For the three months ended September 30, 2021, the Company calculated the dilutive impact of the outstanding stock options of 157,965,711, common stock purchase warrants of 94,895,239, and the convertible debt of $1,150,800, which is convertible into shares of common stock. The stock options were not included, because their impact was antidilutive. </p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">September 30, 2020</span></b></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended September 30, 2020, the Company calculated the dilutive impact of the outstanding stock options of 186,000,000, and the convertible debt of $1,797,000, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 157965711 94895239 1150800 186000000 1797000 <p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Equity Incentive Plan and Stock Options</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Equity Incentive Plan</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On December 17, 2018, the Board of Directors approved and adopted the 2019 Equity Incentive Plan (“the Plan”), with 300,000,000 shares reserved for issuance pursuant to the Plan. The purpose of the Plan is to promote the success of the Corporation and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. The awards are performance-based compensation that are granted under the Plan as incentive stock options (ISO) or nonqualified stock options. The per share exercise price for each option shall not be less than 100% of the fair market value of a share of common stock on the date of grant of the option. The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing cost. The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date. The options are exercisable into common stock.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2021, there were 157,965,711 stock options issued, and a reserve of 142,034,289.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 300000000 1 157965711 142034289 <p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Stock Based Compensation</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Warrant Accounting</span> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the warrants to purchase shares of common stock using the estimated fair value on the date of issuance as calculated using the Black-Scholes valuation model.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Fair Value of Financial Instruments</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized on the balance sheet, where it is practicable to estimate that value. As of September 30, 2021, the amounts reported for cash, accrued interest and other expenses, notes payables, convertible notes, and derivative liability approximate the fair value because of their short maturities.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows on September 30, 2021 (See Note 6):</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; vertical-align: top; padding-left: 0.25in; width: 52%; text-align: left; padding-bottom: 1.5pt">Corporate bonds</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">8,393,442</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">8,393,442</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; vertical-align: top; padding-left: 0.25in; text-align: left; padding-bottom: 4pt">Derivative liability measured at fair value</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85,895,178</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85,895,178</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Balance as of June 30, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">135,247,303</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Gain on change in derivative liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(49,352,125</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Balance as of September 30, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85,895,178</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; vertical-align: top; padding-left: 0.25in; width: 52%; text-align: left; padding-bottom: 1.5pt">Corporate bonds</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">8,393,442</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">8,393,442</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; vertical-align: top; padding-left: 0.25in; text-align: left; padding-bottom: 4pt">Derivative liability measured at fair value</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85,895,178</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85,895,178</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 8393442 8393442 85895178 85895178 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Balance as of June 30, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">135,247,303</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Gain on change in derivative liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(49,352,125</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Balance as of September 30, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">85,895,178</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> </p> 135247303 -49352125 85895178 <p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Research and Development </span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development costs are expensed as incurred. Total research and development costs were $151,362 and $138,260 for the three months ended September 30, 2021 and 2020, respectively.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 151362 138260 <p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Accounting for Derivatives </span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Recently Issued Accounting Pronouncements</span></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements as of September 30, 2021.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAPITAL STOCK</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">Three months ended September 30, 2021</span></b></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">During the three months ended September 30, 2021, the Company issued 180,480,692 shares of common stock upon conversion of convertible notes in the amount of $120,400 of principal, plus accrued interest of $51,057 based upon a conversion price of $0.00095 per share. The notes were converted per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">Three months ended September 30, 2020</span></b></span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended September 30, 2020, the Company issued 35,573,090 shares of common stock for cash for aggregate gross proceeds of $800,000.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended September 30, 2020, the Company issued 79,908,088 shares of common stock upon conversion of convertible notes in the amount of $233,000 in principal, plus accrued interest of $23,335 and other fees of $900 based upon conversion prices ranging from $0.00095 - $0.017995 per share. All note conversions were performed per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended September 30, 2020, the Company issued 2,813,903 shares of common stock for services rendered at fair value prices of $0.028 - $0.035 per share in the aggregate amount of $88,301.</span></p> 180480692 120400 51057 0.00095 35573090 800000 79908088 233000 23335 900 0.00095 0.017995 2813903 0.028 0.035 88301 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPTIONS AND WARRANTS</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2020, 10,000,000 non-qualified common stock options were outstanding. Each option expires on the date specified in the option agreement, which date is not later than the fifth (5<sup>th</sup>) anniversary from the grant date of the options. Of the 10,000,000 non-qualified common stock options, one-third vest immediately, and one-third vest the second and third year, such that, the options are fully vested with a maturity date of October 2, 2022 and are exercisable at an exercise price of $0.01 per share.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 23, 2019, the Company issued 170,000,000 stock options. One-third of the options vested immediately, and the remainder vest 1/24 per month over the first twenty-four months following the option grant. The options expire 10 years from the initial grant date. The options fully vest by January 23, 2022</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 31, 2019, the Company issued 6,000,000 stock options, of which two-third (2/3) vest immediately, and the remaining amount shall vest one-twelfth (1/12) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on January 31, 2020.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 22, 2019, the Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on July 22, 2020.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s stock option activity and related information follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">9/30/21</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">9/30/2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Number</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Number</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Of</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">of</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Outstanding, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">182,853,174</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.01</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">196,250,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.01</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-right: 0pt; vertical-align: top; text-indent: 0pt; padding-left: 0pt; text-align: left"><p style="margin: 0; font: 10pt Times New Roman, Times, Serif">Buyback of options</p></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24,887,463</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.0099</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(250,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">0.01</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Outstanding, end of period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">157,965,711</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.0089</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">196,000,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.01</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercisable at the end of period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">157,965,711</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.0089</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">174,332,250</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.01</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">During the three months ended September 30, 2021, the Company bought back a total of 24,887,463 of the Company’s stock options for a total of $1,450,000. The options were bought back for the market price at the date of the buy back less the exercise price of the grant similar to a cashless feature. All options that were bought back were fully vested and previously expensed accordingly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"/><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average remaining contractual life of options outstanding as of September 30, 2021 and 2020 was as follows: </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">9/30/2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">9/30/2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Options<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Options<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Remaining<br/> Contractual Life<br/> (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Options<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Options<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Remaining<br/> Contractual Life<br/> (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.0100</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">3,071,212</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">3,071,212</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">1.01</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.0100</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">10,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">10,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2.01</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">$</td><td style="text-align: right">0.0097</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.34</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0097</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.32</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td style="text-align: right">0.0099</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">138,894,499</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">138,894,499</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.32</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.0099</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">170,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">157,110,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.34</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.0060</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">10,000,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">10,000,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right">4.81</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.0060</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">10,000,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">7,222,083</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right">5.81</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right"> </td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">157,965,711</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">157,965,711</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right"> </td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right"> </td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">196,250,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">180,332,250</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right"> </td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The stock-based compensation expense recognized in the statement of operations during the three months ended September 30, 2021 and 2020, related to the granting of these options was $0 and $112,035, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">WARRANTS</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As of September 30, 2021, the Company had an aggregate of 94,895,239 common stock purchase warrants outstanding, with exercise prices ranging from $0.0938 - $0.13125 per share. The warrants were estimated at fair value on the date of issuance as calculated using the Black-Scholes valuation model. The warrants can be exercised over a three (3) year period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s warrant activity and related information follows for the three months ended September 30, 2021. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">9/30/21</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">exercise</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Outstanding, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">94,895,239</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.11</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Forfeited/Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Outstanding, end of period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">94,895,239</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.11</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercisable at the end of period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">94,895,239</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.11</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="margin-top: 0; margin-bottom: 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="10" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">9/30/2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"><b>Weighted<br/> Average<br/> Remaining</b></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants <br/> Outstanding</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants <br/> Exercisable</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Contractual <br/> Life (years)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 22%; text-align: right">0.0938</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 23%; text-align: right">16,800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 23%; text-align: right">16,800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.67 - 2.25</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">$</td><td style="text-align: right">0.13125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,666,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,666,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">4.41</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.12</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">71,428,572</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">71,428,572</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: center">4.42</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right"> </td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">94,895,239</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">94,895,239</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: center"> </td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At September 30, 2021, the aggregate intrinsic value of the warrants outstanding was $0.</span></p> 10000000 Of the 10,000,000 non-qualified common stock options, one-third vest immediately, and one-third vest the second and third year, such that, the options are fully vested with a maturity date of October 2, 2022 and are exercisable at an exercise price of $0.01 per share. 170000000 One-third of the options vested immediately, and the remainder vest 1/24 per month over the first twenty-four months following the option grant. The options expire 10 years from the initial grant date. The options fully vest by January 23, 2022On January 31, 2019, the Company issued 6,000,000 stock options, of which two-third (2/3) vest immediately, and the remaining amount shall vest one-twelfth (1/12) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on January 31, 2020. On July 22, 2019, the Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of the option grant. The options expire 10 years from the initial grant date. the Company issued 6,000,000 stock options, of which two-third (2/3) vest immediately, and the remaining amount shall vest one-twelfth (1/12) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on January 31, 2020.On July 22, 2019, the Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of the option grant. The options expire 10 years from the initial grant date. the Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on July 22, 2020. <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">9/30/21</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="6" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">9/30/2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Number</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Number</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Of</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">of</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Outstanding, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">182,853,174</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.01</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">196,250,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.01</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-right: 0pt; vertical-align: top; text-indent: 0pt; padding-left: 0pt; text-align: left"><p style="margin: 0; font: 10pt Times New Roman, Times, Serif">Buyback of options</p></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24,887,463</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.0099</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(250,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">0.01</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Outstanding, end of period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">157,965,711</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.0089</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">196,000,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.01</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercisable at the end of period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">157,965,711</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.0089</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">174,332,250</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.01</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> </p> 182853174 0.01 196250000 0.01 0.01 24887463 0.0099 250000 0.01 157965711 0.0089 196000000 0.01 157965711 0.0089 174332250 0.01 24887463 1450000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">9/30/2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">9/30/2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Options<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Options<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Remaining<br/> Contractual Life<br/> (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Options<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Options<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Remaining<br/> Contractual Life<br/> (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.0100</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">3,071,212</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">3,071,212</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">1.01</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.0100</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">10,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">10,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2.01</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">$</td><td style="text-align: right">0.0097</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.34</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.0097</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.32</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td style="text-align: right">0.0099</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">138,894,499</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">138,894,499</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.32</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.0099</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">170,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">157,110,167</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.34</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.0060</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">10,000,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">10,000,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right">4.81</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.0060</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">10,000,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">7,222,083</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right">5.81</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right"> </td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">157,965,711</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">157,965,711</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right"> </td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right"> </td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">196,250,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">180,332,250</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right"> </td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> 0.01 3071212 3071212 P1Y3D 0.01 10000000 10000000 P2Y3D 0.0097 6000000 6000000 P4Y4M2D 0.0097 6000000 6000000 P5Y3M25D 0.0099 138894499 138894499 P4Y3M25D 0.0099 170000000 157110167 P5Y4M2D 0.006 10000000 10000000 P4Y9M21D 0.006 10000000 7222083 P5Y9M21D 157965711 157965711 196250000 180332250 0 112035 94895239 0.0938 0.13125 P3Y <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">9/30/21</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">average</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">exercise</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Outstanding, beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">94,895,239</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.11</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Forfeited/Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Outstanding, end of period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">94,895,239</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.11</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercisable at the end of period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">94,895,239</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.11</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="margin-top: 0; margin-bottom: 0"> </p> 94895239 0.11 94895239 0.11 94895239 0.11 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="10" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">9/30/2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"><b>Weighted<br/> Average<br/> Remaining</b></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants <br/> Outstanding</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants <br/> Exercisable</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Contractual <br/> Life (years)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 22%; text-align: right">0.0938</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 23%; text-align: right">16,800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 23%; text-align: right">16,800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.67 - 2.25</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">$</td><td style="text-align: right">0.13125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,666,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,666,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">4.41</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt; text-align: left">$</td><td style="padding-bottom: 2pt; text-align: right">0.12</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">71,428,572</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">71,428,572</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: center">4.42</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt; text-align: right"> </td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">94,895,239</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">94,895,239</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2pt; text-align: center"> </td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> 0.0938 16800000 16800000 P1Y8M1D P2Y3M 0.13125 6666667 6666667 P4Y4M28D 0.12 71428572 71428572 P4Y5M1D 94895239 94895239 0 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONVERTIBLE PROMISSORY NOTES</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of September 30, 2021, the outstanding convertible promissory notes net of debt discount are summarized as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Convertible Promissory Notes, net of debt discount</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">821,622</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">123,540</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total long-term liabilities</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">698,082</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Maturities of long-term debt for the next four years are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Period Ended September</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">152,800</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">888,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left">2025</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,150,800</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="margin-top: 0; margin-bottom: 0"> </p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At September 30, 2021, the $1,150,800 in convertible promissory notes had a remaining debt discount of $329,178, leaving a net balance of $821,622.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company issued a 10% convertible promissory note on February 3, 2017 (the “Feb 2017 Note”) in the aggregate principal amount of up to $500,000. The Company received tranches for an aggregate principal total of $500,000. The Feb 2017 Note had a maturity date of February 3, 2018, the investor extended the Feb 2017 Note for an additional sixty (60) months from the effective date of the note, which matures on February 3, 2022. The Feb 2017 Note is convertible into shares of common stock of the Company at a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Feb 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. During the period ended on September 30, 2021, the Company issued 180,480,692 shares of common stock upon conversion of principal in the amount of $120,400, plus accrued interest of $51,057. The balance of the Feb 2017 Note as of September 30, 2021 was $187,800.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company issued a 10% convertible promissory note on November 9, 2017 (the “Nov 2017 Note”) in the aggregate principal amount of up to $500,000. The Company received tranches for an aggregate principal total of $500,000. The Nov 2017 Note had a maturity date of November 9, 2018, with an automatic extension of sixty (60) months from the effective date of the note. The Nov 2017 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Nov 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The balance of the Nov 2017 Note as of September 30, 2021 was $313,000.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued a 10% convertible promissory note on June 27, 2018 (the “Jun 2018 Note”) in the aggregate principal amount of up to $500,000. The Company received tranches for an aggregate principal total of $500,000. The Jun 2018 Note matured on June 27, 2019, which was automatically extended for sixty (60) months from the effective date of the note. The Jun 2018 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Jun 2018 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $103,342 during the three months ended September 30, 2021. The balance of the Jun 2018 Note as of September 30, 2021 was $500,000.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued a 10% convertible promissory note on August 10, 2018 (the “Aug 2018 Note”) in the aggregate principal amount of up to $100,000. The Aug 2018 Note had a maturity date of August 10, 2019, with an extension of sixty (60) months from the date of the note. The Aug 2018 Note matures on August 10, 2023. The Aug 2018 Note may be converted into shares of the Company’s common stock at a conversion price of the lesser of a) $0.005 per share or b) sixty-one (61%) percent of the lowest trading price per common stock recorded on any trade day after the effective date. The conversion feature of the Aug 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The balance of the Aug 2018 Note as of September 30, 2021 was $100,000.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 15, 2020, the Company issued a convertible promissory note (the “Apr 2020 Note”) to an investor in the aggregate principal amount of $50,000. The Company received tranches for an aggregate principal total of $50,000. The Apr 2020 Note matures twelve (12) months from the effective dates of each respective tranche, such that the Apr 2020 Note matures on April 15, 2021, with an automatic extension of sixty (60) months from the effective date of each tranche. The Apr Note is convertible into shares of common stock of the Company at a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price of the common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of four (4) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Apr 2020 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the fourth business day (inclusive of the day of the conversion) until the shares are delivered. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Apr 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $10,083 during the three months ended September 30, 2021. The balance of the Apr 2020 Note as of September 30, 2021 was $50,000.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All note conversions were performed per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Convertible Promissory Notes, net of debt discount</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">821,622</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">123,540</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total long-term liabilities</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">698,082</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> 821622 -123540 698082 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Period Ended September</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">152,800</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">888,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left">2025</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,150,800</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table><p style="margin-top: 0; margin-bottom: 0"> </p> 152800 888000 100000 10000 1150800 1150800 329178 821622 0.10 500000 500000 February 3, 2018, the investor extended the Feb 2017 Note for an additional sixty (60) months from the effective date of the note, which matures on February 3, 2022. The Feb 2017 Note is convertible into shares of common stock of the Company at a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. The Feb 2017 Note is convertible into shares of common stock of the Company at a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Feb 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. 180480692 120400 51057 187800 0.10 500000 500000 0.0499 1500 313000 0.10 500000 500000 The Jun 2018 Note matured on June 27, 2019, which was automatically extended for sixty (60) months from the effective date of the note. 103342 500000 0.10 100000 The Aug 2018 Note had a maturity date of August 10, 2019, with an extension of sixty (60) months from the date of the note. The Aug 2018 Note matures on August 10, 2023. The Aug 2018 Note may be converted into shares of the Company’s common stock at a conversion price of the lesser of a) $0.005 per share or b) sixty-one (61%) percent of the lowest trading price per common stock recorded on any trade day after the effective date. 100000 50000 50000 0.01 0.0499 2000 10083 50000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DERIVATIVE LIABILITIES</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 815 provides guidance applicable to convertible debt issued by the Company in instances where the number into which the debt can be converted is not fixed. For example, when a convertible debt converts at a discount to market based on the stock price on the date of conversion, ASC Topic 815 requires that the embedded conversion option of the convertible debt be bifurcated from the host contract and recorded at their fair value. In accounting for derivatives under accounting standards, the Company recorded a liability representing the estimated present value of the conversion feature considering the historic volatility of the Company’s stock, and a discount representing the imputed interest associated with the embedded derivative. The discount is amortized over the life of the convertible debt, and the derivative liability is adjusted periodically according to stock price fluctuations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The convertible notes (the “Notes”) issued do not have fixed settlement provisions because their conversion prices are not fixed. The conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During the three months ended September 30, 2021, the Company recorded a net gain in change in derivative of $49,352,125 in the statement of operations due to the change in fair value of the remaining notes, for the three months ended September 30, 2021. </p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At September 30, 2021, the fair value of the derivative liability was $85,895,178.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Binomial lattice formula. The significant assumptions used in the Binomial lattice formula of the derivatives are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Risk free interest rate</td><td style="width: 1%"> </td> <td style="width: 22%; text-align: center">0<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.09% - 0.35%</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock volatility factor</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153.0% - 243.0%</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Weighted average expected option life</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 months - 5 year</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-73">None</span></span></td><td style="text-align: left"> </td></tr> </table> 49352125 85895178 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Risk free interest rate</td><td style="width: 1%"> </td> <td style="width: 22%; text-align: center">0<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.09% - 0.35%</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock volatility factor</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153.0% - 243.0%</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Weighted average expected option life</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 months - 5 year</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-73">None</span></span></td><td style="text-align: left"> </td></tr> </table> 0.0035 1.53 2.43 3 5 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MARKETABLE SECURITIES</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended September 30, 2021, the Company invested in corporate bonds, which have been recognized in the financial statements at historical cost.</span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company considers corporate bonds (“bonds”) as investments due to their ratings. The bonds are rated based on their default probability, health of the corporation’s debt structure, as well as the overall health of the economy. The bonds fall into the category as investments if they have a rating between AAA and BBB.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2021, the components of the Company’s cash and short and long-term investments are summarized as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Cash</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">45,493,787</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Short term investments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 9pt">Bonds (held-to-maturity)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,580,795</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Long term investments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Bonds (held-to-maturity)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,812,647</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Total cash and short and long-term investments</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">53,887,229</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company has invested in bonds maturing from April 1, 2022 through August 16, 2023 that are held to maturity. The current trading prices or fair market value of the bonds vary, and we believe any decline in fair value is temporary. All bonds are current and not in default.</p><p style="margin-top: 0; margin-bottom: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The following table summarizes the amortized cost of the held-to-maturity bonds at September 30, 2021, aggregated by credit quality indicator.</p><p style="margin-top: 0; margin-bottom: 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Credit Quality Indicators for the Corporate Bonds</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">AA/A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,629,275</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">BBB</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,764,167</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">8,393,442</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="margin-top: 0; margin-bottom: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The amortized cost of our corporate bonds and the related gross unrealized gains and losses, were as follows at September 30, 2021:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Gross Unrealized</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Level</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Cost</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Gains</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Losses</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Fair Value</b></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"/><td style="width: 14%; text-align: left">Bonds</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 14%; text-align: center">2</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">8,393,442</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">(77,735</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">8,315,707</td><td style="width: 1%; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 2.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">During the period ended September 30, 2021, the Company recognized interest income of $11,625 in the financial statements.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Cash</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">45,493,787</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Short term investments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 9pt">Bonds (held-to-maturity)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,580,795</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Long term investments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Bonds (held-to-maturity)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,812,647</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Total cash and short and long-term investments</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">53,887,229</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> 45493787 2580795 5812647 53887229 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Credit Quality Indicators for the Corporate Bonds</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">AA/A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,629,275</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">BBB</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,764,167</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">8,393,442</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="margin-top: 0; margin-bottom: 0"> </p> 2629275 5764167 8393442 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Gross Unrealized</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Level</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Cost</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Gains</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Losses</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Fair Value</b></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"/><td style="width: 14%; text-align: left">Bonds</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 14%; text-align: center">2</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">8,393,442</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">(77,735</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">8,315,707</td><td style="width: 1%; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 2.5in"> </p> 8393442 77735 8315707 11625 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">8.</span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">COMMITMENTS AND CONTINGENCIES</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On September 15, 2020, the Company entered into a marketing agreement. The fees are to be paid in cash and registered unrestricted stock. As of September 30, 2021, the Company has paid a $34,250 deposit, with the balance of the payments and the stock issuances due upon completion of a deliverable.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective September 1, 2021, the Company entered into a new research agreement with the University of Iowa. As consideration under the research agreement, the University of Iowa will receive a maximum of $350,000 from the Company. The contract period is from September 1, 2021 through August 31, 2022. The research agreement may be terminated by either party upon sixty (60) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. This agreement was signed by the Company on September 13, 2021. As of September 30, 2021, the Company has accrued the amount due of $29,167.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective October 1, 2021, the Company entered into a research agreement with the University of Michigan. As consideration under the research agreement, the University of Michigan will receive a maximum of $296,448, from the Company. The research agreement may be terminated by either party upon ninety (90) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. This agreement was signed by the Company on September 23, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position or results of operation.</span></p> 34250 the Company entered into a new research agreement with the University of Iowa. As consideration under the research agreement, the University of Iowa will receive a maximum of $350,000 from the Company. The contract period is from September 1, 2021 through August 31, 2022. The research agreement may be terminated by either party upon sixty (60) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. This agreement was signed by the Company on September 13, 2021. As of September 30, 2021, the Company has accrued the amount due of $29,167. As consideration under the research agreement, the University of Michigan will receive a maximum of $296,448, from the Company. The research agreement may be terminated by either party upon ninety (90) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. This agreement was signed by the Company on September 23, 2021. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RELATED PARTY</span></td> </tr></table><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2021, the Company reported an accrual associated with the CEO’s prior years’ salary in the amount of $211,750, plus current accrual of $9,833 for a total of $221,583, which is recorded in accrued expenses, related party. The Company began accruing the salary in 2011 and used the funds for operating expenses. The CEO will be paid during the fiscal year.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">During the three months ended September 30, 2021, the Company redeemed 24,887,463 of the Company’s stock options to related parties for a total of $1,450,000.</p> 211750 9833 221583 24887463 1450000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUBSEQUENT EVENTS</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p><p style="margin-left: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855, and there are no events to report.</span></p> false --06-30 Q1 0001481028 0.0009 XML 10 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document And Entity Information - shares
 3 Months Ended
Sep. 30, 2021
Nov. 12, 2021
Document Information Line Items    
Entity Registrant Name SUNHYDROGEN, INC.  
Document Type 10-Q  
Current Fiscal Year End Date --06-30  
Entity Common Stock, Shares Outstanding   4,029,789,187
Amendment Flag false  
Entity Central Index Key 0001481028  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q1  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-54437  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 26-4298300  
Entity Address, Address Line One 10 E. Yanonali  
Entity Address, Address Line Two Suite 36  
Entity Address, City or Town Santa Barbara  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 93101  
City Area Code (805)  
Local Phone Number 966-6566  
Entity Interactive Data Current Yes  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2021
Jun. 30, 2021
CURRENT ASSETS    
Cash and cash equivalent $ 45,493,787 $ 56,006,555
Marketable securities 2,580,795
Prepaid expenses 9,047
TOTAL CURRENT ASSETS 48,083,629 56,006,555
LONG TERM INVESTMENTS    
Marketable securities 5,812,647
PROPERTY & EQUIPMENT    
Computers and peripherals 11,529 11,529
Vehicle 155,000 155,000
Gross property and equipment 166,529 166,529
Less: accumulated depreciation (21,356) (11,072)
NET PROPERTY AND EQUIPMENT 145,173 155,457
OTHER ASSETS    
Domain, net of amortization of $4,665 and $4,223, respectively 650 738
Trademark, net of amortization of $514 and $371, respectively 628 657
Patents, net of amortization of $24,856 and $16,250, respectively 76,287 77,928
TOTAL OTHER ASSETS 77,565 79,323
TOTAL ASSETS 54,119,014 56,241,335
CURRENT LIABILITIES    
Accounts payable 127,034 223,520
Accrued expenses 12,056 11,912
Accrued expenses, related party 221,583 214,820
Accrued interest on convertible notes 262,563 282,505
Derivative liability 85,895,178 135,247,303
Convertible promissory notes, net of debt discount of $329,178 and $409,074, respectively 123,540 125,598
TOTAL CURRENT LIABILITIES 86,641,954 136,105,658
LONG TERM LIABILITIES    
Convertible promissory notes, net of debt discount of $0 and $0, respectively 698,082 703,000
TOTAL LONG TERM LIABILITIES 698,082 703,000
TOTAL LIABILITIES 87,340,036 136,808,658
COMMIMENTS AND CONTINGENCIES (SEE NOTE 9)
SHAREHOLDERS’ DEFICIT    
Preferred Stock, $0.001 par value; 5,000,000 authorized preferred shares, no shares issued or outstanding
Common Stock, $0.001 par value; 5,000,000,000 authorized common shares 4,029,789,187 and 3,849,308,495 shares issued and outstanding, respectively 4,029,789 3,849,308
Additional Paid in Capital 87,101,297 88,560,321
Accumulated deficit (124,352,108) (172,976,952)
TOTAL SHAREHOLDERS’ DEFICIT (33,221,022) (80,567,323)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT $ 54,119,014 $ 56,241,335
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Balance Sheets (Parentheticals) - USD ($)
Sep. 30, 2021
Jun. 30, 2021
Statement of Financial Position [Abstract]    
Amortization of domain (in Dollars) $ 4,665 $ 4,223
Amortization of trademark (in Dollars) 514 371
Amortization of patents (in Dollars) 24,856 16,250
Convertible promissory notes, net of debt discount for current liabilities (in Dollars) 329,178 409,074
Convertible promissory notes, net of debt discount for long term liabilities (in Dollars) $ 0 $ 0
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 5,000,000,000 5,000,000,000
Common stock, shares issued 4,029,789,187 3,849,308,495
Common stock, shares outstanding 4,029,789,187 3,849,308,495
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Operations - USD ($)
 3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]    
REVENUE
OPERATING EXPENSES    
Selling and Marketing 109,776
General and administrative expenses 326,585 438,190
Research and development cost 151,362 138,260
Depreciation and amortization 12,043 2,036
TOTAL OPERATING EXPENSES 599,766 578,486
LOSS FROM OPERATIONS BEFORE OTHER INCOME (EXPENSES) (599,766) (578,486)
OTHER INCOME/(EXPENSES)    
Other income 17,023
Gain (Loss) on change in derivative liability 49,352,125 (1,380,085)
Interest expense (144,538) (247,689)
TOTAL OTHER INCOME (EXPENSES) 49,224,610 (1,627,774)
NET INCOME (LOSS) $ 48,624,844 $ (2,206,260)
BASIC EARNINGS (LOSS) PER SHARE (in Dollars per share) $ 0.01 $ 0
DILUTED EARNINGS (LOSS) PER SHARE (in Dollars per share) $ 0.01 $ 0
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING    
BASIC (in Shares) 4,000,362,987 2,139,179,833
DILUTED (in Dollars per share) $ 5,523,313,069 $ 2,139,179,833
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Shareholders’ Deficit - USD ($)
Preferred stock
Common stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jun. 30, 2020 $ 2,053,410 $ 11,664,657 $ (75,550,515) $ (61,832,448)
Balance (in Shares) at Jun. 30, 2020 2,053,410,161      
Issuance of common stock for conversion of debt and accrued interest $ 35,573 764,427 800,000
Issuance of common stock for conversion of debt and accrued interest (in Shares) 35,573,090      
Issuance of common stock for services $ 79,908 177,327 257,235
Issuance of common stock for services (in Shares) 79,908,088      
Issuance of common stock for services $ 2,814 85,487 88,301
Issuance of common stock for services (in Shares) 2,813,903      
Stock based compensation expense 112,035 112,035
Net Income (loss) (2,206,260) (2,206,260)
Balance at Sep. 30, 2020 $ 2,171,705 12,803,933 (77,756,775) (62,781,137)
Balance (in Shares) at Sep. 30, 2020 2,171,705,242      
Balance at Jun. 30, 2021 $ 3,849,308 88,560,321 (172,976,952) (80,567,323)
Balance (in Shares) at Jun. 30, 2021 3,849,308,495      
Issuance of common stock for conversion of debt and accrued interest $ 180,481 (9,024) 171,457
Issuance of common stock for conversion of debt and accrued interest (in Shares) 180,480,692      
Stock options redeemed by Company (1,450,000) (1,450,000)
Net Income (loss) 48,624,844 48,624,844
Balance at Sep. 30, 2021 $ 4,029,789 $ 87,101,297 $ (124,352,108) $ (33,221,022)
Balance (in Shares) at Sep. 30, 2021 4,029,789,187      
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Cash Flows - USD ($)
 3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Income (loss) $ 48,624,844 $ (2,206,260)
Adjustment to reconcile net income (loss) to net cash (used in) provided by operating activities    
Depreciation & amortization expense 12,043 2,036
Stock based compensation expense 112,035
Stock issued for services 88,301
Net (Gain) Loss on change in derivative liability (49,352,125) 1,380,085
Amortization of debt discount recorded as interest expense 113,425 199,024
Change in assets and liabilities :    
Prepaid expense (9,047) (3,167)
Accounts payable (96,486) (76,515)
Accrued expenses 6,907 11,861
Accrued interest on convertible notes 31,114 48,234
NET CASH USED IN OPERATING ACTIVITIES (669,326) (444,366)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of marketable securities (8,393,442)
Purchase of property and equipment (50,000)
NET CASH USED IN INVESTING ACTIVITIES: (8,393,442) (50,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Redemption of related parties stock options (1,450,000)
Net proceeds from common stock purchase agreements 800,000
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (1,450,000) 800,000
NET INCREASE (DECREASE) IN CASH (10,512,768) 305,634
CASH, BEGINNING OF PERIOD 56,006,555 195,010
CASH, END OF PERIOD 45,493,787 500,644
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION    
Interest paid 2,249
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS    
Fair value of common stock upon conversion of convertible notes, and accrued interest $ 171,457 $ 257,235
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Basis of Presentation
 3 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Basis of Presentation
1.Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ended June 30, 2022. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended June 30, 2021.
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies
 3 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies of SunHydrogen, Inc. is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

 

Cash and Cash Equivalent

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

 

Investments

 

The Company considers corporate bonds (“bonds”) as investments due to their ratings. The bonds are rated based on their default probability, health of the corporation’s debt structure, as well as the overall health of the economy. The bonds fall into the category as investments if they have a rating of AAA and BBB.

The bonds have varied due dates and were classified as current and noncurrent, based on to their maturity dates. The bonds are generally valued using quoted prices and are classified in Level 2 of the fair value hierarchy as prices are not always from active markets. We consider our investments held to maturity and we believe there are no other than temporary declines in fair value. Our investments are recorded at historical cost.

 

Use of Estimates

 

In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Binomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates.

 

Property and Equipment

 

Property and equipment are stated at cost and are depreciated using straight line over its estimated useful lives.

 

Computers and peripheral equipment   5 Years 
Vehicle   5 Years 

 

The Company recognized depreciation expense of $10,284 and $278 for the three months ended September 30, 2021 and 2020, respectively. 

 

Intangible Assets

 

The Company has patent applications to protect the inventions and processes behind its proprietary solar-to-hydrogen based technology. Intangible assets that have finite useful lives continue to be amortized over their useful lives.

 

The Company recognized amortization expense of $1,758 and $1,758 for the three months ended September 30, 2021 and 2020, respectively. 

 

Net Earnings (Loss) per Share Calculations

 

Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5). 

 

September 30, 2021 

 

For the three months ended September 30, 2021, the Company calculated the dilutive impact of the outstanding stock options of 157,965,711, common stock purchase warrants of 94,895,239, and the convertible debt of $1,150,800, which is convertible into shares of common stock. The stock options were not included, because their impact was antidilutive.

 

September 30, 2020

 

For the three months ended September 30, 2020, the Company calculated the dilutive impact of the outstanding stock options of 186,000,000, and the convertible debt of $1,797,000, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. 

 

Equity Incentive Plan and Stock Options

 

Equity Incentive Plan

 

On December 17, 2018, the Board of Directors approved and adopted the 2019 Equity Incentive Plan (“the Plan”), with 300,000,000 shares reserved for issuance pursuant to the Plan. The purpose of the Plan is to promote the success of the Corporation and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. The awards are performance-based compensation that are granted under the Plan as incentive stock options (ISO) or nonqualified stock options. The per share exercise price for each option shall not be less than 100% of the fair market value of a share of common stock on the date of grant of the option. The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing cost. The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date. The options are exercisable into common stock.

 

As of September 30, 2021, there were 157,965,711 stock options issued, and a reserve of 142,034,289.

 

Stock Based Compensation

 

The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date.

 

Warrant Accounting 

 

The Company accounts for the warrants to purchase shares of common stock using the estimated fair value on the date of issuance as calculated using the Black-Scholes valuation model.

 

Fair Value of Financial Instruments

 

Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized on the balance sheet, where it is practicable to estimate that value. As of September 30, 2021, the amounts reported for cash, accrued interest and other expenses, notes payables, convertible notes, and derivative liability approximate the fair value because of their short maturities.

 

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

 

●Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets.

 

●Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active.

 

●Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows on September 30, 2021 (See Note 6):

 

   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                    
Corporate bonds  $8,393,442   $
-
   $8,393,442   $
-
 
Liabilities:                    
Derivative liability measured at fair value  $85,895,178   $
-
   $
-
   $85,895,178 

 

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:

 

Balance as of June 30, 2021   135,247,303 
Gain on change in derivative liability   (49,352,125)
Balance as of September 30, 2021  $85,895,178 

 

Research and Development

 

Research and development costs are expensed as incurred. Total research and development costs were $151,362 and $138,260 for the three months ended September 30, 2021 and 2020, respectively.

 

Accounting for Derivatives

 

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates.

 

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 

Recently Issued Accounting Pronouncements

 

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements as of September 30, 2021.
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Capital Stock
 3 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]  
CAPITAL STOCK
3.CAPITAL STOCK

 

Three months ended September 30, 2021

 

During the three months ended September 30, 2021, the Company issued 180,480,692 shares of common stock upon conversion of convertible notes in the amount of $120,400 of principal, plus accrued interest of $51,057 based upon a conversion price of $0.00095 per share. The notes were converted per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded.

 

Three months ended September 30, 2020

 

During the three months ended September 30, 2020, the Company issued 35,573,090 shares of common stock for cash for aggregate gross proceeds of $800,000.

 

During the three months ended September 30, 2020, the Company issued 79,908,088 shares of common stock upon conversion of convertible notes in the amount of $233,000 in principal, plus accrued interest of $23,335 and other fees of $900 based upon conversion prices ranging from $0.00095 - $0.017995 per share. All note conversions were performed per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded.

 

During the three months ended September 30, 2020, the Company issued 2,813,903 shares of common stock for services rendered at fair value prices of $0.028 - $0.035 per share in the aggregate amount of $88,301.
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Options and Warrants
 3 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
OPTIONS AND WARRANTS
4.OPTIONS AND WARRANTS

 

As of September 30, 2020, 10,000,000 non-qualified common stock options were outstanding. Each option expires on the date specified in the option agreement, which date is not later than the fifth (5th) anniversary from the grant date of the options. Of the 10,000,000 non-qualified common stock options, one-third vest immediately, and one-third vest the second and third year, such that, the options are fully vested with a maturity date of October 2, 2022 and are exercisable at an exercise price of $0.01 per share.

 

On January 23, 2019, the Company issued 170,000,000 stock options. One-third of the options vested immediately, and the remainder vest 1/24 per month over the first twenty-four months following the option grant. The options expire 10 years from the initial grant date. The options fully vest by January 23, 2022

 

On January 31, 2019, the Company issued 6,000,000 stock options, of which two-third (2/3) vest immediately, and the remaining amount shall vest one-twelfth (1/12) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on January 31, 2020.

 

On July 22, 2019, the Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on July 22, 2020.

 

A summary of the Company’s stock option activity and related information follows:

 

   9/30/21   9/30/2020 
       Weighted       Weighted 
   Number   average   Number   average 
   Of   exercise   of   exercise 
   Options   price   Options   price 
Outstanding, beginning of period   182,853,174   $0.01    196,250,000   $0.01 
Granted   
-
   $0.01    
-
   $
-
 
Exercised   
-
    
-
    
-
    
-
 

Buyback of options

   (24,887,463)  $0.0099    (250,000)   0.01 
Outstanding, end of period   157,965,711   $0.0089    196,000,000   $0.01 
Exercisable at the end of period   157,965,711   $0.0089    174,332,250   $0.01 

 

During the three months ended September 30, 2021, the Company bought back a total of 24,887,463 of the Company’s stock options for a total of $1,450,000. The options were bought back for the market price at the date of the buy back less the exercise price of the grant similar to a cashless feature. All options that were bought back were fully vested and previously expensed accordingly.

The weighted average remaining contractual life of options outstanding as of September 30, 2021 and 2020 was as follows: 

 

9/30/2021   9/30/2020 
Exercise
Price		   Stock Options
Outstanding		   Stock Options
Exercisable		   Weighted Average Remaining
Contractual Life
(years)		   Exercise
Price		   Stock Options
Outstanding		   Stock Options
Exercisable		   Weighted Average Remaining
Contractual Life
(years)		 
$0.0100    3,071,212    3,071,212    1.01   $0.0100    10,000,000    10,000,000    2.01 
$0.0097    6,000,000    6,000,000    4.34    0.0097    6,000,000    6,000,000    5.32 
$0.0099    138,894,499    138,894,499    4.32   $0.0099    170,000,000    157,110,167    5.34 
$0.0060    10,000,000    10,000,000    4.81   $0.0060    10,000,000    7,222,083    5.81 
      157,965,711    157,965,711              196,250,000    180,332,250      

 

The stock-based compensation expense recognized in the statement of operations during the three months ended September 30, 2021 and 2020, related to the granting of these options was $0 and $112,035, respectively.

 

WARRANTS

 

As of September 30, 2021, the Company had an aggregate of 94,895,239 common stock purchase warrants outstanding, with exercise prices ranging from $0.0938 - $0.13125 per share. The warrants were estimated at fair value on the date of issuance as calculated using the Black-Scholes valuation model. The warrants can be exercised over a three (3) year period.

 

A summary of the Company’s warrant activity and related information follows for the three months ended September 30, 2021. 

 

   9/30/21 
       Weighted 
   Number   average 
   of   exercise 
   Warrants   price 
Outstanding, beginning of period   94,895,239   $0.11 
Granted   
-
    
-
 
Exercised   
-
    
-
 
Forfeited/Expired   
-
    
-
 
Outstanding, end of period   94,895,239   $0.11 
Exercisable at the end of period   94,895,239   $0.11 

 

9/30/2021   Weighted
Average
Remaining		 
Exercise
Price		   Warrants
Outstanding		   Warrants
Exercisable		   Contractual
Life (years)		 
$0.0938    16,800,000    16,800,000   1.67 - 2.25 
$0.13125    6,666,667    6,666,667   4.41 
$0.12    71,428,572    71,428,572   4.42 
      94,895,239    94,895,239     

 

At September 30, 2021, the aggregate intrinsic value of the warrants outstanding was $0.
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Convertible Promissory Notes
 3 Months Ended
Sep. 30, 2021
Debt Disclosure [Abstract]  
CONVERTIBLE PROMISSORY NOTES
5.CONVERTIBLE PROMISSORY NOTES

 

As of September 30, 2021, the outstanding convertible promissory notes net of debt discount are summarized as follows:

 

Convertible Promissory Notes, net of debt discount  $821,622 
Less current portion   123,540 
Total long-term liabilities  $698,082 

 

Maturities of long-term debt for the next four years are as follows:

 

Period Ended September  Amount 
2022  $152,800 
2023   888,000 
2024   100,000 
2025   10,000 
   $1,150,800 

 

At September 30, 2021, the $1,150,800 in convertible promissory notes had a remaining debt discount of $329,178, leaving a net balance of $821,622.

 

The Company issued a 10% convertible promissory note on February 3, 2017 (the “Feb 2017 Note”) in the aggregate principal amount of up to $500,000. The Company received tranches for an aggregate principal total of $500,000. The Feb 2017 Note had a maturity date of February 3, 2018, the investor extended the Feb 2017 Note for an additional sixty (60) months from the effective date of the note, which matures on February 3, 2022. The Feb 2017 Note is convertible into shares of common stock of the Company at a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Feb 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. During the period ended on September 30, 2021, the Company issued 180,480,692 shares of common stock upon conversion of principal in the amount of $120,400, plus accrued interest of $51,057. The balance of the Feb 2017 Note as of September 30, 2021 was $187,800.

 

The Company issued a 10% convertible promissory note on November 9, 2017 (the “Nov 2017 Note”) in the aggregate principal amount of up to $500,000. The Company received tranches for an aggregate principal total of $500,000. The Nov 2017 Note had a maturity date of November 9, 2018, with an automatic extension of sixty (60) months from the effective date of the note. The Nov 2017 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Nov 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The balance of the Nov 2017 Note as of September 30, 2021 was $313,000.

 

The Company issued a 10% convertible promissory note on June 27, 2018 (the “Jun 2018 Note”) in the aggregate principal amount of up to $500,000. The Company received tranches for an aggregate principal total of $500,000. The Jun 2018 Note matured on June 27, 2019, which was automatically extended for sixty (60) months from the effective date of the note. The Jun 2018 Note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Jun 2018 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $103,342 during the three months ended September 30, 2021. The balance of the Jun 2018 Note as of September 30, 2021 was $500,000.

 

The Company issued a 10% convertible promissory note on August 10, 2018 (the “Aug 2018 Note”) in the aggregate principal amount of up to $100,000. The Aug 2018 Note had a maturity date of August 10, 2019, with an extension of sixty (60) months from the date of the note. The Aug 2018 Note matures on August 10, 2023. The Aug 2018 Note may be converted into shares of the Company’s common stock at a conversion price of the lesser of a) $0.005 per share or b) sixty-one (61%) percent of the lowest trading price per common stock recorded on any trade day after the effective date. The conversion feature of the Aug 2018 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The balance of the Aug 2018 Note as of September 30, 2021 was $100,000.

 

On April 15, 2020, the Company issued a convertible promissory note (the “Apr 2020 Note”) to an investor in the aggregate principal amount of $50,000. The Company received tranches for an aggregate principal total of $50,000. The Apr 2020 Note matures twelve (12) months from the effective dates of each respective tranche, such that the Apr 2020 Note matures on April 15, 2021, with an automatic extension of sixty (60) months from the effective date of each tranche. The Apr Note is convertible into shares of common stock of the Company at a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price of the common stock recorded on any trade day after the effective date, or (c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of four (4) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Apr 2020 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the fourth business day (inclusive of the day of the conversion) until the shares are delivered. The conversion feature of the April 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Apr 2020 Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $10,083 during the three months ended September 30, 2021. The balance of the Apr 2020 Note as of September 30, 2021 was $50,000.

 

All note conversions were performed per the terms of their respective agreements and therefore no gain or loss on the conversion was recorded.
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Derivative Liabilities
 3 Months Ended
Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE LIABILITIES
6.DERIVATIVE LIABILITIES

 

ASC Topic 815 provides guidance applicable to convertible debt issued by the Company in instances where the number into which the debt can be converted is not fixed. For example, when a convertible debt converts at a discount to market based on the stock price on the date of conversion, ASC Topic 815 requires that the embedded conversion option of the convertible debt be bifurcated from the host contract and recorded at their fair value. In accounting for derivatives under accounting standards, the Company recorded a liability representing the estimated present value of the conversion feature considering the historic volatility of the Company’s stock, and a discount representing the imputed interest associated with the embedded derivative. The discount is amortized over the life of the convertible debt, and the derivative liability is adjusted periodically according to stock price fluctuations.

The convertible notes (the “Notes”) issued do not have fixed settlement provisions because their conversion prices are not fixed. The conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations.

 

During the three months ended September 30, 2021, the Company recorded a net gain in change in derivative of $49,352,125 in the statement of operations due to the change in fair value of the remaining notes, for the three months ended September 30, 2021.

 

At September 30, 2021, the fair value of the derivative liability was $85,895,178.

 

For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used the Binomial lattice formula. The significant assumptions used in the Binomial lattice formula of the derivatives are as follows:

 

Risk free interest rate  0.09% - 0.35% 
Stock volatility factor  153.0% - 243.0% 
Weighted average expected option life  3 months - 5 year 
Expected dividend yield  None 
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Marketable Securities
 3 Months Ended
Sep. 30, 2021
Investments, Debt and Equity Securities [Abstract]  
MARKETABLE SECURITIES
7.MARKETABLE SECURITIES

 

During the period ended September 30, 2021, the Company invested in corporate bonds, which have been recognized in the financial statements at historical cost.

 

The Company considers corporate bonds (“bonds”) as investments due to their ratings. The bonds are rated based on their default probability, health of the corporation’s debt structure, as well as the overall health of the economy. The bonds fall into the category as investments if they have a rating between AAA and BBB.

 

As of September 30, 2021, the components of the Company’s cash and short and long-term investments are summarized as follows:

 

Cash    
Cash and cash equivalents  $45,493,787 
      
Short term investments:     
Bonds (held-to-maturity)   2,580,795 
      
Long term investments:     
Bonds (held-to-maturity)   5,812,647 
Total cash and short and long-term investments  $53,887,229 

 

The Company has invested in bonds maturing from April 1, 2022 through August 16, 2023 that are held to maturity. The current trading prices or fair market value of the bonds vary, and we believe any decline in fair value is temporary. All bonds are current and not in default.

 

The following table summarizes the amortized cost of the held-to-maturity bonds at September 30, 2021, aggregated by credit quality indicator.

 

Credit Quality Indicators for the Corporate Bonds    
AA/A  $2,629,275 
BBB  $5,764,167 
Total  $8,393,442 

 

The amortized cost of our corporate bonds and the related gross unrealized gains and losses, were as follows at September 30, 2021:

 

            Gross Unrealized     
    Level   Cost   Gains   Losses   Fair Value 
Bonds    2    8,393,442    
-
    (77,735)  $8,315,707 

 

During the period ended September 30, 2021, the Company recognized interest income of $11,625 in the financial statements.
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies
 3 Months Ended
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
8.COMMITMENTS AND CONTINGENCIES

 

On September 15, 2020, the Company entered into a marketing agreement. The fees are to be paid in cash and registered unrestricted stock. As of September 30, 2021, the Company has paid a $34,250 deposit, with the balance of the payments and the stock issuances due upon completion of a deliverable.

 

Effective September 1, 2021, the Company entered into a new research agreement with the University of Iowa. As consideration under the research agreement, the University of Iowa will receive a maximum of $350,000 from the Company. The contract period is from September 1, 2021 through August 31, 2022. The research agreement may be terminated by either party upon sixty (60) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. This agreement was signed by the Company on September 13, 2021. As of September 30, 2021, the Company has accrued the amount due of $29,167.

 

Effective October 1, 2021, the Company entered into a research agreement with the University of Michigan. As consideration under the research agreement, the University of Michigan will receive a maximum of $296,448, from the Company. The research agreement may be terminated by either party upon ninety (90) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. This agreement was signed by the Company on September 23, 2021.

 

In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position or results of operation.
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party
 3 Months Ended
Sep. 30, 2021
Related Party Transactions [Abstract]  
RELATED PARTY
9.RELATED PARTY

 

As of June 30, 2021, the Company reported an accrual associated with the CEO’s prior years’ salary in the amount of $211,750, plus current accrual of $9,833 for a total of $221,583, which is recorded in accrued expenses, related party. The Company began accruing the salary in 2011 and used the funds for operating expenses. The CEO will be paid during the fiscal year.

 

During the three months ended September 30, 2021, the Company redeemed 24,887,463 of the Company’s stock options to related parties for a total of $1,450,000.
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events
 3 Months Ended
Sep. 30, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
10.SUBSEQUENT EVENTS

 

Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855, and there are no events to report.
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Accounting Policies, by Policy (Policies)
 3 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Cash and Cash Equivalent

Cash and Cash Equivalent

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

 
Investments

Investments

 

The Company considers corporate bonds (“bonds”) as investments due to their ratings. The bonds are rated based on their default probability, health of the corporation’s debt structure, as well as the overall health of the economy. The bonds fall into the category as investments if they have a rating of AAA and BBB.

The bonds have varied due dates and were classified as current and noncurrent, based on to their maturity dates. The bonds are generally valued using quoted prices and are classified in Level 2 of the fair value hierarchy as prices are not always from active markets. We consider our investments held to maturity and we believe there are no other than temporary declines in fair value. Our investments are recorded at historical cost.

 
Use of Estimates

Use of Estimates

 

In accordance with accounting principles generally accepted in the United States, management utilizes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates and assumptions relate to useful lives and impairment of tangible and intangible assets, accruals, income taxes, stock-based compensation expense, Binomial lattice valuation model inputs, derivative liabilities and other factors. Management believes it has exercised reasonable judgment in deriving these estimates. Consequently, a change in conditions could affect these estimates.

 
Property and Equipment

Property and Equipment

 

Property and equipment are stated at cost and are depreciated using straight line over its estimated useful lives.

 

Computers and peripheral equipment   5 Years 
Vehicle   5 Years 

 

The Company recognized depreciation expense of $10,284 and $278 for the three months ended September 30, 2021 and 2020, respectively. 

 
Intangible Assets

Intangible Assets

 

The Company has patent applications to protect the inventions and processes behind its proprietary solar-to-hydrogen based technology. Intangible assets that have finite useful lives continue to be amortized over their useful lives.

 

The Company recognized amortization expense of $1,758 and $1,758 for the three months ended September 30, 2021 and 2020, respectively. 

 
Net Earnings (Loss) per Share Calculations

Net Earnings (Loss) per Share Calculations

 

Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5). 

 

September 30, 2021 

 

For the three months ended September 30, 2021, the Company calculated the dilutive impact of the outstanding stock options of 157,965,711, common stock purchase warrants of 94,895,239, and the convertible debt of $1,150,800, which is convertible into shares of common stock. The stock options were not included, because their impact was antidilutive.

 

September 30, 2020

 

For the three months ended September 30, 2020, the Company calculated the dilutive impact of the outstanding stock options of 186,000,000, and the convertible debt of $1,797,000, which is convertible into shares of common stock. The stock options and convertible debt were not included in the calculation of net earnings per share, because their impact was antidilutive. 

 
Equity Incentive Plan and Stock Options

Equity Incentive Plan and Stock Options

 

Equity Incentive Plan

 

On December 17, 2018, the Board of Directors approved and adopted the 2019 Equity Incentive Plan (“the Plan”), with 300,000,000 shares reserved for issuance pursuant to the Plan. The purpose of the Plan is to promote the success of the Corporation and to increase stockholder value by providing an additional means through the grant of awards to attract, motivate, retain and reward selected employees and other eligible persons. The awards are performance-based compensation that are granted under the Plan as incentive stock options (ISO) or nonqualified stock options. The per share exercise price for each option shall not be less than 100% of the fair market value of a share of common stock on the date of grant of the option. The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing cost. The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date. The options are exercisable into common stock.

 

As of September 30, 2021, there were 157,965,711 stock options issued, and a reserve of 142,034,289.

 
Stock Based Compensation

Stock Based Compensation

 

The Company accounts for stock option grants issued and vesting to employees and non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested, and the total stock-based compensation charge is recorded in the period of the measurement date.

 
Warrant Accounting

Warrant Accounting 

 

The Company accounts for the warrants to purchase shares of common stock using the estimated fair value on the date of issuance as calculated using the Black-Scholes valuation model.

 
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

Fair value of financial instruments requires disclosure of the fair value information, whether or not recognized on the balance sheet, where it is practicable to estimate that value. As of September 30, 2021, the amounts reported for cash, accrued interest and other expenses, notes payables, convertible notes, and derivative liability approximate the fair value because of their short maturities.

 

We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

 

●Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets.

 

●Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active.

 

●Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows on September 30, 2021 (See Note 6):

 

   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                    
Corporate bonds  $8,393,442   $
-
   $8,393,442   $
-
 
Liabilities:                    
Derivative liability measured at fair value  $85,895,178   $
-
   $
-
   $85,895,178 

 

The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value:

 

Balance as of June 30, 2021   135,247,303 
Gain on change in derivative liability   (49,352,125)
Balance as of September 30, 2021  $85,895,178 

 
Research and Development

Research and Development

 

Research and development costs are expensed as incurred. Total research and development costs were $151,362 and $138,260 for the three months ended September 30, 2021 and 2020, respectively.

 
Accounting for Derivatives

Accounting for Derivatives

 

The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates.

 

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 
Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements as of September 30, 2021.
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Sep. 30, 2021
Accounting Policies [Abstract]  
Schedule of property and equipment estimated useful lives
Computers and peripheral equipment   5 Years 
Vehicle   5 Years 

 
Schedule of measurement of assets and liabilities at fair value on recurring basis
   Total   (Level 1)   (Level 2)   (Level 3) 
Assets:                    
Corporate bonds  $8,393,442   $
-
   $8,393,442   $
-
 
Liabilities:                    
Derivative liability measured at fair value  $85,895,178   $
-
   $
-
   $85,895,178 

 
Schedule of reconciliation of the derivative liability
Balance as of June 30, 2021   135,247,303 
Gain on change in derivative liability   (49,352,125)
Balance as of September 30, 2021  $85,895,178 

 
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Options and Warrants (Tables)
 3 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of the company's stock option activity and related information
   9/30/21   9/30/2020 
       Weighted       Weighted 
   Number   average   Number   average 
   Of   exercise   of   exercise 
   Options   price   Options   price 
Outstanding, beginning of period   182,853,174   $0.01    196,250,000   $0.01 
Granted   
-
   $0.01    
-
   $
-
 
Exercised   
-
    
-
    
-
    
-
 

Buyback of options

   (24,887,463)  $0.0099    (250,000)   0.01 
Outstanding, end of period   157,965,711   $0.0089    196,000,000   $0.01 
Exercisable at the end of period   157,965,711   $0.0089    174,332,250   $0.01 

 
Schedule of weighted average remaining contractual life of options outstanding
9/30/2021   9/30/2020 
Exercise
Price		   Stock Options
Outstanding		   Stock Options
Exercisable		   Weighted Average Remaining
Contractual Life
(years)		   Exercise
Price		   Stock Options
Outstanding		   Stock Options
Exercisable		   Weighted Average Remaining
Contractual Life
(years)		 
$0.0100    3,071,212    3,071,212    1.01   $0.0100    10,000,000    10,000,000    2.01 
$0.0097    6,000,000    6,000,000    4.34    0.0097    6,000,000    6,000,000    5.32 
$0.0099    138,894,499    138,894,499    4.32   $0.0099    170,000,000    157,110,167    5.34 
$0.0060    10,000,000    10,000,000    4.81   $0.0060    10,000,000    7,222,083    5.81 
      157,965,711    157,965,711              196,250,000    180,332,250      

 
Schedule of company’s warrant activity and related information
   9/30/21 
       Weighted 
   Number   average 
   of   exercise 
   Warrants   price 
Outstanding, beginning of period   94,895,239   $0.11 
Granted   
-
    
-
 
Exercised   
-
    
-
 
Forfeited/Expired   
-
    
-
 
Outstanding, end of period   94,895,239   $0.11 
Exercisable at the end of period   94,895,239   $0.11 

 
Schedule of aggregate intrinsic value of the warrants outstanding
9/30/2021   Weighted
Average
Remaining		 
Exercise
Price		   Warrants
Outstanding		   Warrants
Exercisable		   Contractual
Life (years)		 
$0.0938    16,800,000    16,800,000   1.67 - 2.25 
$0.13125    6,666,667    6,666,667   4.41 
$0.12    71,428,572    71,428,572   4.42 
      94,895,239    94,895,239     

 
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Convertible Promissory Notes (Tables)
 3 Months Ended
Sep. 30, 2021
Debt Disclosure [Abstract]  
Schedule of convertible promissory notes
Convertible Promissory Notes, net of debt discount  $821,622 
Less current portion   123,540 
Total long-term liabilities  $698,082 

 
Schedule of maturities of long-term debt
Period Ended September  Amount 
2022  $152,800 
2023   888,000 
2024   100,000 
2025   10,000 
   $1,150,800 

 
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Derivative Liabilities (Tables)
 3 Months Ended
Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of fair market value of the derivative liability
Risk free interest rate  0.09% - 0.35% 
Stock volatility factor  153.0% - 243.0% 
Weighted average expected option life  3 months - 5 year 
Expected dividend yield  None 
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Marketable Securities (Tables)
 3 Months Ended
Sep. 30, 2021
Investments, Debt and Equity Securities [Abstract]  
Schedule of cash and short and long-term investments
Cash    
Cash and cash equivalents  $45,493,787 
      
Short term investments:     
Bonds (held-to-maturity)   2,580,795 
      
Long term investments:     
Bonds (held-to-maturity)   5,812,647 
Total cash and short and long-term investments  $53,887,229 

 
Schedule of amortized cost of the held-to-maturity bonds
Credit Quality Indicators for the Corporate Bonds    
AA/A  $2,629,275 
BBB  $5,764,167 
Total  $8,393,442 

 
Schedule of gross unrealized gains and losses
            Gross Unrealized     
    Level   Cost   Gains   Losses   Fair Value 
Bonds    2    8,393,442    
-
    (77,735)  $8,315,707 

 
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details) - USD ($)
 1 Months Ended 3 Months Ended
Dec. 17, 2018
Sep. 30, 2021
Sep. 30, 2020
Summary of Significant Accounting Policies (Details) [Line Items]      
Amortization expense   $ 10,284 $ 278
Depreciation expense   1,758 1,758
Outstanding stock amount   $ 157,965,711 186,000,000
Warrants outstanding (in Shares)   94,895,239  
Convertible debt   $ 1,150,800 1,797,000
Percentage of exercise option 100.00%    
Stock options issued (in Shares)   157,965,711  
Stock options reserve (in Shares)   142,034,289  
Research and development   $ 151,362 $ 138,260
Equity Incentive Plan [Member]      
Summary of Significant Accounting Policies (Details) [Line Items]      
Issuance pursuant to the Plan (in Shares) 300,000,000    
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful lives
 3 Months Ended
Sep. 30, 2021
Computers and Peripheral Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 5 years
Vehicle [Member]  
Property, Plant and Equipment [Line Items]  
Estimated useful lives 5 years
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details) - Schedule of measurement of assets and liabilities at fair value on recurring basis - Fair value on a Recurring Basis [Member]
Sep. 30, 2021
USD ($)
Assets:  
Corporate bonds $ 8,393,442
Liabilities:  
Derivative liability measured at fair value 85,895,178
Level 1 [Member]  
Assets:  
Corporate bonds
Liabilities:  
Derivative liability measured at fair value
Level 2 [Member]  
Assets:  
Corporate bonds 8,393,442
Liabilities:  
Derivative liability measured at fair value
Level 3 [Member]  
Assets:  
Corporate bonds
Liabilities:  
Derivative liability measured at fair value $ 85,895,178
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the derivative liability - Fair Value, Inputs, Level 3 [Member]
 3 Months Ended
Sep. 30, 2021
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Beginning balance $ 135,247,303
Gain on change in derivative liability (49,352,125)
Ending balance $ 85,895,178
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Capital Stock (Details) - USD ($)
 3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Jun. 30, 2021
Capital Stock (Details) [Line Items]      
Common stock share issued (in Shares) 4,029,789,187   3,849,308,495
Common stock shares issued for services (in Shares)   2,813,903  
Aggregate amount   $ 88,301  
Common Stock [Member]      
Capital Stock (Details) [Line Items]      
Shares issued (in Shares) 180,480,692    
Convertible note principal amount $ 120,400 233,000  
Accrued interest $ 51,057 $ 23,335  
Conversion prices per share (in Dollars per share) $ 0.00095    
Common stock share issued (in Shares)   35,573,090  
Gross proceeds   $ 800,000  
Convertible promissory note amount   79,908,088  
Other fees   $ 900  
Minimum [Member] | Common Stock [Member]      
Capital Stock (Details) [Line Items]      
Conversion prices per share (in Dollars per share)   $ 0.00095  
Maximum [Member]      
Capital Stock (Details) [Line Items]      
Fair value closing market price per share (in Dollars per share)   $ 0.028  
Common stock value issued for services   $ 0.035  
Maximum [Member] | Common Stock [Member]      
Capital Stock (Details) [Line Items]      
Conversion prices per share (in Dollars per share)   $ 0.017995  
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Options and Warrants (Details) - USD ($)
 1 Months Ended 3 Months Ended
Sep. 30, 2020
Jul. 22, 2019
Jan. 31, 2019
Jan. 23, 2019
Sep. 30, 2021
Sep. 30, 2020
Options and Warrants (Details) [Line Items]            
Stock options granted        
Stock option, description   the Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on July 22, 2020. the Company issued 6,000,000 stock options, of which two-third (2/3) vest immediately, and the remaining amount shall vest one-twelfth (1/12) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on January 31, 2020.On July 22, 2019, the Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of the option grant. The options expire 10 years from the initial grant date.      
Bought back shares         24,887,463  
Stock option total         $ 1,450,000  
Stock compensation expense         $ 0 $ 112,035
Warrants purchased for a period         3 years  
Warrants outstanding         $ 0  
Warrant [Member]            
Options and Warrants (Details) [Line Items]            
Stock options granted          
Stock warrants purchased         94,895,239  
Warrant [Member] | Minimum [Member]            
Options and Warrants (Details) [Line Items]            
Warrant exercise price         $ 0.0938  
Warrant [Member] | Maximum [Member]            
Options and Warrants (Details) [Line Items]            
Warrant exercise price         $ 0.13125  
Stock Option Plan [Member]            
Options and Warrants (Details) [Line Items]            
Stock options granted 10,000,000     170,000,000    
Stock option, description Of the 10,000,000 non-qualified common stock options, one-third vest immediately, and one-third vest the second and third year, such that, the options are fully vested with a maturity date of October 2, 2022 and are exercisable at an exercise price of $0.01 per share.     One-third of the options vested immediately, and the remainder vest 1/24 per month over the first twenty-four months following the option grant. The options expire 10 years from the initial grant date. The options fully vest by January 23, 2022On January 31, 2019, the Company issued 6,000,000 stock options, of which two-third (2/3) vest immediately, and the remaining amount shall vest one-twelfth (1/12) per month from after the date of the option grant. The options expire 10 years from the initial grant date. The options fully vested on January 31, 2020. On July 22, 2019, the Company issued 10,000,000 stock options, of which one-third (1/3) vest immediately, and the remaining shall vest one-twenty fourth (1/24) per month from after the date of the option grant. The options expire 10 years from the initial grant date.    
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Options and Warrants (Details) - Schedule of the company's stock option activity and related information
 3 Months Ended
Sep. 30, 2021
$ / shares
shares
Sep. 30, 2020
$ / shares
shares
Schedule of the company's stock option activity and related information [Abstract]    
Number of Options outstanding, beginning of period | shares 182,853,174 196,250,000
Weighted average exercise price, beginning of period | $ / shares $ 0.01 $ 0.01
Number of Options Granted | shares
Weighted average exercise price Granted | $ / shares $ 0.01
Number of Options Exercised | shares
Weighted average exercise price Exercised | $ / shares
Number of Options Buyback of options | shares (24,887,463) (250,000)
Weighted average exercise price Buyback of options | $ / shares $ 0.0099 $ 0.01
Number of Options Outstanding, end of period | shares 157,965,711 196,000,000
Weighted average exercise price Outstanding, end of period | $ / shares $ 0.0089 $ 0.01
Number of Options Exercisable at the end of period | shares 157,965,711 174,332,250
Weighted average exercise price Exercisable at the end of period | $ / shares $ 0.0089 $ 0.01
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding - $ / shares
 3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding [Line Items]    
Stock Options Outstanding 157,965,711 196,250,000
Stock Options Exercisable 157,965,711 180,332,250
0.0100 [Member]    
Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding [Line Items]    
Exercise Price (in Dollars per share) $ 0.01 $ 0.01
Stock Options Outstanding 3,071,212 10,000,000
Stock Options Exercisable 3,071,212 10,000,000
Weighted Average Remaining Contractual Life (years) 1 year 3 days 2 years 3 days
0.0097 [Member]    
Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding [Line Items]    
Exercise Price (in Dollars per share) $ 0.0097 $ 0.0097
Stock Options Outstanding 6,000,000 6,000,000
Stock Options Exercisable 6,000,000 6,000,000
Weighted Average Remaining Contractual Life (years) 4 years 4 months 2 days 5 years 3 months 25 days
0.0099 [Member]    
Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding [Line Items]    
Exercise Price (in Dollars per share) $ 0.0099 $ 0.0099
Stock Options Outstanding 138,894,499 170,000,000
Stock Options Exercisable 138,894,499 157,110,167
Weighted Average Remaining Contractual Life (years) 4 years 3 months 25 days 5 years 4 months 2 days
0.0060 [Member]    
Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding [Line Items]    
Exercise Price (in Dollars per share) $ 0.006 $ 0.006
Stock Options Outstanding 10,000,000 10,000,000
Stock Options Exercisable 10,000,000 7,222,083
Weighted Average Remaining Contractual Life (years) 4 years 9 months 21 days 5 years 9 months 21 days
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Options and Warrants (Details) - Schedule of company's warrant activity and related information - Warrant [Member]
 3 Months Ended
Sep. 30, 2021
$ / shares
shares
Options and Warrants (Details) - Schedule of company's warrant activity and related information [Line Items]  
Number of Warrants, outstanding, beginning of period | shares 94,895,239
Weighted average exercise price, beginning of period | $ / shares $ 0.11
Number of Warrants, granted | shares
Weighted average exercise price, granted | $ / shares
Number of Warrants, exercised | shares
Weighted average exercise price, exercised | $ / shares
Number of Warrants, forfeited/Expired | shares
Weighted average exercise price, forfeited/Expired | $ / shares
Number of Warrants, end of period | shares 94,895,239
Weighted average exercise price, outstanding, end of period | $ / shares $ 0.11
Number of Warrants, exercisable at the end of period | shares 94,895,239
Weighted average exercise price, exercisable at the end of period | $ / shares $ 0.11
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding - Warrant [Member]
 3 Months Ended
Sep. 30, 2021
$ / shares
shares
Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding [Line Items]  
Warrants Outstanding 94,895,239
Warrants Exercisable 94,895,239
0.0938 [Member]  
Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding [Line Items]  
Exercisable Price (in Dollars per share) | $ / shares $ 0.0938
Warrants Outstanding 16,800,000
Warrants Exercisable 16,800,000
0.0938 [Member] | Minimum [Member]  
Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding [Line Items]  
Weighted Average Remaining Contractual Life (years) 1 year 8 months 1 day
0.0938 [Member] | Maximum [Member]  
Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding [Line Items]  
Weighted Average Remaining Contractual Life (years) 2 years 3 months
0.13125 [Member]  
Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding [Line Items]  
Exercisable Price (in Dollars per share) | $ / shares $ 0.13125
Warrants Outstanding 6,666,667
Warrants Exercisable 6,666,667
Weighted Average Remaining Contractual Life (years) 4 years 4 months 28 days
0.12 [Member]  
Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding [Line Items]  
Exercisable Price (in Dollars per share) | $ / shares $ 0.12
Warrants Outstanding 71,428,572
Warrants Exercisable 71,428,572
Weighted Average Remaining Contractual Life (years) 4 years 5 months 1 day
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Convertible Promissory Notes (Details) - USD ($)
 1 Months Ended 3 Months Ended
Aug. 10, 2018
Nov. 09, 2017
Feb. 03, 2017
Jun. 27, 2018
Sep. 30, 2021
Sep. 30, 2020
Apr. 15, 2020
Convertible Promissory Notes (Details) [Line Items]              
Convertible debt         $ 1,150,800 $ 1,797,000  
Convertible promissory note principal amount       $ 500,000      
Stock issued during period shares conversion of convertible securities (in Shares)         120,400    
Accrued interest         $ 51,057    
Convertible promissory note percentage   10.00%          
Recognized interest expense amount         103,342    
Convertible promissory notes [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Convertible debt         1,150,800    
Debt discount         329,178    
Net balance of convertible debt         821,622    
10% Convertible Promissory Note [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Convertible promissory note principal amount   $ 500,000          
10% Convertible Promissory Note [Member] | Feb 2017 Note [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Convertible notes, interest rate     10.00%        
Convertible promissory note principal amount     $ 500,000   187,800    
Debt instrument, maturity date description     The Feb 2017 Note is convertible into shares of common stock of the Company at a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Company fails to deliver shares in accordance with the timeframe of three (3) business days of the receipt of a notice of conversion, the lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the principal sum with the rescinded conversion shares returned to the Company. In no event shall the lender be entitled to convert any portion of the Feb 2017 Note such that would result in beneficial ownership by the lender and its affiliates of more than 4.99% of the outstanding shares of common stock of the Company. In addition, for each conversion, in the event, that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered.        
10% Convertible Promissory Note [Member] | Jan 2016 Note [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Amount received from funds     $ 500,000        
Debt instrument, maturity date description     February 3, 2018, the investor extended the Feb 2017 Note for an additional sixty (60) months from the effective date of the note, which matures on February 3, 2022. The Feb 2017 Note is convertible into shares of common stock of the Company at a variable conversion price of the lesser of $0.01 per share or fifty percent (50%) of the lowest trading price since the original effective date of the note or the lowest effective price per share granted to any person or entity after the effective date to acquire common stock.        
10% Convertible Promissory Note [Member] | Nov 2017 Note [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Convertible promissory note principal amount         313,000    
Aggregate principal amount   $ 500,000          
Percentage of beneficial ownership   4.99%          
Penalty amount   $ 1,500          
10% Convertible Promissory Note [Member] | Jun 2018 Note [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Convertible notes, interest rate       10.00%      
Convertible promissory note principal amount       $ 500,000      
Debt instrument, maturity date description       The Jun 2018 Note matured on June 27, 2019, which was automatically extended for sixty (60) months from the effective date of the note.      
10% Convertible Promissory Note [Member] | June 18, 2020 Note [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Convertible promissory note principal amount         500,000    
10% Unsecured Convertible Note [Member] | Aug 2018 Note [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Convertible notes, interest rate 10.00%            
Convertible promissory note principal amount $ 100,000            
Debt instrument, maturity date description The Aug 2018 Note had a maturity date of August 10, 2019, with an extension of sixty (60) months from the date of the note. The Aug 2018 Note matures on August 10, 2023.            
10% Unsecured Convertible Note [Member] | April 2020 Note [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Debt instrument, maturity date description The Aug 2018 Note may be converted into shares of the Company’s common stock at a conversion price of the lesser of a) $0.005 per share or b) sixty-one (61%) percent of the lowest trading price per common stock recorded on any trade day after the effective date.            
Conversion price (in Dollars per share)             $ 0.01
10% Unsecured Convertible Note [Member] | Jan 2020 [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Convertible promissory note principal amount         100,000    
10% Unsecured Convertible Note [Member] | Feb 2020 Note [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Convertible promissory note principal amount             $ 50,000
10% Unsecured Convertible Note [Member] | March 2020 [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Convertible promissory note principal amount             $ 50,000
10% Unsecured Convertible Note [Member] | April 15, 2020 [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Percentage of beneficial ownership             4.99%
Penalty amount             $ 2,000
Interest expense amount         10,083    
Convertible notes payable         $ 50,000    
Common Stock [Member]              
Convertible Promissory Notes (Details) [Line Items]              
Common stock shares Issued (in Shares)         180,480,692    
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Convertible Promissory Notes (Details) - Schedule of convertible promissory notes
Dec. 30, 2021
USD ($)
Debt Disclosure [Abstract]  
Convertible Promissory Notes, net of debt discount $ 821,622
Less current portion 123,540
Total long-term liabilities $ 698,082
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Convertible Promissory Notes (Details) - Schedule of maturities of long-term debt
Sep. 30, 2021
USD ($)
Debt Disclosure [Abstract]  
2022 $ 152,800
2023 888,000
2024 100,000
2025 10,000
Total maturities of long-term debt $ 1,150,800
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.21.2
Derivative Liabilities (Details)
 3 Months Ended
Sep. 30, 2021
USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Change in derivative liabilities $ 49,352,125
Fair value of the derivative liability $ 85,895,178
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Derivative Liabilities (Details) - Schedule of fair market value of the derivative liability
 12 Months Ended
Mar. 31, 2008
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Expected dividend yield
Minimum [Member]  
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Risk free interest rate 0.09%
Stock volatility factor 153.00%
Weighted average expected option life 3
Maximum [Member]  
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Risk free interest rate 0.35%
Stock volatility factor 243.00%
Weighted average expected option life 5
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.21.2
Marketable Securities (Details)
 3 Months Ended
Sep. 30, 2021
USD ($)
Investments, Debt and Equity Securities [Abstract]  
Interest income $ 11,625
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Marketable Securities (Details) - Schedule of cash and short and long-term investments
Sep. 30, 2021
USD ($)
Cash  
Cash and cash equivalents $ 45,493,787
Short term investments:  
Bonds (held-to-maturity) 2,580,795
Long term investments:  
Bonds (held-to-maturity) 5,812,647
Total cash and short and long-term investments $ 53,887,229
XML 49 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Marketable Securities (Details) - Schedule of amortized cost of the held-to-maturity bonds
Sep. 30, 2021
USD ($)
Marketable Securities (Details) - Schedule of amortized cost of the held-to-maturity bonds [Line Items]  
Total $ 8,393,442
AA/A [Member]  
Marketable Securities (Details) - Schedule of amortized cost of the held-to-maturity bonds [Line Items]  
Total 2,629,275
BBB [Member]  
Marketable Securities (Details) - Schedule of amortized cost of the held-to-maturity bonds [Line Items]  
Total $ 5,764,167
XML 50 R41.htm IDEA: XBRL DOCUMENT v3.21.2
Marketable Securities (Details) - Schedule of gross unrealized gains and losses - Bonds [Member] - Level 2 [Member]
 3 Months Ended
Sep. 30, 2021
USD ($)
Marketable Securities (Details) - Schedule of gross unrealized gains and losses [Line Items]  
Cost $ 8,393,442
Gross Unrealized Gains
Gross Unrealized Losses (77,735)
Fair Value $ 8,315,707
XML 51 R42.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies (Details) - USD ($)
Oct. 01, 2021
Sep. 01, 2021
Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]      
Deposits paid     $ 34,250
Research agreement, description As consideration under the research agreement, the University of Michigan will receive a maximum of $296,448, from the Company. The research agreement may be terminated by either party upon ninety (90) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. This agreement was signed by the Company on September 23, 2021. the Company entered into a new research agreement with the University of Iowa. As consideration under the research agreement, the University of Iowa will receive a maximum of $350,000 from the Company. The contract period is from September 1, 2021 through August 31, 2022. The research agreement may be terminated by either party upon sixty (60) day prior written notice or a material breach or default, which is not cured within 90 days of receipt of a written notice of such breach. This agreement was signed by the Company on September 13, 2021. As of September 30, 2021, the Company has accrued the amount due of $29,167.  
XML 52 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party (Details) - USD ($)
 1 Months Ended 3 Months Ended
Jun. 30, 2021
Sep. 30, 2021
Related Party Transactions [Abstract]    
Salary $ 211,750  
Current accrual 9,833  
Accrued expenses $ 221,583  
Aggregate redeemed option to purchase (in Shares)   24,887,463
Stock options to related parties   $ 1,450,000
EXCEL 53 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 55 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 56 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 113 324 1 false 40 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://sunhydrogen.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Balance Sheets Sheet http://sunhydrogen.com/role/ConsolidatedBalanceSheet Condensed Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Balance Sheets (Parentheticals) Sheet http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Statements of Operations Sheet http://sunhydrogen.com/role/ConsolidatedIncomeStatement Condensed Statements of Operations Statements 4 false false R5.htm 004 - Statement - Condensed Statements of Shareholders??? Deficit Sheet http://sunhydrogen.com/role/ShareholdersEquityType2or3 Condensed Statements of Shareholders??? Deficit Statements 5 false false R6.htm 005 - Statement - Condensed Statements of Cash Flows Sheet http://sunhydrogen.com/role/ConsolidatedCashFlow Condensed Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Basis of Presentation Sheet http://sunhydrogen.com/role/BasisofPresentation Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Summary of Significant Accounting Policies Sheet http://sunhydrogen.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Capital Stock Sheet http://sunhydrogen.com/role/CapitalStock Capital Stock Notes 9 false false R10.htm 009 - Disclosure - Options and Warrants Sheet http://sunhydrogen.com/role/OptionsandWarrants Options and Warrants Notes 10 false false R11.htm 010 - Disclosure - Convertible Promissory Notes Notes http://sunhydrogen.com/role/ConvertiblePromissoryNotes Convertible Promissory Notes Notes 11 false false R12.htm 011 - Disclosure - Derivative Liabilities Sheet http://sunhydrogen.com/role/DerivativeLiabilities Derivative Liabilities Notes 12 false false R13.htm 012 - Disclosure - Marketable Securities Sheet http://sunhydrogen.com/role/MarketableSecurities Marketable Securities Notes 13 false false R14.htm 013 - Disclosure - Commitments and Contingencies Sheet http://sunhydrogen.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 14 false false R15.htm 014 - Disclosure - Related Party Sheet http://sunhydrogen.com/role/RelatedParty Related Party Notes 15 false false R16.htm 015 - Disclosure - Subsequent Events Sheet http://sunhydrogen.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 016 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://sunhydrogen.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://sunhydrogen.com/role/SummaryofSignificantAccountingPolicies 17 false false R18.htm 017 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://sunhydrogen.com/role/SummaryofSignificantAccountingPolicies 18 false false R19.htm 018 - Disclosure - Options and Warrants (Tables) Sheet http://sunhydrogen.com/role/OptionsandWarrantsTables Options and Warrants (Tables) Tables http://sunhydrogen.com/role/OptionsandWarrants 19 false false R20.htm 019 - Disclosure - Convertible Promissory Notes (Tables) Notes http://sunhydrogen.com/role/ConvertiblePromissoryNotesTables Convertible Promissory Notes (Tables) Tables http://sunhydrogen.com/role/ConvertiblePromissoryNotes 20 false false R21.htm 020 - Disclosure - Derivative Liabilities (Tables) Sheet http://sunhydrogen.com/role/DerivativeLiabilitiesTables Derivative Liabilities (Tables) Tables http://sunhydrogen.com/role/DerivativeLiabilities 21 false false R22.htm 021 - Disclosure - Marketable Securities (Tables) Sheet http://sunhydrogen.com/role/MarketableSecuritiesTables Marketable Securities (Tables) Tables http://sunhydrogen.com/role/MarketableSecurities 22 false false R23.htm 022 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesTables 23 false false R24.htm 023 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful lives Sheet http://sunhydrogen.com/role/ScheduleofpropertyandequipmentestimatedusefullivesTable Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful lives Details http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesTables 24 false false R25.htm 024 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of measurement of assets and liabilities at fair value on recurring basis Sheet http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable Summary of Significant Accounting Policies (Details) - Schedule of measurement of assets and liabilities at fair value on recurring basis Details http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesTables 25 false false R26.htm 025 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the derivative liability Sheet http://sunhydrogen.com/role/ScheduleofreconciliationofthederivativeliabilityTable Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the derivative liability Details http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesTables 26 false false R27.htm 026 - Disclosure - Capital Stock (Details) Sheet http://sunhydrogen.com/role/CapitalStockDetails Capital Stock (Details) Details http://sunhydrogen.com/role/CapitalStock 27 false false R28.htm 027 - Disclosure - Options and Warrants (Details) Sheet http://sunhydrogen.com/role/OptionsandWarrantsDetails Options and Warrants (Details) Details http://sunhydrogen.com/role/OptionsandWarrantsTables 28 false false R29.htm 028 - Disclosure - Options and Warrants (Details) - Schedule of the company's stock option activity and related information Sheet http://sunhydrogen.com/role/ScheduleofthecompanysstockoptionactivityandrelatedinformationTable Options and Warrants (Details) - Schedule of the company's stock option activity and related information Details http://sunhydrogen.com/role/OptionsandWarrantsTables 29 false false R30.htm 029 - Disclosure - Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding Sheet http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding Details http://sunhydrogen.com/role/OptionsandWarrantsTables 30 false false R31.htm 030 - Disclosure - Options and Warrants (Details) - Schedule of company's warrant activity and related information Sheet http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable Options and Warrants (Details) - Schedule of company's warrant activity and related information Details http://sunhydrogen.com/role/OptionsandWarrantsTables 31 false false R32.htm 031 - Disclosure - Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding Sheet http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding Details http://sunhydrogen.com/role/OptionsandWarrantsTables 32 false false R33.htm 032 - Disclosure - Convertible Promissory Notes (Details) Notes http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails Convertible Promissory Notes (Details) Details http://sunhydrogen.com/role/ConvertiblePromissoryNotesTables 33 false false R34.htm 033 - Disclosure - Convertible Promissory Notes (Details) - Schedule of convertible promissory notes Notes http://sunhydrogen.com/role/ScheduleofconvertiblepromissorynotesTable Convertible Promissory Notes (Details) - Schedule of convertible promissory notes Details http://sunhydrogen.com/role/ConvertiblePromissoryNotesTables 34 false false R35.htm 034 - Disclosure - Convertible Promissory Notes (Details) - Schedule of maturities of long-term debt Notes http://sunhydrogen.com/role/ScheduleofmaturitiesoflongtermdebtTable Convertible Promissory Notes (Details) - Schedule of maturities of long-term debt Details http://sunhydrogen.com/role/ConvertiblePromissoryNotesTables 35 false false R36.htm 035 - Disclosure - Derivative Liabilities (Details) Sheet http://sunhydrogen.com/role/DerivativeLiabilitiesDetails Derivative Liabilities (Details) Details http://sunhydrogen.com/role/DerivativeLiabilitiesTables 36 false false R37.htm 036 - Disclosure - Derivative Liabilities (Details) - Schedule of fair market value of the derivative liability Sheet http://sunhydrogen.com/role/ScheduleoffairmarketvalueofthederivativeliabilityTable Derivative Liabilities (Details) - Schedule of fair market value of the derivative liability Details http://sunhydrogen.com/role/DerivativeLiabilitiesTables 37 false false R38.htm 037 - Disclosure - Marketable Securities (Details) Sheet http://sunhydrogen.com/role/MarketableSecuritiesDetails Marketable Securities (Details) Details http://sunhydrogen.com/role/MarketableSecuritiesTables 38 false false R39.htm 038 - Disclosure - Marketable Securities (Details) - Schedule of cash and short and long-term investments Sheet http://sunhydrogen.com/role/ScheduleofcashandshortandlongterminvestmentsTable Marketable Securities (Details) - Schedule of cash and short and long-term investments Details http://sunhydrogen.com/role/MarketableSecuritiesTables 39 false false R40.htm 039 - Disclosure - Marketable Securities (Details) - Schedule of amortized cost of the held-to-maturity bonds Sheet http://sunhydrogen.com/role/ScheduleofamortizedcostoftheheldtomaturitybondsTable Marketable Securities (Details) - Schedule of amortized cost of the held-to-maturity bonds Details http://sunhydrogen.com/role/MarketableSecuritiesTables 40 false false R41.htm 040 - Disclosure - Marketable Securities (Details) - Schedule of gross unrealized gains and losses Sheet http://sunhydrogen.com/role/ScheduleofgrossunrealizedgainsandlossesTable Marketable Securities (Details) - Schedule of gross unrealized gains and losses Details http://sunhydrogen.com/role/MarketableSecuritiesTables 41 false false R42.htm 041 - Disclosure - Commitments and Contingencies (Details) Sheet http://sunhydrogen.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://sunhydrogen.com/role/CommitmentsandContingencies 42 false false R43.htm 042 - Disclosure - Related Party (Details) Sheet http://sunhydrogen.com/role/RelatedPartyDetails Related Party (Details) Details http://sunhydrogen.com/role/RelatedParty 43 false false All Reports Book All Reports f10q0921_sunhydrogeninc.htm f10q0921ex31-1_sunhydrogen.htm f10q0921ex32-1_sunhydrogen.htm hysr-20210930.xsd hysr-20210930_cal.xml hysr-20210930_def.xml hysr-20210930_lab.xml hysr-20210930_pre.xml http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/dei/2021 true true JSON 59 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10q0921_sunhydrogeninc.htm": { "axisCustom": 0, "axisStandard": 12, "contextCount": 113, "dts": { "calculationLink": { "local": [ "hysr-20210930_cal.xml" ] }, "definitionLink": { "local": [ "hysr-20210930_def.xml" ] }, "inline": { "local": [ "f10q0921_sunhydrogeninc.htm" ] }, "labelLink": { "local": [ "hysr-20210930_lab.xml" ] }, "presentationLink": { "local": [ "hysr-20210930_pre.xml" ] }, "schema": { "local": [ "hysr-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 393, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 69, "http://sunhydrogen.com/20210930": 7, "http://xbrl.sec.gov/dei/2021": 4, "total": 80 }, "keyCustom": 54, "keyStandard": 270, "memberCustom": 27, "memberStandard": 12, "nsprefix": "hysr", "nsuri": "http://sunhydrogen.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://sunhydrogen.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Options and Warrants", "role": "http://sunhydrogen.com/role/OptionsandWarrants", "shortName": "Options and Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Convertible Promissory Notes", "role": "http://sunhydrogen.com/role/ConvertiblePromissoryNotes", "shortName": "Convertible Promissory Notes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Derivative Liabilities", "role": "http://sunhydrogen.com/role/DerivativeLiabilities", "shortName": "Derivative Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Marketable Securities", "role": "http://sunhydrogen.com/role/MarketableSecurities", "shortName": "Marketable Securities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Commitments and Contingencies", "role": "http://sunhydrogen.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Related Party", "role": "http://sunhydrogen.com/role/RelatedParty", "shortName": "Related Party", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Subsequent Events", "role": "http://sunhydrogen.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://sunhydrogen.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Options and Warrants (Tables)", "role": "http://sunhydrogen.com/role/OptionsandWarrantsTables", "shortName": "Options and Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Condensed Balance Sheets", "role": "http://sunhydrogen.com/role/ConsolidatedBalanceSheet", "shortName": "Condensed Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Convertible Promissory Notes (Tables)", "role": "http://sunhydrogen.com/role/ConvertiblePromissoryNotesTables", "shortName": "Convertible Promissory Notes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Derivative Liabilities (Tables)", "role": "http://sunhydrogen.com/role/DerivativeLiabilitiesTables", "shortName": "Derivative Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Marketable Securities (Tables)", "role": "http://sunhydrogen.com/role/MarketableSecuritiesTables", "shortName": "Marketable Securities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Summary of Significant Accounting Policies (Details)", "role": "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c33", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful lives", "role": "http://sunhydrogen.com/role/ScheduleofpropertyandequipmentestimatedusefullivesTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of property and equipment estimated useful lives", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c33", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c35", "decimals": "0", "first": true, "lang": null, "name": "hysr:CorporateBonds", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of measurement of assets and liabilities at fair value on recurring basis", "role": "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of measurement of assets and liabilities at fair value on recurring basis", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c35", "decimals": "0", "first": true, "lang": null, "name": "hysr:CorporateBonds", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c39", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the derivative liability", "role": "http://sunhydrogen.com/role/ScheduleofreconciliationofthederivativeliabilityTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of reconciliation of the derivative liability", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c39", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Capital Stock (Details)", "role": "http://sunhydrogen.com/role/CapitalStockDetails", "shortName": "Capital Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c4", "decimals": "0", "lang": null, "name": "hysr:CommonStockSharesIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c49", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Options and Warrants (Details)", "role": "http://sunhydrogen.com/role/OptionsandWarrantsDetails", "shortName": "Options and Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c49", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Options and Warrants (Details) - Schedule of the company's stock option activity and related information", "role": "http://sunhydrogen.com/role/ScheduleofthecompanysstockoptionactivityandrelatedinformationTable", "shortName": "Options and Warrants (Details) - Schedule of the company's stock option activity and related information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "hysr:AmortizationDomainOfSolar", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Condensed Balance Sheets (Parentheticals)", "role": "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Condensed Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "hysr:AmortizationDomainOfSolar", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "hysr:ScheduleOfWeightedAverageRemainingContractualLifeOfOptionsOutstandingTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding", "role": "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable", "shortName": "Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "hysr:ScheduleOfWeightedAverageRemainingContractualLifeOfOptionsOutstandingTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "hysr:ScheduleOfShareBasedCompensationWarrantStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c69", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Options and Warrants (Details) - Schedule of company's warrant activity and related information", "role": "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable", "shortName": "Options and Warrants (Details) - Schedule of company's warrant activity and related information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "hysr:ScheduleOfShareBasedCompensationWarrantStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c69", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "hysr:ScheduleOfAggregateIntrinsicValueOfTheWarrantsOutstandingTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c70", "decimals": "INF", "first": true, "lang": null, "name": "hysr:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeWarrantsOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding", "role": "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable", "shortName": "Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "hysr:ScheduleOfAggregateIntrinsicValueOfTheWarrantsOutstandingTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c70", "decimals": "INF", "first": true, "lang": null, "name": "hysr:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeWarrantsOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Convertible Promissory Notes (Details)", "role": "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails", "shortName": "Convertible Promissory Notes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c90", "decimals": "0", "lang": null, "name": "us-gaap:ConvertibleNotesPayable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c103", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleNotesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Convertible Promissory Notes (Details) - Schedule of convertible promissory notes", "role": "http://sunhydrogen.com/role/ScheduleofconvertiblepromissorynotesTable", "shortName": "Convertible Promissory Notes (Details) - Schedule of convertible promissory notes", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c103", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleNotesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Convertible Promissory Notes (Details) - Schedule of maturities of long-term debt", "role": "http://sunhydrogen.com/role/ScheduleofmaturitiesoflongtermdebtTable", "shortName": "Convertible Promissory Notes (Details) - Schedule of maturities of long-term debt", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "hysr:ChangeInDerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Derivative Liabilities (Details)", "role": "http://sunhydrogen.com/role/DerivativeLiabilitiesDetails", "shortName": "Derivative Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "hysr:ChangeInDerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c104", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Derivative Liabilities (Details) - Schedule of fair market value of the derivative liability", "role": "http://sunhydrogen.com/role/ScheduleoffairmarketvalueofthederivativeliabilityTable", "shortName": "Derivative Liabilities (Details) - Schedule of fair market value of the derivative liability", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c104", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeInterestAndDividend", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Marketable Securities (Details)", "role": "http://sunhydrogen.com/role/MarketableSecuritiesDetails", "shortName": "Marketable Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeInterestAndDividend", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Marketable Securities (Details) - Schedule of cash and short and long-term investments", "role": "http://sunhydrogen.com/role/ScheduleofcashandshortandlongterminvestmentsTable", "shortName": "Marketable Securities (Details) - Schedule of cash and short and long-term investments", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SellingAndMarketingExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Condensed Statements of Operations", "role": "http://sunhydrogen.com/role/ConsolidatedIncomeStatement", "shortName": "Condensed Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SellingAndMarketingExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "hysr:ScheduleOfAmortizedCostOfTheHeldtomaturityBondsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:HeldToMaturitySecuritiesRestricted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Marketable Securities (Details) - Schedule of amortized cost of the held-to-maturity bonds", "role": "http://sunhydrogen.com/role/ScheduleofamortizedcostoftheheldtomaturitybondsTable", "shortName": "Marketable Securities (Details) - Schedule of amortized cost of the held-to-maturity bonds", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "hysr:ScheduleOfAmortizedCostOfTheHeldtomaturityBondsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:HeldToMaturitySecuritiesRestricted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c109", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSoldAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Marketable Securities (Details) - Schedule of gross unrealized gains and losses", "role": "http://sunhydrogen.com/role/ScheduleofgrossunrealizedgainsandlossesTable", "shortName": "Marketable Securities (Details) - Schedule of gross unrealized gains and losses", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c109", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSoldAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DepositsPaidForSecuritiesBorrowedAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Commitments and Contingencies (Details)", "role": "http://sunhydrogen.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DepositsPaidForSecuritiesBorrowedAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c112", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OfficersCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Related Party (Details)", "role": "http://sunhydrogen.com/role/RelatedPartyDetails", "shortName": "Related Party (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c112", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OfficersCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Condensed Statements of Shareholders\u2019 Deficit", "role": "http://sunhydrogen.com/role/ShareholdersEquityType2or3", "shortName": "Condensed Statements of Shareholders\u2019 Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Condensed Statements of Cash Flows", "role": "http://sunhydrogen.com/role/ConsolidatedCashFlow", "shortName": "Condensed Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - Basis of Presentation", "role": "http://sunhydrogen.com/role/BasisofPresentation", "shortName": "Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Summary of Significant Accounting Policies", "role": "http://sunhydrogen.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Capital Stock", "role": "http://sunhydrogen.com/role/CapitalStock", "shortName": "Capital Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0921_sunhydrogeninc.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 40, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://sunhydrogen.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "hysr_AccruedExpenses": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include tax, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "AccruedExpenses", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedExpenses", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "hysr_AccruedExpensesRelatedParty": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "AccruedExpensesRelatedParty", "terseLabel": "Accrued expenses, related party" } } }, "localname": "AccruedExpensesRelatedParty", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "hysr_AccruedInterestOnConvertibleNotes": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount related to accrued interest on convertible notes.", "label": "AccruedInterestOnConvertibleNotes", "terseLabel": "Accrued interest on convertible notes" } } }, "localname": "AccruedInterestOnConvertibleNotes", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "hysr_AggregateAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount.", "label": "AggregateAmount", "terseLabel": "Aggregate amount" } } }, "localname": "AggregateAmount", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails" ], "xbrltype": "monetaryItemType" }, "hysr_AmortizationDomainOfSolar": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of amortization related to domain.", "label": "AmortizationDomainOfSolar", "terseLabel": "Amortization of domain (in Dollars)" } } }, "localname": "AmortizationDomainOfSolar", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "hysr_AmortizationOfTrademarks": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "AmortizationOfTrademarks", "terseLabel": "Amortization of trademark (in Dollars)" } } }, "localname": "AmortizationOfTrademarks", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "hysr_April2020NoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "April2020NoteMember", "terseLabel": "April 2020 Note [Member]" } } }, "localname": "April2020NoteMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_BuybackOfStockOptionsFromRelatedParties": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "BuybackOfStockOptionsFromRelatedParties", "negatedLabel": "Redemption of related parties stock options" } } }, "localname": "BuybackOfStockOptionsFromRelatedParties", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "hysr_CapitalStockDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capital Stock (Details) [Line Items]" } } }, "localname": "CapitalStockDetailsLineItems", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails" ], "xbrltype": "stringItemType" }, "hysr_CapitalStockDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capital Stock (Details) [Table]" } } }, "localname": "CapitalStockDetailsTable", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails" ], "xbrltype": "stringItemType" }, "hysr_CashAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CashAbstract", "terseLabel": "Cash" } } }, "localname": "CashAbstract", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcashandshortandlongterminvestmentsTable" ], "xbrltype": "stringItemType" }, "hysr_ChangeInAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ChangeInAssetsAndLiabilitiesAbstract", "terseLabel": "Change in assets and liabilities :" } } }, "localname": "ChangeInAssetsAndLiabilitiesAbstract", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "hysr_ChangeInDerivativeLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ChangeInDerivativeLiabilities", "terseLabel": "Change in derivative liabilities" } } }, "localname": "ChangeInDerivativeLiabilities", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/DerivativeLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "hysr_CommonStockSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock shares issued for services.", "label": "CommonStockSharesIssuedForServices", "terseLabel": "Common stock shares issued for services (in Shares)" } } }, "localname": "CommonStockSharesIssuedForServices", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails" ], "xbrltype": "sharesItemType" }, "hysr_CommonStockValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock value issued for services.", "label": "CommonStockValueIssuedForServices", "terseLabel": "Common stock value issued for services" } } }, "localname": "CommonStockValueIssuedForServices", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails" ], "xbrltype": "monetaryItemType" }, "hysr_ComputersAndPeripheralEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ComputersAndPeripheralEquipmentMember", "terseLabel": "Computers and Peripheral Equipment [Member]" } } }, "localname": "ComputersAndPeripheralEquipmentMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofpropertyandequipmentestimatedusefullivesTable" ], "xbrltype": "domainItemType" }, "hysr_ConvertibleLongTermNotesPayableOne": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ScheduleofconvertiblepromissorynotesTable": { "order": 2.0, "parentTag": "hysr_TotalLongtermLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "ConvertibleLongTermNotesPayableOne", "negatedLabel": "Less current portion" } } }, "localname": "ConvertibleLongTermNotesPayableOne", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofconvertiblepromissorynotesTable" ], "xbrltype": "monetaryItemType" }, "hysr_ConvertibleNotePrincipalAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Convertible note principal amount.", "label": "ConvertibleNotePrincipalAmount", "terseLabel": "Convertible note principal amount" } } }, "localname": "ConvertibleNotePrincipalAmount", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails" ], "xbrltype": "monetaryItemType" }, "hysr_ConvertiblePromissoryAprilOneNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConvertiblePromissoryAprilOneNotesMember", "terseLabel": "April 15, 2020 [Member]" } } }, "localname": "ConvertiblePromissoryAprilOneNotesMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_ConvertiblePromissoryFebNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConvertiblePromissoryFebNotesMember", "terseLabel": "Feb 2020 Note [Member]" } } }, "localname": "ConvertiblePromissoryFebNotesMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_ConvertiblePromissoryJuneOneNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConvertiblePromissoryJuneOneNotesMember", "terseLabel": "June 18, 2020 Note [Member]" } } }, "localname": "ConvertiblePromissoryJuneOneNotesMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_ConvertiblePromissoryMarchNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConvertiblePromissoryMarchNotesMember", "terseLabel": "March 2020 [Member]" } } }, "localname": "ConvertiblePromissoryMarchNotesMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_ConvertiblePromissoryMarchOneNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConvertiblePromissoryMarchOneNotesMember", "terseLabel": "Jan 2020 [Member]" } } }, "localname": "ConvertiblePromissoryMarchOneNotesMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_ConvertiblePromissoryNotePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible promissory note percentage.", "label": "ConvertiblePromissoryNotePercentage", "terseLabel": "Convertible promissory note percentage" } } }, "localname": "ConvertiblePromissoryNotePercentage", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "percentItemType" }, "hysr_ConvertiblePromissoryNotesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Promissory Notes (Details) [Line Items]" } } }, "localname": "ConvertiblePromissoryNotesDetailsLineItems", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "stringItemType" }, "hysr_ConvertiblePromissoryNotesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Promissory Notes (Details) [Table]" } } }, "localname": "ConvertiblePromissoryNotesDetailsTable", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "stringItemType" }, "hysr_ConvertiblePromissoryNotesFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConvertiblePromissoryNotesFourMember", "terseLabel": "Jan 2016 Note [Member]" } } }, "localname": "ConvertiblePromissoryNotesFourMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_ConvertiblePromissoryNotesNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConvertiblePromissoryNotesNineMember", "terseLabel": "Aug 2018 Note [Member]" } } }, "localname": "ConvertiblePromissoryNotesNineMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_ConvertiblePromissoryNotesSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConvertiblePromissoryNotesSixMember", "terseLabel": "Nov 2017 Note [Member]" } } }, "localname": "ConvertiblePromissoryNotesSixMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_ConvertiblePromissoryNotesTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConvertiblePromissoryNotesTenMember", "terseLabel": "Convertible promissory notes [Member]" } } }, "localname": "ConvertiblePromissoryNotesTenMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_ConvertiblePromissoryNotesTenPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "ConvertiblePromissoryNotesTenPercentMember", "terseLabel": "10% Convertible Promissory Note [Member]" } } }, "localname": "ConvertiblePromissoryNotesTenPercentMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_CorporateBonds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of corporate bonds.", "label": "CorporateBonds", "terseLabel": "Corporate bonds" } } }, "localname": "CorporateBonds", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable" ], "xbrltype": "monetaryItemType" }, "hysr_CorporateBondsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CorporateBondsOneMember", "terseLabel": "AA/A [Member]" } } }, "localname": "CorporateBondsOneMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofamortizedcostoftheheldtomaturitybondsTable" ], "xbrltype": "domainItemType" }, "hysr_CorporateBondsTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CorporateBondsTwoMember", "terseLabel": "BBB [Member]" } } }, "localname": "CorporateBondsTwoMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofamortizedcostoftheheldtomaturitybondsTable" ], "xbrltype": "domainItemType" }, "hysr_DebtInstrumentIncreaseAccruedInterests": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "DebtInstrumentIncreaseAccruedInterests", "terseLabel": "Accrued interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterests", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails" ], "xbrltype": "monetaryItemType" }, "hysr_DerivativesLiabilitiesCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "DerivativesLiabilitiesCurrent", "terseLabel": "Fair value of the derivative liability" } } }, "localname": "DerivativesLiabilitiesCurrent", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/DerivativeLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "hysr_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://sunhydrogen.com/20210930", "xbrltype": "stringItemType" }, "hysr_DomainNet": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net carrying amount after amortization as of balance sheet date pertaining to the solar domain.", "label": "DomainNet", "terseLabel": "Domain, net of amortization of $4,665 and $4,223, respectively" } } }, "localname": "DomainNet", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "hysr_EquityIncentiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EquityIncentiveMember", "terseLabel": "Equity Incentive Plan [Member]" } } }, "localname": "EquityIncentiveMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "hysr_EquityIncentivePlanAndStockOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Incentive Plan and Stock Options.", "label": "EquityIncentivePlanAndStockOptions", "terseLabel": "Equity Incentive Plan and Stock Options" } } }, "localname": "EquityIncentivePlanAndStockOptions", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "hysr_ExercisePriceOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisePriceOneMember", "terseLabel": "0.0938 [Member]" } } }, "localname": "ExercisePriceOneMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "hysr_ExercisePriceThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisePriceThreeMember", "terseLabel": "0.12 [Member]" } } }, "localname": "ExercisePriceThreeMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "hysr_ExercisePriceTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisePriceTwoMember", "terseLabel": "0.13125 [Member]" } } }, "localname": "ExercisePriceTwoMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "hysr_FairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value.", "label": "FairValue", "terseLabel": "Fair Value" } } }, "localname": "FairValue", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofgrossunrealizedgainsandlossesTable" ], "xbrltype": "monetaryItemType" }, "hysr_FairValueOfCommonStockUponConversionOfConvertibleNotesAccruedInterestAndOtherFees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of fair value of common stock upon conversion of convertible notes , accrued interest and other fees.", "label": "FairValueOfCommonStockUponConversionOfConvertibleNotesAccruedInterestAndOtherFees", "terseLabel": "Fair value of common stock upon conversion of convertible notes, and accrued interest" } } }, "localname": "FairValueOfCommonStockUponConversionOfConvertibleNotesAccruedInterestAndOtherFees", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "hysr_Feb2017NoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Feb2017NoteMember", "terseLabel": "Feb 2017 Note [Member]" } } }, "localname": "Feb2017NoteMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_FiniteLivedPatentsNet": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.", "label": "FiniteLivedPatentsNet", "terseLabel": "Patents, net of amortization of $24,856 and $16,250, respectively" } } }, "localname": "FiniteLivedPatentsNet", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "hysr_GrossProceeds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross proceeds.", "label": "GrossProceeds", "terseLabel": "Gross proceeds" } } }, "localname": "GrossProceeds", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails" ], "xbrltype": "monetaryItemType" }, "hysr_GrossUnrealizedGains": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.", "label": "GrossUnrealizedGains", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "GrossUnrealizedGains", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofgrossunrealizedgainsandlossesTable" ], "xbrltype": "monetaryItemType" }, "hysr_GrossUnrealizedLosses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized loss before deducting unrealized gain on investments.", "label": "GrossUnrealizedLosses", "negatedLabel": "Gross Unrealized Losses" } } }, "localname": "GrossUnrealizedLosses", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofgrossunrealizedgainsandlossesTable" ], "xbrltype": "monetaryItemType" }, "hysr_IncreaseDecreaseInAccruedInterestOnConvertibleNotes": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "IncreaseDecreaseInAccruedInterestOnConvertibleNotes", "terseLabel": "Accrued interest on convertible notes" } } }, "localname": "IncreaseDecreaseInAccruedInterestOnConvertibleNotes", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "hysr_IssuanceOfCommonStockForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock for services", "label": "IssuanceOfCommonStockForServices", "terseLabel": "Issuance of common stock for services (in Shares)" } } }, "localname": "IssuanceOfCommonStockForServices", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "hysr_IssuanceOfCommonStockForServicesValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "IssuanceOfCommonStockForServicesValue", "terseLabel": "Issuance of common stock for services" } } }, "localname": "IssuanceOfCommonStockForServicesValue", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "hysr_IssuancePursuantToPlanShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IssuancePursuantToPlanShares", "terseLabel": "Issuance pursuant to the Plan (in Shares)" } } }, "localname": "IssuancePursuantToPlanShares", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "hysr_Jun2018NoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Jun2018NoteMember", "terseLabel": "Jun 2018 Note [Member]" } } }, "localname": "Jun2018NoteMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_LessAccumulatedDepreciation": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "accumulated depreciation.", "label": "LessAccumulatedDepreciation", "terseLabel": "Less: accumulated depreciation" } } }, "localname": "LessAccumulatedDepreciation", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "hysr_MarketableSecuritiesDetailsScheduleofamortizedcostoftheheldtomaturitybondsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Marketable Securities (Details) - Schedule of amortized cost of the held-to-maturity bonds [Line Items]" } } }, "localname": "MarketableSecuritiesDetailsScheduleofamortizedcostoftheheldtomaturitybondsLineItems", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofamortizedcostoftheheldtomaturitybondsTable" ], "xbrltype": "stringItemType" }, "hysr_MarketableSecuritiesDetailsScheduleofamortizedcostoftheheldtomaturitybondsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Marketable Securities (Details) - Schedule of amortized cost of the held-to-maturity bonds [Table]" } } }, "localname": "MarketableSecuritiesDetailsScheduleofamortizedcostoftheheldtomaturitybondsTable", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofamortizedcostoftheheldtomaturitybondsTable" ], "xbrltype": "stringItemType" }, "hysr_MarketableSecuritiesDetailsScheduleofgrossunrealizedgainsandlossesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Marketable Securities (Details) - Schedule of gross unrealized gains and losses [Line Items]" } } }, "localname": "MarketableSecuritiesDetailsScheduleofgrossunrealizedgainsandlossesLineItems", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofgrossunrealizedgainsandlossesTable" ], "xbrltype": "stringItemType" }, "hysr_MarketableSecuritiesDetailsScheduleofgrossunrealizedgainsandlossesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Marketable Securities (Details) - Schedule of gross unrealized gains and losses [Table]" } } }, "localname": "MarketableSecuritiesDetailsScheduleofgrossunrealizedgainsandlossesTable", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofgrossunrealizedgainsandlossesTable" ], "xbrltype": "stringItemType" }, "hysr_OptionsandWarrantsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options and Warrants (Details) [Line Items]" } } }, "localname": "OptionsandWarrantsDetailsLineItems", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "stringItemType" }, "hysr_OptionsandWarrantsDetailsScheduleofaggregateintrinsicvalueofthewarrantsoutstandingLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding [Line Items]" } } }, "localname": "OptionsandWarrantsDetailsScheduleofaggregateintrinsicvalueofthewarrantsoutstandingLineItems", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable" ], "xbrltype": "stringItemType" }, "hysr_OptionsandWarrantsDetailsScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options and Warrants (Details) - Schedule of aggregate intrinsic value of the warrants outstanding [Table]" } } }, "localname": "OptionsandWarrantsDetailsScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable" ], "xbrltype": "stringItemType" }, "hysr_OptionsandWarrantsDetailsScheduleofcompanyswarrantactivityandrelatedinformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options and Warrants (Details) - Schedule of company's warrant activity and related information [Line Items]" } } }, "localname": "OptionsandWarrantsDetailsScheduleofcompanyswarrantactivityandrelatedinformationLineItems", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable" ], "xbrltype": "stringItemType" }, "hysr_OptionsandWarrantsDetailsScheduleofcompanyswarrantactivityandrelatedinformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options and Warrants (Details) - Schedule of company's warrant activity and related information [Table]" } } }, "localname": "OptionsandWarrantsDetailsScheduleofcompanyswarrantactivityandrelatedinformationTable", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable" ], "xbrltype": "stringItemType" }, "hysr_OptionsandWarrantsDetailsScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding [Line Items]" } } }, "localname": "OptionsandWarrantsDetailsScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingLineItems", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable" ], "xbrltype": "stringItemType" }, "hysr_OptionsandWarrantsDetailsScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options and Warrants (Details) - Schedule of weighted average remaining contractual life of options outstanding [Table]" } } }, "localname": "OptionsandWarrantsDetailsScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable" ], "xbrltype": "stringItemType" }, "hysr_OptionsandWarrantsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options and Warrants (Details) [Table]" } } }, "localname": "OptionsandWarrantsDetailsTable", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "stringItemType" }, "hysr_OutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Outstanding amount", "label": "OutstandingAmount", "terseLabel": "Outstanding stock amount" } } }, "localname": "OutstandingAmount", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "hysr_Penalty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Penalty amount.", "label": "Penalty", "terseLabel": "Penalty amount" } } }, "localname": "Penalty", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "monetaryItemType" }, "hysr_ProceedsFromConvertiblePromissoryNotes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From Convertible Promissory Notes", "label": "ProceedsFromConvertiblePromissoryNotes", "terseLabel": "Amount received from funds" } } }, "localname": "ProceedsFromConvertiblePromissoryNotes", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "monetaryItemType" }, "hysr_RangeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangeFourMember", "terseLabel": "0.0060 [Member]" } } }, "localname": "RangeFourMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "hysr_RangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range one.", "label": "RangeOneMember", "terseLabel": "0.0100 [Member]" } } }, "localname": "RangeOneMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "hysr_RangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RangeThreeMember", "terseLabel": "0.0099 [Member]" } } }, "localname": "RangeThreeMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "hysr_RangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range two.", "label": "RangeTwoMember", "terseLabel": "0.0097 [Member]" } } }, "localname": "RangeTwoMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "hysr_RecentlyIssuedAccountingPronouncementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recently issued accounting pronouncements", "label": "RecentlyIssuedAccountingPronouncementsPolicyTextBlock", "terseLabel": "Recently Issued Accounting Pronouncements" } } }, "localname": "RecentlyIssuedAccountingPronouncementsPolicyTextBlock", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "hysr_RecognizedInterestExpenseAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "RecognizedInterestExpenseAmount", "terseLabel": "Recognized interest expense amount" } } }, "localname": "RecognizedInterestExpenseAmount", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "monetaryItemType" }, "hysr_ResearchAgreementDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of research agreement.", "label": "ResearchAgreementDescription", "terseLabel": "Research agreement, description" } } }, "localname": "ResearchAgreementDescription", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "hysr_ScheduleOfAggregateIntrinsicValueOfTheWarrantsOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of aggregate intrinsic value of the warrants outstanding [Abstract]" } } }, "localname": "ScheduleOfAggregateIntrinsicValueOfTheWarrantsOutstandingAbstract", "nsuri": "http://sunhydrogen.com/20210930", "xbrltype": "stringItemType" }, "hysr_ScheduleOfAggregateIntrinsicValueOfTheWarrantsOutstandingTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for aggregate intrinsic value of the warrants outstanding.", "label": "ScheduleOfAggregateIntrinsicValueOfTheWarrantsOutstandingTableTextBlock", "terseLabel": "Schedule of aggregate intrinsic value of the warrants outstanding" } } }, "localname": "ScheduleOfAggregateIntrinsicValueOfTheWarrantsOutstandingTableTextBlock", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsTables" ], "xbrltype": "textBlockItemType" }, "hysr_ScheduleOfAmortizedCostOfTheHeldToMaturityBondsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of amortized cost of the held-to-maturity bonds [Abstract]" } } }, "localname": "ScheduleOfAmortizedCostOfTheHeldToMaturityBondsAbstract", "nsuri": "http://sunhydrogen.com/20210930", "xbrltype": "stringItemType" }, "hysr_ScheduleOfAmortizedCostOfTheHeldtomaturityBondsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of amortized cost of the held-to-maturity bonds Table Text Block.", "label": "ScheduleOfAmortizedCostOfTheHeldtomaturityBondsTableTextBlock", "terseLabel": "Schedule of amortized cost of the held-to-maturity bonds" } } }, "localname": "ScheduleOfAmortizedCostOfTheHeldtomaturityBondsTableTextBlock", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/MarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "hysr_ScheduleOfCashAndShortAndLongTermInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of cash and short and long-term investments [Abstract]" } } }, "localname": "ScheduleOfCashAndShortAndLongTermInvestmentsAbstract", "nsuri": "http://sunhydrogen.com/20210930", "xbrltype": "stringItemType" }, "hysr_ScheduleOfCompanysWarrantActivityAndRelatedInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of company's warrant activity and related information [Abstract]" } } }, "localname": "ScheduleOfCompanysWarrantActivityAndRelatedInformationAbstract", "nsuri": "http://sunhydrogen.com/20210930", "xbrltype": "stringItemType" }, "hysr_ScheduleOfFairMarketValueOfTheDerivativeLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of fair market value of the derivative liability [Abstract]" } } }, "localname": "ScheduleOfFairMarketValueOfTheDerivativeLiabilityAbstract", "nsuri": "http://sunhydrogen.com/20210930", "xbrltype": "stringItemType" }, "hysr_ScheduleOfGrossUnrealizedGainsAndLossesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of gross unrealized gains and losses [Abstract]" } } }, "localname": "ScheduleOfGrossUnrealizedGainsAndLossesAbstract", "nsuri": "http://sunhydrogen.com/20210930", "xbrltype": "stringItemType" }, "hysr_ScheduleOfMeasurementOfAssetsAndLiabilitiesAtFairValueOnRecurringBasisAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of measurement of assets and liabilities at fair value on recurring basis [Abstract]" } } }, "localname": "ScheduleOfMeasurementOfAssetsAndLiabilitiesAtFairValueOnRecurringBasisAbstract", "nsuri": "http://sunhydrogen.com/20210930", "xbrltype": "stringItemType" }, "hysr_ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of property and equipment estimated useful lives [Abstract]" } } }, "localname": "ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesAbstract", "nsuri": "http://sunhydrogen.com/20210930", "xbrltype": "stringItemType" }, "hysr_ScheduleOfReconciliationOfTheDerivativeLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of reconciliation of the derivative liability [Abstract]" } } }, "localname": "ScheduleOfReconciliationOfTheDerivativeLiabilityAbstract", "nsuri": "http://sunhydrogen.com/20210930", "xbrltype": "stringItemType" }, "hysr_ScheduleOfShareBasedCompensationWarrantStockOptionsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "ScheduleOfShareBasedCompensationWarrantStockOptionsActivityTableTextBlock", "terseLabel": "Schedule of company\u2019s warrant activity and related information" } } }, "localname": "ScheduleOfShareBasedCompensationWarrantStockOptionsActivityTableTextBlock", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsTables" ], "xbrltype": "textBlockItemType" }, "hysr_ScheduleOfTheCompanysStockOptionActivityAndRelatedInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of the company's stock option activity and related information [Abstract]" } } }, "localname": "ScheduleOfTheCompanysStockOptionActivityAndRelatedInformationAbstract", "nsuri": "http://sunhydrogen.com/20210930", "xbrltype": "stringItemType" }, "hysr_ScheduleOfWeightedAverageRemainingContractualLifeOfOptionsOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of weighted average remaining contractual life of options outstanding [Abstract]" } } }, "localname": "ScheduleOfWeightedAverageRemainingContractualLifeOfOptionsOutstandingAbstract", "nsuri": "http://sunhydrogen.com/20210930", "xbrltype": "stringItemType" }, "hysr_ScheduleOfWeightedAverageRemainingContractualLifeOfOptionsOutstandingTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfWeightedAverageRemainingContractualLifeOfOptionsOutstandingTableTextBlock", "terseLabel": "Schedule of weighted average remaining contractual life of options outstanding" } } }, "localname": "ScheduleOfWeightedAverageRemainingContractualLifeOfOptionsOutstandingTableTextBlock", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsTables" ], "xbrltype": "textBlockItemType" }, "hysr_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Weighted average exercise price Outstanding, end of period", "periodStartLabel": "Weighted average exercise price, beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofthecompanysstockoptionactivityandrelatedinformationTable" ], "xbrltype": "perShareItemType" }, "hysr_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeWarrantsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding warrants exercisable as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeWarrantsExercisable", "terseLabel": "Warrants Exercisable" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeWarrantsExercisable", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable" ], "xbrltype": "sharesItemType" }, "hysr_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeWarrantsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the warrants outstanding as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeWarrantsOutstanding", "terseLabel": "Warrants Outstanding" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeWarrantsOutstanding", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable" ], "xbrltype": "sharesItemType" }, "hysr_SharebasedCompensationSharesAuthorizedUnderWarrantsPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "SharebasedCompensationSharesAuthorizedUnderWarrantsPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance", "terseLabel": "Exercisable Price (in Dollars per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderWarrantsPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable" ], "xbrltype": "perShareItemType" }, "hysr_SharebasedCompensationSharesAuthorizedUnderWarrantsPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "SharebasedCompensationSharesAuthorizedUnderWarrantsPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm", "terseLabel": "Weighted Average Remaining Contractual Life (years)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderWarrantsPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable" ], "xbrltype": "durationItemType" }, "hysr_StockCompensationExpense": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "StockCompensationExpense", "terseLabel": "Stock compensation expense" } } }, "localname": "StockCompensationExpense", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "hysr_StockIssuedDuringPeriodStockOptionsToRelatedParties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "StockIssuedDuringPeriodStockOptionsToRelatedParties", "terseLabel": "Stock options to related parties" } } }, "localname": "StockIssuedDuringPeriodStockOptionsToRelatedParties", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/RelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "hysr_StockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "StockOptionPlanMember", "terseLabel": "Stock Option Plan [Member]" } } }, "localname": "StockOptionPlanMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "domainItemType" }, "hysr_StockOptionsReserve": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Options Reserve shares.", "label": "StockOptionsReserve", "terseLabel": "Stock options reserve (in Shares)" } } }, "localname": "StockOptionsReserve", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "hysr_StocksIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "label": "StocksIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "terseLabel": "Stock issued during period shares conversion of convertible securities (in Shares)" } } }, "localname": "StocksIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "sharesItemType" }, "hysr_SummaryofSignificantAccountingPoliciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "hysr_SummaryofSignificantAccountingPoliciesDetailsScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) - Schedule of measurement of assets and liabilities at fair value on recurring basis [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisLineItems", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable" ], "xbrltype": "stringItemType" }, "hysr_SummaryofSignificantAccountingPoliciesDetailsScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) - Schedule of measurement of assets and liabilities at fair value on recurring basis [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable" ], "xbrltype": "stringItemType" }, "hysr_SummaryofSignificantAccountingPoliciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "hysr_TotalCashAndShortAndLongtermInvestments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash and short and long-term investments.", "label": "TotalCashAndShortAndLongtermInvestments", "terseLabel": "Total cash and short and long-term investments" } } }, "localname": "TotalCashAndShortAndLongtermInvestments", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcashandshortandlongterminvestmentsTable" ], "xbrltype": "monetaryItemType" }, "hysr_TotalLongtermLiabilities": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ScheduleofconvertiblepromissorynotesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total long-term liabilities.", "label": "TotalLongtermLiabilities", "totalLabel": "Total long-term liabilities" } } }, "localname": "TotalLongtermLiabilities", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofconvertiblepromissorynotesTable" ], "xbrltype": "monetaryItemType" }, "hysr_TrademarkNet": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "TrademarkNet", "terseLabel": "Trademark, net of amortization of $514 and $371, respectively" } } }, "localname": "TrademarkNet", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "hysr_UnsecuredConvertibleNotesTenPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UnsecuredConvertibleNotesTenPercentMember", "terseLabel": "10% Unsecured Convertible Note [Member]" } } }, "localname": "UnsecuredConvertibleNotesTenPercentMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "hysr_Vehicle": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents of vehicle.", "label": "Vehicle", "terseLabel": "Vehicle" } } }, "localname": "Vehicle", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "hysr_VehicleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "VehicleMember", "terseLabel": "Vehicle [Member]" } } }, "localname": "VehicleMember", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleofpropertyandequipmentestimatedusefullivesTable" ], "xbrltype": "domainItemType" }, "hysr_WarrantAccountingPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantAccountingPolicyTextBlock", "terseLabel": "Warrant Accounting" } } }, "localname": "WarrantAccountingPolicyTextBlock", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "hysr_WeightedAverageExpectedOptionLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average expected option life.", "label": "WeightedAverageExpectedOptionLife", "terseLabel": "Weighted average expected option life" } } }, "localname": "WeightedAverageExpectedOptionLife", "nsuri": "http://sunhydrogen.com/20210930", "presentation": [ "http://sunhydrogen.com/role/ScheduleoffairmarketvalueofthederivativeliabilityTable" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r180", "r217", "r243", "r244", "r332", "r333", "r334", "r335", "r336", "r337", "r339", "r374", "r375", "r406", "r407" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails", "http://sunhydrogen.com/role/OptionsandWarrantsDetails", "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable", "http://sunhydrogen.com/role/ScheduleoffairmarketvalueofthederivativeliabilityTable" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r180", "r217", "r243", "r244", "r332", "r333", "r334", "r335", "r336", "r337", "r339", "r374", "r375", "r406", "r407" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails", "http://sunhydrogen.com/role/OptionsandWarrantsDetails", "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable", "http://sunhydrogen.com/role/ScheduleoffairmarketvalueofthederivativeliabilityTable" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r180", "r217", "r233", "r243", "r244", "r332", "r333", "r334", "r335", "r336", "r337", "r339", "r374", "r375", "r406", "r407" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails", "http://sunhydrogen.com/role/OptionsandWarrantsDetails", "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable", "http://sunhydrogen.com/role/ScheduleoffairmarketvalueofthederivativeliabilityTable" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r180", "r217", "r233", "r243", "r244", "r332", "r333", "r334", "r335", "r336", "r337", "r339", "r374", "r375", "r406", "r407" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails", "http://sunhydrogen.com/role/OptionsandWarrantsDetails", "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable", "http://sunhydrogen.com/role/ScheduleoffairmarketvalueofthederivativeliabilityTable" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccruedLiabilitiesFairValueDisclosure": { "auth_ref": [ "r39" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of accrued expenses.", "label": "Accrued Liabilities, Fair Value Disclosure", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/RelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r25", "r268", "r326" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional Paid in Capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r92", "r93", "r94", "r265", "r266", "r267", "r290" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustment to reconcile net income (loss) to net cash (used in) provided by operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r66", "r76", "r200", "r315" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of debt discount recorded as interest expense" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r76", "r153", "r156" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r88", "r128", "r131", "r137", "r147", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r274", "r279", "r306", "r324", "r326", "r347", "r362" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS", "verboseLabel": "Assets:" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet", "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r8", "r48", "r88", "r147", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r274", "r279", "r306", "r324", "r326" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "TOTAL CURRENT ASSETS" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets, excluding property, plant, and equipment and other property and investments, that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Charges and Other Assets.", "label": "Assets, Noncurrent, Other than Noncurrent Investments and Property, Plant and Equipment", "totalLabel": "TOTAL OTHER ASSETS" } } }, "localname": "AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_BondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt security, in which the authorized issuer owes the holder a debt and is obliged to repay the principal and interest (the coupon).", "label": "Bonds [Member]", "terseLabel": "Bonds [Member]" } } }, "localname": "BondsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofgrossunrealizedgainsandlossesTable" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r2", "r91", "r123" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/BasisofPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedComputerSoftwareGross": { "auth_ref": [ "r408" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.", "label": "Capitalized Computer Software, Gross", "terseLabel": "Computers and peripherals" } } }, "localname": "CapitalizedComputerSoftwareGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r30", "r326", "r382", "r383" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash and cash equivalents" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcashandshortandlongterminvestmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r30", "r78" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "CASH, END OF PERIOD", "periodStartLabel": "CASH, BEGINNING OF PERIOD" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r15", "r79" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalent" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r71", "r307" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET INCREASE (DECREASE) IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r30" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalent" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Warrant exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "periodEndLabel": "Number of Warrants, end of period", "periodStartLabel": "Number of Warrants, outstanding, beginning of period" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrants outstanding (in Shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r44", "r163", "r352", "r368" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "COMMIMENTS AND CONTINGENCIES (SEE NOTE 9)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r160", "r161", "r162", "r164", "r403" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r92", "r93", "r290" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common stock", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails", "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails", "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued", "verboseLabel": "Common stock share issued (in Shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails", "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r24", "r229" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r24", "r326" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common Stock, $0.001 par value; 5,000,000,000 authorized common shares 4,029,789,187 and 3,849,308,495 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r20", "r349", "r364" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible Debt", "terseLabel": "Convertible debt" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails", "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible Debt, Current", "terseLabel": "Convertible promissory notes, net of debt discount of $329,178 and $409,074, respectively" } } }, "localname": "ConvertibleDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Schedule of convertible promissory notes" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r43" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Noncurrent", "terseLabel": "Convertible promissory notes, net of debt discount of $0 and $0, respectively" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r20", "r349", "r363", "r384" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable", "terseLabel": "Convertible promissory note principal amount" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://sunhydrogen.com/role/ScheduleofconvertiblepromissorynotesTable": { "order": 1.0, "parentTag": "hysr_TotalLongtermLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Current", "terseLabel": "Convertible Promissory Notes, net of debt discount" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofconvertiblepromissorynotesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSoldAmortization": { "auth_ref": [ "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.", "label": "Cost, Amortization", "terseLabel": "Cost" } } }, "localname": "CostOfGoodsAndServicesSoldAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofgrossunrealizedgainsandlossesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r81", "r82" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Amount", "terseLabel": "Convertible promissory note amount", "verboseLabel": "Convertible notes payable" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails", "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionOriginalDebtAmount1": { "auth_ref": [ "r81", "r82" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Original Debt, Amount", "terseLabel": "Net balance of convertible debt" } } }, "localname": "DebtConversionOriginalDebtAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r85", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r194", "r201", "r202", "r203", "r214" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "CONVERTIBLE PROMISSORY NOTES" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r18", "r19", "r20", "r87", "r90", "r177", "r178", "r179", "r180", "r181", "r182", "r184", "r190", "r191", "r192", "r193", "r195", "r196", "r197", "r198", "r199", "r200", "r208", "r209", "r210", "r211", "r317", "r348", "r349", "r361" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r20", "r204", "r349", "r361" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r179", "r207" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price (in Dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r87" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt Instrument, Increase, Accrued Interest", "terseLabel": "Accrued interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r41", "r178" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Convertible notes, interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Debt instrument, maturity date description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r43", "r87", "r90", "r177", "r178", "r179", "r180", "r181", "r182", "r184", "r190", "r191", "r192", "r193", "r195", "r196", "r197", "r198", "r199", "r200", "r208", "r209", "r210", "r211", "r317" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": { "auth_ref": [ "r315", "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.", "label": "Debt Instrument, Unamortized Discount, Current", "terseLabel": "Convertible promissory notes, net of debt discount for current liabilities (in Dollars)" } } }, "localname": "DebtInstrumentUnamortizedDiscountCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent": { "auth_ref": [ "r315", "r318" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.", "label": "Debt Instrument, Unamortized Discount, Noncurrent", "terseLabel": "Convertible promissory notes, net of debt discount for long term liabilities (in Dollars)" } } }, "localname": "DebtInstrumentUnamortizedDiscountNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r190", "r205", "r208", "r209", "r316" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "terseLabel": "Debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "auth_ref": [ "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242" ], "lang": { "en-us": { "role": { "documentation": "Information by defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Axis]" } } }, "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DepositLiabilitiesAccruedInterest": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued but unpaid interest on deposit liabilities.", "label": "Deposit Liabilities, Accrued Interest", "terseLabel": "Interest expense amount" } } }, "localname": "DepositLiabilitiesAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsPaidForSecuritiesBorrowedAtCarryingValue": { "auth_ref": [ "r360" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This is the amount of cash advanced as security in return for borrowing securities from another party.", "label": "Deposits Paid for Securities Borrowed, at Carrying Value", "terseLabel": "Deposits paid" } } }, "localname": "DepositsPaidForSecuritiesBorrowedAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r76", "r157" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r76", "r157" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r76", "r127" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation & amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r287" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "negatedLabel": "Net (Gain) Loss on change in derivative liability", "terseLabel": "Gain on change in derivative liability" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow", "http://sunhydrogen.com/role/ScheduleofreconciliationofthederivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r289", "r293" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "DERIVATIVE LIABILITIES" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/DerivativeLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r49", "r50", "r51", "r305" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Derivative liability measured at fair value" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable", "http://sunhydrogen.com/role/ScheduleofreconciliationofthederivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r49" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative liability" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r89", "r283", "r284", "r285", "r286", "r288" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Accounting for Derivatives" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "OPTIONS AND WARRANTS" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrants" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r60", "r97", "r98", "r99", "r100", "r101", "r105", "r106", "r108", "r109", "r110", "r113", "r114", "r291", "r292", "r355", "r372" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "BASIC EARNINGS (LOSS) PER SHARE (in Dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "DILUTED EARNINGS (LOSS) PER SHARE (in Dollars per share)" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r60", "r97", "r98", "r99", "r100", "r101", "r106", "r108", "r109", "r110", "r113", "r114", "r291", "r292", "r355", "r372" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "DILUTED (in Dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r111", "r112" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Earnings (Loss) per Share Calculations" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r54", "r55", "r56", "r92", "r93", "r94", "r96", "r102", "r104", "r115", "r150", "r229", "r231", "r265", "r266", "r267", "r271", "r272", "r290", "r308", "r309", "r310", "r311", "r312", "r313", "r376", "r377", "r378", "r414" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails", "http://sunhydrogen.com/role/OptionsandWarrantsDetails", "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Percentage of beneficial ownership" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r192", "r208", "r209", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r242", "r295", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofgrossunrealizedgainsandlossesTable", "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable", "http://sunhydrogen.com/role/ScheduleofreconciliationofthederivativeliabilityTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r294", "r295", "r296", "r297", "r302" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r192", "r234", "r235", "r240", "r242", "r295", "r329" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r192", "r208", "r209", "r234", "r235", "r240", "r242", "r295", "r330" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofgrossunrealizedgainsandlossesTable", "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r192", "r208", "r209", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r242", "r295", "r331" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]", "verboseLabel": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable", "http://sunhydrogen.com/role/ScheduleofreconciliationofthederivativeliabilityTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofreconciliationofthederivativeliabilityTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r298", "r301" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofreconciliationofthederivativeliabilityTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r298", "r301" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliation of the derivative liability" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Investments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r192", "r208", "r209", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r242", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r299", "r302" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair value on a Recurring Basis [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleoffairmarketvalueofthederivativeliabilityTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r298", "r300" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleoffairmarketvalueofthederivativeliabilityTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": { "auth_ref": [ "r298", "r300" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of fair market value of the derivative liability" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/DerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r303", "r304" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r155" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Amortization of patents (in Dollars)" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r76", "r212", "r213" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "terseLabel": "Gain (Loss) on change in derivative liability" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r63" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_HeldToMaturitySecuritiesRestricted": { "auth_ref": [ "r338", "r381", "r401", "r402" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of restricted investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-maturity, Restricted", "terseLabel": "Total" } } }, "localname": "HeldToMaturitySecuritiesRestricted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofamortizedcostoftheheldtomaturitybondsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r80" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r75" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r75" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r75" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expense" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r84", "r154", "r341", "r342", "r343", "r345" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r57", "r126", "r314", "r316", "r356" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r69", "r72", "r80" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterestAndDividend": { "auth_ref": [ "r64" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Interest and Dividend", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterestAndDividend", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/MarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTableTextBlock": { "auth_ref": [ "r144", "r145", "r148", "r149" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment.", "label": "Investment [Table Text Block]", "terseLabel": "Schedule of cash and short and long-term investments" } } }, "localname": "InvestmentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/MarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofamortizedcostoftheheldtomaturitybondsTable", "http://sunhydrogen.com/role/ScheduleofgrossunrealizedgainsandlossesTable" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofamortizedcostoftheheldtomaturitybondsTable" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r144", "r346", "r358", "r400", "r412" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "terseLabel": "MARKETABLE SECURITIES" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/MarketableSecurities" ], "xbrltype": "textBlockItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r76" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Issuance of Stock and Warrants for Services or Claims", "terseLabel": "Stock issued for services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r37", "r88", "r132", "r147", "r166", "r167", "r168", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r275", "r279", "r280", "r306", "r324", "r325" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmeasurementofassetsandliabilitiesatfairvalueonrecurringbasisTable" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r29", "r88", "r147", "r306", "r326", "r350", "r366" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r40", "r88", "r147", "r166", "r167", "r168", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r275", "r279", "r280", "r306", "r324", "r325", "r326" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "TOTAL CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r12", "r13", "r14", "r20", "r21", "r88", "r147", "r166", "r167", "r168", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r275", "r279", "r280", "r306", "r324", "r325" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "TOTAL LONG TERM LIABILITIES" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "LONG TERM LIABILITIES" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r20", "r191", "r206", "r208", "r209", "r349", "r364" ], "calculation": { "http://sunhydrogen.com/role/ScheduleofmaturitiesoflongtermdebtTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Total maturities of long-term debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmaturitiesoflongtermdebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r90", "r165", "r196" ], "calculation": { "http://sunhydrogen.com/role/ScheduleofmaturitiesoflongtermdebtTable": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmaturitiesoflongtermdebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r90", "r165", "r196" ], "calculation": { "http://sunhydrogen.com/role/ScheduleofmaturitiesoflongtermdebtTable": { "order": 4.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Five", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmaturitiesoflongtermdebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r90", "r165", "r196" ], "calculation": { "http://sunhydrogen.com/role/ScheduleofmaturitiesoflongtermdebtTable": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmaturitiesoflongtermdebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r90", "r165", "r196" ], "calculation": { "http://sunhydrogen.com/role/ScheduleofmaturitiesoflongtermdebtTable": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofmaturitiesoflongtermdebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term Investments [Abstract]", "terseLabel": "LONG TERM INVESTMENTS", "verboseLabel": "Long term investments:" } } }, "localname": "LongTermInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet", "http://sunhydrogen.com/role/ScheduleofcashandshortandlongterminvestmentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "auth_ref": [ "r163" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Current", "terseLabel": "Current accrual" } } }, "localname": "LossContingencyAccrualCarryingValueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/RelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [ "r4", "r38" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable Securities, Current", "terseLabel": "Marketable securities" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesNoncurrent": { "auth_ref": [ "r31" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as noncurrent.", "label": "Marketable Securities, Noncurrent", "terseLabel": "Marketable securities" } } }, "localname": "MarketableSecuritiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r71" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r71" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r71", "r74", "r77" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "NET CASH USED IN OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r52", "r53", "r56", "r59", "r77", "r88", "r95", "r97", "r98", "r99", "r100", "r103", "r104", "r107", "r128", "r130", "r133", "r136", "r138", "r147", "r166", "r167", "r168", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r292", "r306", "r354", "r371" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "NET INCOME (LOSS)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r52", "r53", "r56", "r103", "r104", "r277", "r281" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Net Income (loss)" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r65" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "TOTAL OTHER INCOME (EXPENSES)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "OTHER INCOME/(EXPENSES)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_OfficersCompensation": { "auth_ref": [ "r61" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Salary and Wage, Officer, Excluding Cost of Good and Service Sold", "terseLabel": "Salary" } } }, "localname": "OfficersCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/RelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "TOTAL OPERATING EXPENSES" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "OPERATING EXPENSES" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r128", "r130", "r133", "r136", "r138" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "LOSS FROM OPERATIONS BEFORE OTHER INCOME (EXPENSES)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r9", "r10", "r11", "r39" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Accounts payable" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets [Abstract]", "terseLabel": "OTHER ASSETS" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r373" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other Income", "terseLabel": "Other income" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermInvestments": { "auth_ref": [ "r31", "r369" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term investments classified as other.", "label": "Other Long-term Investments", "terseLabel": "Bonds (held-to-maturity)" } } }, "localname": "OtherLongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcashandshortandlongterminvestmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherShortTermInvestments": { "auth_ref": [ "r47", "r353", "r370" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term investments classified as other.", "label": "Other Short-term Investments", "terseLabel": "Bonds (held-to-maturity)" } } }, "localname": "OtherShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcashandshortandlongterminvestmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForFees": { "auth_ref": [ "r73" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for fees classified as other.", "label": "Payments for Other Fees", "terseLabel": "Other fees" } } }, "localname": "PaymentsForFees", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r143" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchase of marketable securities" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r67" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanAssetCategoriesDomain": { "auth_ref": [ "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242" ], "lang": { "en-us": { "role": { "documentation": "Defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Domain]" } } }, "localname": "PlanAssetCategoriesDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r245", "r264" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r23", "r215" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r23", "r215" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r23", "r326" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred Stock, $0.001 par value; 5,000,000 authorized preferred shares, no shares issued or outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r5", "r7", "r151", "r152" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherDebt": { "auth_ref": [ "r68" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from debt classified as other.", "label": "Proceeds from Other Debt", "terseLabel": "Net proceeds from common stock purchase agreements" } } }, "localname": "ProceedsFromOtherDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r52", "r53", "r56", "r70", "r88", "r95", "r103", "r104", "r128", "r130", "r133", "r136", "r138", "r147", "r166", "r167", "r168", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r273", "r276", "r278", "r281", "r282", "r292", "r306", "r357" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "negatedLabel": "Net Income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r34", "r159" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofpropertyandequipmentestimatedusefullivesTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r33", "r158" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "totalLabel": "Gross property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofpropertyandequipmentestimatedusefullivesTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r16", "r17", "r159", "r326", "r359", "r367" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "NET PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net [Abstract]", "terseLabel": "PROPERTY & EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r32", "r159", "r404", "r405" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r16", "r159" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of property and equipment estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofpropertyandequipmentestimatedusefullivesTable" ], "xbrltype": "durationItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r319", "r320", "r321", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/RelatedParty" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r270", "r340", "r408" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development cost" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentInProcess": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.", "label": "Research and Development in Process", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentInProcess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r26", "r231", "r268", "r326", "r365", "r379", "r380" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r92", "r93", "r94", "r96", "r102", "r104", "r150", "r265", "r266", "r267", "r271", "r272", "r290", "r376", "r378" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r58", "r88", "r124", "r125", "r129", "r134", "r135", "r139", "r140", "r141", "r147", "r166", "r167", "r168", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r306", "r357" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "REVENUE" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r294", "r295" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of measurement of assets and liabilities at fair value on recurring basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r165" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]", "terseLabel": "Schedule of maturities of long-term debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r34", "r159" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofpropertyandequipmentestimatedusefullivesTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r248", "r256", "r257" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of the company's stock option activity and related information" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://sunhydrogen.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Selling and Marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r75" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Warrants purchased for a period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price", "terseLabel": "Conversion prices per share (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleoffairmarketvalueofthederivativeliabilityTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Stock volatility factor" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleoffairmarketvalueofthederivativeliabilityTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleoffairmarketvalueofthederivativeliabilityTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations", "negatedLabel": "Number of Options Buyback of options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofthecompanysstockoptionactivityandrelatedinformationTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted", "terseLabel": "Stock warrants purchased" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Number of Options Exercisable at the end of period", "verboseLabel": "Number of Warrants, exercisable at the end of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable", "http://sunhydrogen.com/role/ScheduleofthecompanysstockoptionactivityandrelatedinformationTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price Exercisable at the end of period", "verboseLabel": "Weighted average exercise price, exercisable at the end of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable", "http://sunhydrogen.com/role/ScheduleofthecompanysstockoptionactivityandrelatedinformationTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "terseLabel": "Number of Warrants, forfeited/Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price Buyback of options", "verboseLabel": "Weighted average exercise price, forfeited/Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable", "http://sunhydrogen.com/role/ScheduleofthecompanysstockoptionactivityandrelatedinformationTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "netLabel": "Stock options granted", "terseLabel": "Number of Options Granted", "verboseLabel": "Number of Warrants, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails", "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable", "http://sunhydrogen.com/role/ScheduleofthecompanysstockoptionactivityandrelatedinformationTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r250", "r264" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Number of Options Outstanding, end of period", "periodStartLabel": "Number of Options outstanding, beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofthecompanysstockoptionactivityandrelatedinformationTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price, outstanding, end of period", "periodStartLabel": "Weighted average exercise price, beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms", "terseLabel": "Stock option, description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price Exercised", "verboseLabel": "Weighted average exercise price, exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable", "http://sunhydrogen.com/role/ScheduleofthecompanysstockoptionactivityandrelatedinformationTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price Granted", "verboseLabel": "Weighted average exercise price, granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable", "http://sunhydrogen.com/role/ScheduleofthecompanysstockoptionactivityandrelatedinformationTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r245", "r247" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable", "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable", "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r255" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Stock Options Exercisable" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "terseLabel": "Stock Options Outstanding" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Percentage of exercise option" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "terseLabel": "Exercise Price (in Dollars per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Life (years)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofweightedaverageremainingcontractuallifeofoptionsoutstandingTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Shares issued (in Shares)", "verboseLabel": "Common stock shares Issued (in Shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails", "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Fair value closing market price per share (in Dollars per share)" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Short-term Investments [Abstract]", "terseLabel": "Short term investments:" } } }, "localname": "ShortTermInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcashandshortandlongterminvestmentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r83", "r91" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r46", "r54", "r55", "r56", "r92", "r93", "r94", "r96", "r102", "r104", "r115", "r150", "r229", "r231", "r265", "r266", "r267", "r271", "r272", "r290", "r308", "r309", "r310", "r311", "r312", "r313", "r376", "r377", "r378", "r414" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStockDetails", "http://sunhydrogen.com/role/OptionsandWarrantsDetails", "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable", "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable", "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r92", "r93", "r94", "r115", "r344" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r45", "r195", "r229", "r230", "r231" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Issuance of common stock for conversion of debt and accrued interest (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Issuance of common stock for services (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Shares, Other", "terseLabel": "Stock options issued (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r23", "r24", "r229", "r231", "r253" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "terseLabel": "Number of Options Exercised", "verboseLabel": "Number of Warrants, exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable", "http://sunhydrogen.com/role/ScheduleofthecompanysstockoptionactivityandrelatedinformationTable" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r46", "r229", "r231" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Issuance of common stock for conversion of debt and accrued interest" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Issuance of common stock for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture", "terseLabel": "Stock based compensation expense" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodValue": { "auth_ref": [ "r229" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Value", "terseLabel": "Stock options redeemed by Company" } } }, "localname": "StockRedeemedOrCalledDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r23", "r24", "r229", "r231" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "terseLabel": "Bought back shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r23", "r24", "r229", "r231" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "terseLabel": "Stock option total" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r24", "r27", "r28", "r88", "r142", "r147", "r306", "r326" ], "calculation": { "http://sunhydrogen.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "TOTAL SHAREHOLDERS\u2019 DEFICIT" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet", "http://sunhydrogen.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "SHAREHOLDERS\u2019 DEFICIT" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r86", "r216", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r231", "r232" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "CAPITAL STOCK" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/CapitalStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r327", "r328" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConvertiblePromissoryNotesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityShareSubscriptions": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been allocated to investors to buy. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Share Subscriptions", "terseLabel": "Aggregate redeemed option to purchase (in Shares)" } } }, "localname": "TemporaryEquityShareSubscriptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/RelatedPartyDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of unrealized gains and losses on investments.", "label": "Unrealized Gain (Loss) on Investments [Table Text Block]", "terseLabel": "Schedule of gross unrealized gains and losses" } } }, "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/MarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r116", "r117", "r118", "r119", "r120", "r121", "r122" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails", "http://sunhydrogen.com/role/ScheduleofaggregateintrinsicvalueofthewarrantsoutstandingTable", "http://sunhydrogen.com/role/ScheduleofcompanyswarrantactivityandrelatedinformationTable" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants and Rights Outstanding", "terseLabel": "Warrants outstanding" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/OptionsandWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r105", "r110" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "BASIC (in Shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://sunhydrogen.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562" }, "r144": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r145": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "321", "URI": "http://asc.fasb.org/topic&trid=75115024" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r148": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r149": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "325", "URI": "http://asc.fasb.org/topic&trid=2197064" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r162": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r164": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r232": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r269": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r293": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r323": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r328": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r346": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "http://asc.fasb.org/subtopic&trid=2176304" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.5)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r358": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/subtopic&trid=2209399" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(f))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.2)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=123726495&loc=d3e600178-122990" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "http://asc.fasb.org/subtopic&trid=2324412" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r409": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r411": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r412": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1403" }, "r413": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r91": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" } }, "version": "2.1" } ZIP 60 0001213900-21-059367-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-21-059367-xbrl.zip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